{
  "data": {
    "type": "predisposition_risk",
    "data": [
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z41.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z41.0*  - TRANSPLANT MARROW BONE",
        "rr": 44.74,
        "risk_count": 3295,
        "predisposition_and_risk": 165,
        "risk_duration": 28784076,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z41.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z41.0*  - TRANSPLANT MARROW BONE",
        "rr": 42.14,
        "risk_count": 3947,
        "predisposition_and_risk": 202,
        "risk_duration": 23233925,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V42.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V42.8* OTHER SPECIFIED ORGAN OR TISSUE REPLACED BY TRANSPLANT",
        "rr": 33.62,
        "risk_count": 2264,
        "predisposition_and_risk": 92,
        "risk_duration": 23348707,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V42.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V42.8* OTHER SPECIFIED ORGAN OR TISSUE REPLACED BY TRANSPLANT",
        "rr": 29.89,
        "risk_count": 1234,
        "predisposition_and_risk": 41,
        "risk_duration": 28981501,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.6* PERIPHERAL RETINAL DEGENERATIONS",
        "rr": 29.54,
        "risk_count": 732,
        "predisposition_and_risk": 26,
        "risk_duration": 23470221,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z78.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z78.0* BONE GRAFT",
        "rr": 28.87,
        "risk_count": 531,
        "predisposition_and_risk": 17,
        "risk_duration": 29049292,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_893_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "893 OPEN WOUND OF TOE(S)",
        "rr": 25.08,
        "risk_count": 969,
        "predisposition_and_risk": 27,
        "risk_duration": 29002511,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V48.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V48.4* SENSORY PROBLEM WITH HEAD",
        "rr": 24.43,
        "risk_count": 375,
        "predisposition_and_risk": 11,
        "risk_duration": 23504701,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z41.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z41.3* DIAGNOSTIC PROCEDURES ON BONE MARROW AND SPLEEN",
        "rr": 19.92,
        "risk_count": 1445,
        "predisposition_and_risk": 32,
        "risk_duration": 28982881,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_277.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "277.3* AMYLOIDOSIS",
        "rr": 17.78,
        "risk_count": 9461,
        "predisposition_and_risk": 209,
        "risk_duration": 22711977,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_719.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "719.7* DIFFICULTY IN WALKING",
        "rr": 17.14,
        "risk_count": 1576,
        "predisposition_and_risk": 30,
        "risk_duration": 29009547,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_336.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "336.9* UNSPECIFIED DISEASE OF SPINAL CORD",
        "rr": 16.91,
        "risk_count": 738,
        "predisposition_and_risk": 15,
        "risk_duration": 23477407,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_733.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "733.1* PATHOLOGICAL FRACTURE",
        "rr": 15.35,
        "risk_count": 1835,
        "predisposition_and_risk": 34,
        "risk_duration": 23378536,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_455.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "455.8* UNSPECIFIED HEMORRHOIDS WITH OTHER COMPLICATION",
        "rr": 14.48,
        "risk_count": 632,
        "predisposition_and_risk": 11,
        "risk_duration": 23474522,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_383.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "383.3* COMPLICATIONS FOLLOWING MASTOIDECTOMY",
        "rr": 13.2,
        "risk_count": 751,
        "predisposition_and_risk": 11,
        "risk_duration": 29034123,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z41.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z41.3* DIAGNOSTIC PROCEDURES ON BONE MARROW AND SPLEEN",
        "rr": 13.03,
        "risk_count": 1529,
        "predisposition_and_risk": 24,
        "risk_duration": 23418070,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_847.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "847.2* LUMBAR SPRAIN",
        "rr": 11.93,
        "risk_count": 1868,
        "predisposition_and_risk": 27,
        "risk_duration": 23287901,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_277.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "277.3* AMYLOIDOSIS",
        "rr": 11.12,
        "risk_count": 10327,
        "predisposition_and_risk": 132,
        "risk_duration": 28025172,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_332.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "332.1* SECONDARY PARKINSONISM",
        "rr": 10.96,
        "risk_count": 2705,
        "predisposition_and_risk": 33,
        "risk_duration": 28938810,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z06.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z06.4* COMPLETE THYROIDECTOMY",
        "rr": 10.7,
        "risk_count": 1475,
        "predisposition_and_risk": 19,
        "risk_duration": 23429939,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_377.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "377.0* PAPILLEDEMA",
        "rr": 10.66,
        "risk_count": 1181,
        "predisposition_and_risk": 14,
        "risk_duration": 28960705,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_F45.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F45.0* SOMATIZATION DISORDER",
        "rr": 10.65,
        "risk_count": 1268,
        "predisposition_and_risk": 15,
        "risk_duration": 28993933,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z81.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z81.6* OTHER ARTHROPLASTY OF HIP",
        "rr": 10.36,
        "risk_count": 1390,
        "predisposition_and_risk": 16,
        "risk_duration": 29000379,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_733.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "733.1* PATHOLOGICAL FRACTURE",
        "rr": 10.2,
        "risk_count": 4207,
        "predisposition_and_risk": 48,
        "risk_duration": 28793115,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_444_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "444 ARTERIAL EMBOLISM AND THROMBOSIS",
        "rr": 9.88,
        "risk_count": 1260,
        "predisposition_and_risk": 15,
        "risk_duration": 23425935,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_731.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "731.0* OSTEITIS DEFORMANS, PAGET'S DISEASE OF BONE",
        "rr": 9.64,
        "risk_count": 1894,
        "predisposition_and_risk": 22,
        "risk_duration": 23426753,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_273.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "273.0* POLYCLONAL HYPERGAMMAGLOBULINEMIA",
        "rr": 9.38,
        "risk_count": 1440,
        "predisposition_and_risk": 15,
        "risk_duration": 29003176,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_474.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "474.0* CHRONIC TONSILLITIS",
        "rr": 9.17,
        "risk_count": 1078,
        "predisposition_and_risk": 11,
        "risk_duration": 28939055,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_595.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "595.0* ACUTE CYSTITIS",
        "rr": 8.56,
        "risk_count": 1068,
        "predisposition_and_risk": 11,
        "risk_duration": 23449285,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_378.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "378.0* ESOTROPIA",
        "rr": 8.45,
        "risk_count": 4440,
        "predisposition_and_risk": 42,
        "risk_duration": 28765089,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z51.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z51.1* DIAGNOSTIC PROCEDURES ON BILIARY TRACT",
        "rr": 8.05,
        "risk_count": 1899,
        "predisposition_and_risk": 17,
        "risk_duration": 28965432,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_682.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "682.3* CELLULITIS AND ABSCESS OF UPPER ARM AND FOREARM",
        "rr": 7.95,
        "risk_count": 1581,
        "predisposition_and_risk": 14,
        "risk_duration": 28930384,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_284.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "284.1* PANCYTOPENIA",
        "rr": 7.91,
        "risk_count": 4679,
        "predisposition_and_risk": 45,
        "risk_duration": 23207542,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_288.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "288.0* AGRANULOCYTOSIS",
        "rr": 7.5,
        "risk_count": 14644,
        "predisposition_and_risk": 138,
        "risk_duration": 22444568,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_530.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "530.3* STRICTURE AND STENOSIS OF ESOPHAGUS",
        "rr": 7.49,
        "risk_count": 1883,
        "predisposition_and_risk": 17,
        "risk_duration": 23394978,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_237.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "237.7* NEUROFIBROMATOSIS",
        "rr": 7.35,
        "risk_count": 1466,
        "predisposition_and_risk": 12,
        "risk_duration": 28913628,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_721.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721.2* THORACIC SPONDYLOSIS WITHOUT MYELOPATHY",
        "rr": 7.23,
        "risk_count": 1490,
        "predisposition_and_risk": 13,
        "risk_duration": 23399318,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_569.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "569.8* OTHER SPECIFIED DISORDERS OF INTESTINE",
        "rr": 7.09,
        "risk_count": 4913,
        "predisposition_and_risk": 39,
        "risk_duration": 28784709,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.1* HALLUCINATIONS",
        "rr": 7.08,
        "risk_count": 1526,
        "predisposition_and_risk": 12,
        "risk_duration": 28996842,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_522.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "522.5* PERIAPICAL ABSCESS WITHOUT SINUS",
        "rr": 6.7,
        "risk_count": 2002,
        "predisposition_and_risk": 15,
        "risk_duration": 28828272,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_284.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "284.1* PANCYTOPENIA",
        "rr": 6.68,
        "risk_count": 4814,
        "predisposition_and_risk": 36,
        "risk_duration": 28785860,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_289.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "289.8* OTHER SPECIFIED DISEASES OF BLOOD AND BLOOD-FORMING ORGANS",
        "rr": 6.66,
        "risk_count": 4550,
        "predisposition_and_risk": 37,
        "risk_duration": 23114642,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.1* ELEVATED SEDIMENTATION RATE",
        "rr": 6.62,
        "risk_count": 4307,
        "predisposition_and_risk": 32,
        "risk_duration": 28704515,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_874.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "874.4* OPEN WOUND OF PHARYNX, WITHOUT MENTION OF COMPLICATION",
        "rr": 6.57,
        "risk_count": 1916,
        "predisposition_and_risk": 14,
        "risk_duration": 28964020,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_432.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "432.9* UNSPECIFIED INTRACRANIAL HEMORRHAGE",
        "rr": 6.55,
        "risk_count": 2527,
        "predisposition_and_risk": 20,
        "risk_duration": 23358574,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_F05.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F05.9* DELIRIUM,UNSPECIFIED",
        "rr": 6.55,
        "risk_count": 1397,
        "predisposition_and_risk": 11,
        "risk_duration": 23459022,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_410.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "410.2* ACUTE MYOCARDIAL INFARCTION OF INFEROLATERAL WALL",
        "rr": 6.36,
        "risk_count": 4002,
        "predisposition_and_risk": 31,
        "risk_duration": 23175313,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z55.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z55.2* DIAGNOSTIC PROCEDURES ON KIDNEY",
        "rr": 6.27,
        "risk_count": 1847,
        "predisposition_and_risk": 14,
        "risk_duration": 23350086,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V58.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V58.1* MAINTENANCE CHEMOTHERAPY",
        "rr": 6.25,
        "risk_count": 18495,
        "predisposition_and_risk": 147,
        "risk_duration": 22184650,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_H72",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "H72* SEROUS OTITIS MEDIA;GLUE",
        "rr": 6.14,
        "risk_count": 1485,
        "predisposition_and_risk": 11,
        "risk_duration": 23391255,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_490",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "490* BRONCHITIS, NOT SPECIFIED AS ACUTE OR CHRONIC",
        "rr": 5.96,
        "risk_count": 1661,
        "predisposition_and_risk": 11,
        "risk_duration": 28982246,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V58.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V58.1* MAINTENANCE CHEMOTHERAPY",
        "rr": 5.57,
        "risk_count": 18725,
        "predisposition_and_risk": 122,
        "risk_duration": 27518570,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_289.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "289.8* OTHER SPECIFIED DISEASES OF BLOOD AND BLOOD-FORMING ORGANS",
        "rr": 5.45,
        "risk_count": 6183,
        "predisposition_and_risk": 38,
        "risk_duration": 28567904,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_676_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "676 OTHER DISORDERS OF BREAST WITH CHILDBIRTH + DISORD.OF LACTATION",
        "rr": 5.39,
        "risk_count": 2327,
        "predisposition_and_risk": 14,
        "risk_duration": 28869848,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_711.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "711.0* PYOGENIC ARTHRITIS",
        "rr": 5.31,
        "risk_count": 2367,
        "predisposition_and_risk": 14,
        "risk_duration": 28920959,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_287.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "287.5* THROMBOCYTOPENIA, UNSPECIFIED",
        "rr": 5.24,
        "risk_count": 6776,
        "predisposition_and_risk": 40,
        "risk_duration": 28620989,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_287.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "287.5* THROMBOCYTOPENIA, UNSPECIFIED",
        "rr": 5.2,
        "risk_count": 8717,
        "predisposition_and_risk": 56,
        "risk_duration": 22858305,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_412.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "412.2* STATUS POST MYOCARDIAL INFARCTION INFERIOR",
        "rr": 5.15,
        "risk_count": 7431,
        "predisposition_and_risk": 47,
        "risk_duration": 22996979,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_996.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "996.8* COMPLICATIONS OF TRANSPLANTED ORGAN",
        "rr": 5.13,
        "risk_count": 3216,
        "predisposition_and_risk": 20,
        "risk_duration": 23268371,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_273.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "273.8* OTHER DISORDERS OF PLASMA PROTEIN METABOLISM",
        "rr": 5.06,
        "risk_count": 12958,
        "predisposition_and_risk": 82,
        "risk_duration": 22556153,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_718.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "718.8* OTHER JOINT DERANGEMENT, NOT ELSEWHERE CLASSIFIED",
        "rr": 5.01,
        "risk_count": 1980,
        "predisposition_and_risk": 12,
        "risk_duration": 23324717,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z48.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z48.6* OTHER RESECTION OF RECTUM",
        "rr": 5.01,
        "risk_count": 2807,
        "predisposition_and_risk": 17,
        "risk_duration": 23341674,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_E93.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "E93.3* PRIM.SYSTEM.AGENTS CAUSING ADV.EFFECTS IN THERAPEUTIC USE",
        "rr": 4.97,
        "risk_count": 1835,
        "predisposition_and_risk": 11,
        "risk_duration": 23413109,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P71_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "P71 ENCOUNTER HEALTH SERVICE FOR OTH COUNSELL MEDICAL ADVICE,NEC",
        "rr": 4.96,
        "risk_count": 2712,
        "predisposition_and_risk": 15,
        "risk_duration": 28870662,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_805_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "805 # OF VERTEBRAL COLUMN WITHOUT SPINAL CORD INJURY",
        "rr": 4.9,
        "risk_count": 18908,
        "predisposition_and_risk": 108,
        "risk_duration": 27641423,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_721.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721.4* THORACIC OR LUMBAR SPONDYLOSIS WITH MYELOPATHY",
        "rr": 4.81,
        "risk_count": 2968,
        "predisposition_and_risk": 16,
        "risk_duration": 28773036,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_710.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "710.2* SICCA SYNDROME",
        "rr": 4.78,
        "risk_count": 17141,
        "predisposition_and_risk": 96,
        "risk_duration": 27501183,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_225.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "225.1* BENIGN NEOPLASM OF CRANIAL NERVES",
        "rr": 4.74,
        "risk_count": 2965,
        "predisposition_and_risk": 17,
        "risk_duration": 23331726,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_725",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "725* POLYMYALGIA RHEUMATICA",
        "rr": 4.74,
        "risk_count": 16377,
        "predisposition_and_risk": 89,
        "risk_duration": 28087151,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z38.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z38.9* PUNCTURE OF VESSEL",
        "rr": 4.73,
        "risk_count": 9145,
        "predisposition_and_risk": 49,
        "risk_duration": 28419891,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_041.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.6* PROTEUS(MIRABILIS,MORGANII)CONDIT,CLASSIF.ELSEWHERE,UNSP.SITE",
        "rr": 4.64,
        "risk_count": 2322,
        "predisposition_and_risk": 12,
        "risk_duration": 28936570,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_461.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "461.9* ACUTE SINUSITIS, UNSPECIFIED",
        "rr": 4.63,
        "risk_count": 2130,
        "predisposition_and_risk": 11,
        "risk_duration": 28861875,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_405_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "405 SECONDARY HYPERTENSION",
        "rr": 4.6,
        "risk_count": 2535,
        "predisposition_and_risk": 13,
        "risk_duration": 28869103,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_721.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721.2* THORACIC SPONDYLOSIS WITHOUT MYELOPATHY",
        "rr": 4.59,
        "risk_count": 3117,
        "predisposition_and_risk": 16,
        "risk_duration": 28836372,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V10.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V10.7* PERSONAL HISTORY OF OTHER LYMPHATIC AND HEMATOPOIETIC NEOPL.",
        "rr": 4.58,
        "risk_count": 2157,
        "predisposition_and_risk": 11,
        "risk_duration": 28926689,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_453.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "453.4* VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF LOWER EXTREMITY",
        "rr": 4.56,
        "risk_count": 5465,
        "predisposition_and_risk": 28,
        "risk_duration": 28680800,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_244.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "244.1* OTHER POSTABLATIVE HYPOTHYROIDISM",
        "rr": 4.54,
        "risk_count": 3350,
        "predisposition_and_risk": 17,
        "risk_duration": 28791371,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_807_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "807 FRACTURE OF RIB(S), STERNUM, LARYNX, AND TRACHEA",
        "rr": 4.51,
        "risk_count": 7693,
        "predisposition_and_risk": 43,
        "risk_duration": 22744724,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_528.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "528.0* STOMATITIS",
        "rr": 4.44,
        "risk_count": 6390,
        "predisposition_and_risk": 35,
        "risk_duration": 22895325,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_285.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "285.8* OTHER SPECIFIED ANEMIAS",
        "rr": 4.43,
        "risk_count": 3038,
        "predisposition_and_risk": 15,
        "risk_duration": 28878213,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_372.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "372.1* CHRONIC CONJUNCTIVITIS",
        "rr": 4.37,
        "risk_count": 3024,
        "predisposition_and_risk": 16,
        "risk_duration": 23292076,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_172.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "172.9* MELANOMA OF SKIN, SITE UNSPECIFIED",
        "rr": 4.35,
        "risk_count": 17714,
        "predisposition_and_risk": 90,
        "risk_duration": 27599780,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_805_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "805 # OF VERTEBRAL COLUMN WITHOUT SPINAL CORD INJURY",
        "rr": 4.15,
        "risk_count": 9095,
        "predisposition_and_risk": 47,
        "risk_duration": 22677756,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_698.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698.2* PRURIGO",
        "rr": 4.13,
        "risk_count": 7848,
        "predisposition_and_risk": 40,
        "risk_duration": 22872012,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_211.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "211.1* BENIGN NEOPLASM OF STOMACH",
        "rr": 4.1,
        "risk_count": 5225,
        "predisposition_and_risk": 24,
        "risk_duration": 28740030,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_288.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "288.0* AGRANULOCYTOSIS",
        "rr": 4.08,
        "risk_count": 22009,
        "predisposition_and_risk": 107,
        "risk_duration": 27062076,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z86.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z86.0* INCISION OF SKIN AND SUBCUTANEOUS TISSUE",
        "rr": 4,
        "risk_count": 5904,
        "predisposition_and_risk": 29,
        "risk_duration": 22996025,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_008.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "008.4* INTESTINAL INFECTION DUE TO OTHER SPECIFIED BACTERIA",
        "rr": 3.98,
        "risk_count": 3375,
        "predisposition_and_risk": 15,
        "risk_duration": 28866736,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z38.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z38.9* PUNCTURE OF VESSEL",
        "rr": 3.98,
        "risk_count": 10297,
        "predisposition_and_risk": 51,
        "risk_duration": 22680316,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.6* PHLEBOGRAPHY",
        "rr": 3.95,
        "risk_count": 3961,
        "predisposition_and_risk": 19,
        "risk_duration": 23233420,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_820.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "820.0* TRANSCERVICAL FRACTURE, CLOSED",
        "rr": 3.91,
        "risk_count": 6378,
        "predisposition_and_risk": 28,
        "risk_duration": 28674887,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_198.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "198.5* SECONDARY MALIGNANT NEOPLASM OF BONE AND BONE MARROW",
        "rr": 3.89,
        "risk_count": 5257,
        "predisposition_and_risk": 23,
        "risk_duration": 28649490,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_805.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "805.4* CLOSED # LUMBAR VERTEBRA WITHOUT SPINAL CORD INJURY",
        "rr": 3.83,
        "risk_count": 3660,
        "predisposition_and_risk": 17,
        "risk_duration": 23242220,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_805.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "805.4* CLOSED # LUMBAR VERTEBRA WITHOUT SPINAL CORD INJURY",
        "rr": 3.77,
        "risk_count": 5898,
        "predisposition_and_risk": 25,
        "risk_duration": 28660308,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_805.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "805.2* CLOSED # DORSAL(THORAC.)VERTEBRA WITHOUT SPINAL CORD INJURY",
        "rr": 3.74,
        "risk_count": 3115,
        "predisposition_and_risk": 13,
        "risk_duration": 28852607,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z55.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z55.5* COMPLETE NEPHRECTOMY",
        "rr": 3.73,
        "risk_count": 3842,
        "predisposition_and_risk": 16,
        "risk_duration": 28832767,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z45.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z45.7* PARTIAL EXCISION OF LARGE INTESTINE",
        "rr": 3.7,
        "risk_count": 6201,
        "predisposition_and_risk": 28,
        "risk_duration": 23097953,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_694.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "694.5* PEMPHIGOID",
        "rr": 3.67,
        "risk_count": 3176,
        "predisposition_and_risk": 13,
        "risk_duration": 28874790,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z92.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z92.2* THERAPEUTIC RADIOLOGY AND NUCLEAR MEDICINE",
        "rr": 3.67,
        "risk_count": 3656,
        "predisposition_and_risk": 15,
        "risk_duration": 28784661,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_733.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "733.9* OTHER AND UNSPECIFIED DISORDERS OF BONE AND CARTILAGE",
        "rr": 3.64,
        "risk_count": 5632,
        "predisposition_and_risk": 25,
        "risk_duration": 23110780,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_300.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "300.9* UNSPECIFIED NEUROTIC DISORDER",
        "rr": 3.62,
        "risk_count": 2722,
        "predisposition_and_risk": 12,
        "risk_duration": 23201532,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_789.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "789.2* SPLENOMEGALY",
        "rr": 3.62,
        "risk_count": 11076,
        "predisposition_and_risk": 46,
        "risk_duration": 28090869,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_725",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "725* POLYMYALGIA RHEUMATICA",
        "rr": 3.61,
        "risk_count": 4572,
        "predisposition_and_risk": 20,
        "risk_duration": 23262497,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_378.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "378.0* ESOTROPIA",
        "rr": 3.58,
        "risk_count": 2541,
        "predisposition_and_risk": 11,
        "risk_duration": 23341882,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V58.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V58.0* RADIOTHERAPY SESSION",
        "rr": 3.56,
        "risk_count": 6881,
        "predisposition_and_risk": 30,
        "risk_duration": 23025081,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_E84.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "E84.9* PLACE OF OCCURRENCE",
        "rr": 3.55,
        "risk_count": 4033,
        "predisposition_and_risk": 16,
        "risk_duration": 28800369,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_791.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "791.9* OTHER NONSPECIFIC FINDINGS ON EXAMINATION OF URINE",
        "rr": 3.54,
        "risk_count": 2566,
        "predisposition_and_risk": 11,
        "risk_duration": 23332688,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_371.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "371.5* HEREDITARY CORNEAL DYSTROPHIES",
        "rr": 3.5,
        "risk_count": 3333,
        "predisposition_and_risk": 13,
        "risk_duration": 28896751,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_710.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "710.0* SYSTEMIC LUPUS ERYTHEMATOSUS",
        "rr": 3.49,
        "risk_count": 14570,
        "predisposition_and_risk": 60,
        "risk_duration": 27339762,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_556_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "556 IDIOPATHIC PROCTOCOLITIS",
        "rr": 3.48,
        "risk_count": 12121,
        "predisposition_and_risk": 53,
        "risk_duration": 22444514,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_482.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "482.9* BACTERIAL PNEUMONIA, UNSPECIFIED",
        "rr": 3.46,
        "risk_count": 2853,
        "predisposition_and_risk": 11,
        "risk_duration": 28898478,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.9* OTHER DIAGNOSTIC IMAGING",
        "rr": 3.46,
        "risk_count": 2848,
        "predisposition_and_risk": 11,
        "risk_duration": 28854600,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_812.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "812.2* CLOSED FRACTURE OF SHAFT OR UNSPECIFIED PART OF HUMERUS",
        "rr": 3.45,
        "risk_count": 3886,
        "predisposition_and_risk": 15,
        "risk_duration": 28814205,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_138_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "138 LATE EFFECTS OF ACUTE POLIOMYELITIS",
        "rr": 3.45,
        "risk_count": 5893,
        "predisposition_and_risk": 23,
        "risk_duration": 28484364,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_790.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.7* UNSPECIFIED BACTEREMIA",
        "rr": 3.44,
        "risk_count": 8721,
        "predisposition_and_risk": 37,
        "risk_duration": 22881954,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z86.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z86.0* INCISION OF SKIN AND SUBCUTANEOUS TISSUE",
        "rr": 3.44,
        "risk_count": 5170,
        "predisposition_and_risk": 20,
        "risk_duration": 28641630,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_572.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "572.2* HEPATIC COMA",
        "rr": 3.39,
        "risk_count": 7610,
        "predisposition_and_risk": 29,
        "risk_duration": 28637171,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z39.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z39.4* REVISION OF VASCULAR PROCEDURE",
        "rr": 3.39,
        "risk_count": 2908,
        "predisposition_and_risk": 11,
        "risk_duration": 28897016,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_281.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "281.9* UNSPECIFIED DEFICIENCY ANEMIA",
        "rr": 3.37,
        "risk_count": 5302,
        "predisposition_and_risk": 20,
        "risk_duration": 28748012,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_231.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "231.7* THROMBOCYTOSIS",
        "rr": 3.36,
        "risk_count": 2704,
        "predisposition_and_risk": 11,
        "risk_duration": 23313753,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_282.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "282.4* THALASSEMIAS",
        "rr": 3.32,
        "risk_count": 7819,
        "predisposition_and_risk": 32,
        "risk_duration": 22924528,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V42.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V42.0* KIDNEY REPLACED BY TRANSPLANT",
        "rr": 3.31,
        "risk_count": 9804,
        "predisposition_and_risk": 37,
        "risk_duration": 28218572,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_382.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "382.0* ACUTE SUPPURATIVE OTITIS MEDIA",
        "rr": 3.3,
        "risk_count": 2976,
        "predisposition_and_risk": 11,
        "risk_duration": 28793886,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_590.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "590.1* ACUTE PYELONEPHRITIS",
        "rr": 3.28,
        "risk_count": 3266,
        "predisposition_and_risk": 13,
        "risk_duration": 23265108,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_275.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "275.2* DISORDERS OF MAGNESIUM METABOLISM",
        "rr": 3.27,
        "risk_count": 3031,
        "predisposition_and_risk": 12,
        "risk_duration": 23330452,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.3* OTHER X-RAY",
        "rr": 3.27,
        "risk_count": 7844,
        "predisposition_and_risk": 29,
        "risk_duration": 28475711,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_577.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "577.1* CHRONIC PANCREATITIS",
        "rr": 3.26,
        "risk_count": 4260,
        "predisposition_and_risk": 17,
        "risk_duration": 23069817,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_733.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "733.6* TIETZE'S DISEASE",
        "rr": 3.25,
        "risk_count": 4104,
        "predisposition_and_risk": 15,
        "risk_duration": 28657321,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z79.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z79.1* CLOSED REDUCTION OF FRACTURE WITH INTERNAL FIXATION",
        "rr": 3.25,
        "risk_count": 3555,
        "predisposition_and_risk": 14,
        "risk_duration": 23258368,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_225.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "225.0* BENIGN NEOPLASM OF BRAIN",
        "rr": 3.23,
        "risk_count": 3051,
        "predisposition_and_risk": 11,
        "risk_duration": 28891245,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_378.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "378.1* EXOTROPIA",
        "rr": 3.23,
        "risk_count": 8204,
        "predisposition_and_risk": 30,
        "risk_duration": 28443262,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z99.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.0* TRANSFUSION OF BLOOD AND BLOOD COMPONENTS",
        "rr": 3.23,
        "risk_count": 28294,
        "predisposition_and_risk": 109,
        "risk_duration": 27029078,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L09",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L09* ARM SYMPTOMS/COMPLAINTS",
        "rr": 3.23,
        "risk_count": 5767,
        "predisposition_and_risk": 23,
        "risk_duration": 22887930,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V87.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V87.4* PERSONAL HISTORY OF DRUG THERAPY",
        "rr": 3.22,
        "risk_count": 7374,
        "predisposition_and_risk": 29,
        "risk_duration": 23074872,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_578.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "578.0* HEMATEMESIS",
        "rr": 3.21,
        "risk_count": 3839,
        "predisposition_and_risk": 15,
        "risk_duration": 23208235,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_280.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "280.0* IRON DEFICIENCY ANEMIA SECONDARY TO BLOOD LOSS (CHRONIC)",
        "rr": 3.18,
        "risk_count": 5593,
        "predisposition_and_risk": 20,
        "risk_duration": 28664013,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V02.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V02.6* CARRIER OR SUSPECTED CARRIER OF VIRAL HEPATITIS",
        "rr": 3.18,
        "risk_count": 9667,
        "predisposition_and_risk": 35,
        "risk_duration": 28290653,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_244_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "244 ACQUIRED HYPOTHYROIDISM",
        "rr": 3.18,
        "risk_count": 10169,
        "predisposition_and_risk": 40,
        "risk_duration": 22828701,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_535.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "535.5* __GASTRODUODENITIS____1992 AND GASTRITIS UNSPECIFIED",
        "rr": 3.17,
        "risk_count": 8669,
        "predisposition_and_risk": 34,
        "risk_duration": 22778857,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_786.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "786.6* SWELLING, MASS, OR LUMP IN CHEST",
        "rr": 3.16,
        "risk_count": 4429,
        "predisposition_and_risk": 17,
        "risk_duration": 23216125,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_242.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "242.0* TOXIC DIFFUSE GOITER",
        "rr": 3.15,
        "risk_count": 5600,
        "predisposition_and_risk": 20,
        "risk_duration": 28406297,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_259.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "259.2* CARCINOID SYNDROME",
        "rr": 3.13,
        "risk_count": 4841,
        "predisposition_and_risk": 17,
        "risk_duration": 28701550,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_389.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "389.0* CONDUCTIVE HEARING LOSS",
        "rr": 3.13,
        "risk_count": 2903,
        "predisposition_and_risk": 11,
        "risk_duration": 23277402,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V13.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V13.0* PERSONAL HISTORY OF DISORDERS OF URINARY SYSTEM",
        "rr": 3.12,
        "risk_count": 6837,
        "predisposition_and_risk": 24,
        "risk_duration": 28629251,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_715.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "715.8* OSTEOARTHROSIS,MORE THAN ONE SITE,BUT NOT GENERALIZED",
        "rr": 3.11,
        "risk_count": 6272,
        "predisposition_and_risk": 22,
        "risk_duration": 28595867,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A01",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A01* PAIN:GENERALIZED/UNSPECIFIED",
        "rr": 3.09,
        "risk_count": 5735,
        "predisposition_and_risk": 20,
        "risk_duration": 28539857,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_372.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "372.1* CHRONIC CONJUNCTIVITIS",
        "rr": 3.08,
        "risk_count": 5193,
        "predisposition_and_risk": 18,
        "risk_duration": 28583809,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_738.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "738.4* ACQUIRED SPONDYLOLISTHESIS",
        "rr": 3.08,
        "risk_count": 17750,
        "predisposition_and_risk": 64,
        "risk_duration": 27564180,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V15.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V15.3* PERSONAL HISTORY OF IRRADIATION, PRESENTING HAZARDS TO HEALTH",
        "rr": 3.08,
        "risk_count": 6121,
        "predisposition_and_risk": 23,
        "risk_duration": 23141474,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_789.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "789.1* HEPATOMEGALY",
        "rr": 3.05,
        "risk_count": 9205,
        "predisposition_and_risk": 32,
        "risk_duration": 28273346,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_528.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "528.0* STOMATITIS",
        "rr": 3.03,
        "risk_count": 12518,
        "predisposition_and_risk": 44,
        "risk_duration": 27812317,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_281.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "281.1* OTHER VITAMIN B12 DEFICIENCY ANEMIA",
        "rr": 3.01,
        "risk_count": 3023,
        "predisposition_and_risk": 11,
        "risk_duration": 23320783,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_223.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "223.0* BENIGN NEOPLASM OF KIDNEY, EXCEPT PELVIS",
        "rr": 2.99,
        "risk_count": 3290,
        "predisposition_and_risk": 11,
        "risk_duration": 28846679,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_317",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "317* MILD MENTAL RETARDATION",
        "rr": 2.98,
        "risk_count": 4621,
        "predisposition_and_risk": 17,
        "risk_duration": 22875041,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_789.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "789.1* HEPATOMEGALY",
        "rr": 2.97,
        "risk_count": 7392,
        "predisposition_and_risk": 27,
        "risk_duration": 22912308,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z06.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z06.4* COMPLETE THYROIDECTOMY",
        "rr": 2.97,
        "risk_count": 3311,
        "predisposition_and_risk": 11,
        "risk_duration": 28821948,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_446.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "446.5* GIANT CELL ARTERITIS",
        "rr": 2.95,
        "risk_count": 7834,
        "predisposition_and_risk": 26,
        "risk_duration": 28600166,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_721.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721.4* THORACIC OR LUMBAR SPONDYLOSIS WITH MYELOPATHY",
        "rr": 2.94,
        "risk_count": 3633,
        "predisposition_and_risk": 13,
        "risk_duration": 23209671,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_E81.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "E81.3* MOTOR VEHICLE TRAFFIC ACCIDENT INVOLVING COLLISION WITH OTHER VEHICLE",
        "rr": 2.94,
        "risk_count": 3935,
        "predisposition_and_risk": 13,
        "risk_duration": 28627239,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_454.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "454.1* VARICOSE VEINS OF LOWER EXTREMITIES WITH INFLAMMATION",
        "rr": 2.93,
        "risk_count": 4476,
        "predisposition_and_risk": 16,
        "risk_duration": 23140160,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_852.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "852.2* SUBDURAL HEMORRH.FOLLOW.INJURY WITHOUT OPEN INTRACR.WOUND",
        "rr": 2.93,
        "risk_count": 5054,
        "predisposition_and_risk": 18,
        "risk_duration": 23196464,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_275.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "275.3* DISORDERS OF PHOSPHORUS METABOLISM",
        "rr": 2.92,
        "risk_count": 3395,
        "predisposition_and_risk": 12,
        "risk_duration": 23294878,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z92.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z92.1* OTHER RADIOISOTOPE SCAN",
        "rr": 2.9,
        "risk_count": 3697,
        "predisposition_and_risk": 12,
        "risk_duration": 28799130,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.9* OTHER NONSPECIFIC FINDINGS ON EXAMINATION OF BLOOD",
        "rr": 2.89,
        "risk_count": 4633,
        "predisposition_and_risk": 15,
        "risk_duration": 28770488,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V14.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.2* PERSONAL HISTORY OF ALLERGY TO SULFONAMIDES",
        "rr": 2.89,
        "risk_count": 3149,
        "predisposition_and_risk": 11,
        "risk_duration": 23312319,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z37.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z37.8* REPLACEMENT, REVISION, AND REMOVAL OF CARDIAC PACEMAKER SYSTEM",
        "rr": 2.88,
        "risk_count": 4350,
        "predisposition_and_risk": 14,
        "risk_duration": 28853109,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_340.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "340.0* MULTIPLE SCLEROSIS",
        "rr": 2.87,
        "risk_count": 5939,
        "predisposition_and_risk": 21,
        "risk_duration": 22909886,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_574.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "574.5* CALCULUS OF BILE DUCT WITHOUT MENTION OF CHOLECYSTITIS",
        "rr": 2.87,
        "risk_count": 5572,
        "predisposition_and_risk": 18,
        "risk_duration": 28665617,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.6* PYREXIA (OF UNKNOWN ORIGIN)",
        "rr": 2.87,
        "risk_count": 31512,
        "predisposition_and_risk": 110,
        "risk_duration": 26527587,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_275.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "275.4* DISORDERS OF CALCIUM METABOLISM",
        "rr": 2.86,
        "risk_count": 21138,
        "predisposition_and_risk": 78,
        "risk_duration": 21847105,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_525.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "525.9* UNSP.DISORDER OF THE TEETH AND SUPPORTING STRUCTURES",
        "rr": 2.85,
        "risk_count": 7078,
        "predisposition_and_risk": 23,
        "risk_duration": 28224764,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_441_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "441 AORTIC ANEURYSM",
        "rr": 2.84,
        "risk_count": 3472,
        "predisposition_and_risk": 11,
        "risk_duration": 28888436,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_995.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "995.9* SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)",
        "rr": 2.83,
        "risk_count": 17584,
        "predisposition_and_risk": 63,
        "risk_duration": 22308586,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z86.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z86.1* DIAGNOSTIC PROCEDURES ON SKIN AND SUBCUTANEOUS TISSUE",
        "rr": 2.83,
        "risk_count": 3465,
        "predisposition_and_risk": 11,
        "risk_duration": 28764951,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_721_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721 SPONDYLOSIS AND ALLIED DISORDERS",
        "rr": 2.83,
        "risk_count": 4401,
        "predisposition_and_risk": 14,
        "risk_duration": 28707498,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_573.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "573.8* OTHER SPECIFIED DISORDERS OF LIVER",
        "rr": 2.81,
        "risk_count": 5244,
        "predisposition_and_risk": 18,
        "risk_duration": 23136834,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_528.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "528.2* ORAL APHTHAE",
        "rr": 2.8,
        "risk_count": 6634,
        "predisposition_and_risk": 23,
        "risk_duration": 22826577,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_K75",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "K75* ACUTE MYOCARDIAL INFARCTION",
        "rr": 2.8,
        "risk_count": 4673,
        "predisposition_and_risk": 16,
        "risk_duration": 23111412,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_252.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "252.1* HYPOPARATHYROIDISM",
        "rr": 2.79,
        "risk_count": 3840,
        "predisposition_and_risk": 12,
        "risk_duration": 28783230,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z99.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.0* TRANSFUSION OF BLOOD AND BLOOD COMPONENTS",
        "rr": 2.79,
        "risk_count": 28110,
        "predisposition_and_risk": 103,
        "risk_duration": 21455071,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_560_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "560 INTESTINAL OBSTRUCTION WITHOUT MENTION OF HERNIA",
        "rr": 2.79,
        "risk_count": 4705,
        "predisposition_and_risk": 16,
        "risk_duration": 23153037,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_364.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "364.3* UNSPECIFIED IRIDOCYCLITIS",
        "rr": 2.78,
        "risk_count": 11516,
        "predisposition_and_risk": 37,
        "risk_duration": 27876151,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_518_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "518 OTHER DISEASES OF LUNG",
        "rr": 2.78,
        "risk_count": 7025,
        "predisposition_and_risk": 22,
        "risk_duration": 28585822,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_601.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "601.0* ACUTE PROSTATITIS",
        "rr": 2.77,
        "risk_count": 3267,
        "predisposition_and_risk": 11,
        "risk_duration": 23227378,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_273.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "273.8* OTHER DISORDERS OF PLASMA PROTEIN METABOLISM",
        "rr": 2.75,
        "risk_count": 12731,
        "predisposition_and_risk": 40,
        "risk_duration": 28162576,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_919.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "919.0* ABRASION OR FRICTION BURN OF MULT.+UNSP.SITES,WITHOUT INFECT.",
        "rr": 2.75,
        "risk_count": 5353,
        "predisposition_and_risk": 18,
        "risk_duration": 23037702,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_350.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "350.1* TRIGEMINAL NEURALGIA",
        "rr": 2.73,
        "risk_count": 5386,
        "predisposition_and_risk": 18,
        "risk_duration": 23080812,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V14.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.6* PERSONAL HISTORY OF ALLERGY TO ANALGESIC AGENT",
        "rr": 2.72,
        "risk_count": 12609,
        "predisposition_and_risk": 43,
        "risk_duration": 22467967,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_300.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "300.9* UNSPECIFIED NEUROTIC DISORDER",
        "rr": 2.7,
        "risk_count": 3630,
        "predisposition_and_risk": 11,
        "risk_duration": 28710045,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_369.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "369.1* BETTER EYE:MODER./SEVERE IMPAIRM.,LESSER EYE;PROFOND IMPAIRM.",
        "rr": 2.7,
        "risk_count": 6625,
        "predisposition_and_risk": 22,
        "risk_duration": 22969713,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_041.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.0* STREPTOCOCCUS INFECT.IN CONDITION CLASSIF.ELSEWHERE;UNSP.SITE",
        "rr": 2.69,
        "risk_count": 4314,
        "predisposition_and_risk": 13,
        "risk_duration": 28751892,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z37.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z37.7* INSERTION OF CARDIAC PACEMAKER SYSTEM",
        "rr": 2.69,
        "risk_count": 4598,
        "predisposition_and_risk": 15,
        "risk_duration": 23237142,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z99.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.2* INJECT.OR INFUSION OF OTHER THERAPEUTIC OR PROPHYLACTIC SUBS.",
        "rr": 2.67,
        "risk_count": 46382,
        "predisposition_and_risk": 159,
        "risk_duration": 25111240,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_110.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "110.2* DERMATOPHYTOSIS OF HAND",
        "rr": 2.66,
        "risk_count": 5790,
        "predisposition_and_risk": 19,
        "risk_duration": 22903120,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_F31_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F31 BIPOLAR AFFECTIVE DISORDER",
        "rr": 2.63,
        "risk_count": 4401,
        "predisposition_and_risk": 13,
        "risk_duration": 28730961,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A04",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A04* GENERAL WEAKNESS/TIREDNESS",
        "rr": 2.63,
        "risk_count": 10272,
        "predisposition_and_risk": 31,
        "risk_duration": 28087540,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_733.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "733.0* OSTEOPOROSIS",
        "rr": 2.62,
        "risk_count": 36951,
        "predisposition_and_risk": 131,
        "risk_duration": 20818551,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V43.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V43.6* JOINT REPLACED BY OTHER MEANS",
        "rr": 2.61,
        "risk_count": 7831,
        "predisposition_and_risk": 23,
        "risk_duration": 28623096,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_820_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "820 FRACTURE OF NECK OF FEMUR",
        "rr": 2.61,
        "risk_count": 6287,
        "predisposition_and_risk": 20,
        "risk_duration": 23109354,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_202.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "202.1* MYCOSIS FUNGOIDES",
        "rr": 2.59,
        "risk_count": 6612,
        "predisposition_and_risk": 21,
        "risk_duration": 23007039,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.6* PYREXIA (OF UNKNOWN ORIGIN)",
        "rr": 2.58,
        "risk_count": 35614,
        "predisposition_and_risk": 125,
        "risk_duration": 20752669,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_924.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "924.5* CONTUSION OF UNSPECIFIED PART OF LOWER LIMB",
        "rr": 2.58,
        "risk_count": 4129,
        "predisposition_and_risk": 12,
        "risk_duration": 28649797,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z34.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z34.0* INCISION OF CHEST WALL AND PLEURA",
        "rr": 2.58,
        "risk_count": 4776,
        "predisposition_and_risk": 15,
        "risk_duration": 23168091,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_356_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "356 HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY",
        "rr": 2.58,
        "risk_count": 54680,
        "predisposition_and_risk": 189,
        "risk_duration": 24001587,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_485",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "485* BRONCHOPNEUMONIA, ORGANISM UNSPECIFIED",
        "rr": 2.58,
        "risk_count": 12107,
        "predisposition_and_risk": 39,
        "risk_duration": 22602297,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.5* SHOCK WITHOUT MENTION OF TRAUMA",
        "rr": 2.57,
        "risk_count": 10336,
        "predisposition_and_risk": 33,
        "risk_duration": 22748337,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_922.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "922.8* CONTUSION OF MULTIPLE SITES OF TRUNK",
        "rr": 2.57,
        "risk_count": 9829,
        "predisposition_and_risk": 29,
        "risk_duration": 28113536,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_799.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "799.4* CACHEXIA",
        "rr": 2.56,
        "risk_count": 4191,
        "predisposition_and_risk": 13,
        "risk_duration": 23256814,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_527.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "527.2* SIALOADENITIS",
        "rr": 2.55,
        "risk_count": 11224,
        "predisposition_and_risk": 33,
        "risk_duration": 27939466,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_381.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "381.4* NONSUPPURATIVE OTITIS MEDIA, NOT SPECIFIED AS ACUTE OR CHRONIC",
        "rr": 2.53,
        "risk_count": 5794,
        "predisposition_and_risk": 18,
        "risk_duration": 22991897,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_444.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "444.2* EMBOLISM AND THROMBOSIS OF ARTERIES OF THE EXTREMITIES",
        "rr": 2.52,
        "risk_count": 4248,
        "predisposition_and_risk": 12,
        "risk_duration": 28737797,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V02.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V02.5* CARRIER OR SUSP.CARRIER OF OTHER SPECIFIED BACTERIAL DISEASES",
        "rr": 2.52,
        "risk_count": 5654,
        "predisposition_and_risk": 16,
        "risk_duration": 28691386,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z96.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z96.7* OTHER CONTINUOUS MECHANICAL VENTILATION",
        "rr": 2.52,
        "risk_count": 11485,
        "predisposition_and_risk": 33,
        "risk_duration": 28253019,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.1* PAROXYSMAL VENTRICULAR TACHYCARDIA",
        "rr": 2.51,
        "risk_count": 3916,
        "predisposition_and_risk": 11,
        "risk_duration": 28799370,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_709.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "709.3* DEGENERATIVE SKIN DISORDERS",
        "rr": 2.5,
        "risk_count": 3929,
        "predisposition_and_risk": 11,
        "risk_duration": 28780083,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.5* OTHER NONSPECIFIC ABNORMAL SERUM ENZYME LEVELS",
        "rr": 2.5,
        "risk_count": 4638,
        "predisposition_and_risk": 13,
        "risk_duration": 28698379,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_361.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "361.0* RETINAL DETACHMENT WITH RETINAL DEFECT",
        "rr": 2.49,
        "risk_count": 10636,
        "predisposition_and_risk": 33,
        "risk_duration": 22658305,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_707.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "707.2* PRESSURE ULCER STAGES",
        "rr": 2.47,
        "risk_count": 4012,
        "predisposition_and_risk": 12,
        "risk_duration": 23282582,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_518_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "518 OTHER DISEASES OF LUNG",
        "rr": 2.47,
        "risk_count": 5978,
        "predisposition_and_risk": 18,
        "risk_duration": 23116498,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_824_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "824 FRACTURE OF ANKLE",
        "rr": 2.47,
        "risk_count": 4939,
        "predisposition_and_risk": 15,
        "risk_duration": 22984521,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z85.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z85.1* DIAGNOSTIC PROCEDURES ON BREAST",
        "rr": 2.46,
        "risk_count": 4341,
        "predisposition_and_risk": 12,
        "risk_duration": 28689359,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_280_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "280 IRON DEFICIENCY ANEMIAS",
        "rr": 2.46,
        "risk_count": 4663,
        "predisposition_and_risk": 14,
        "risk_duration": 23124353,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_812_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "812 FRACTURE OF HUMERUS",
        "rr": 2.45,
        "risk_count": 11097,
        "predisposition_and_risk": 31,
        "risk_duration": 28244908,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_355.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "355.0* LESION OF SCIATIC NERVE",
        "rr": 2.42,
        "risk_count": 16880,
        "predisposition_and_risk": 48,
        "risk_duration": 27412759,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_812.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "812.0* FRACTURE OF UPPER END OF HUMERUS, CLOSED",
        "rr": 2.42,
        "risk_count": 7061,
        "predisposition_and_risk": 21,
        "risk_duration": 22937919,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_999.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "999.9* UNSPECIFIED COMPLICATIONS OF MEDICAL CARE,NOT ELSEW.CLASSIFIED",
        "rr": 2.42,
        "risk_count": 25383,
        "predisposition_and_risk": 73,
        "risk_duration": 27112769,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V02.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V02.6* CARRIER OR SUSPECTED CARRIER OF VIRAL HEPATITIS",
        "rr": 2.42,
        "risk_count": 12985,
        "predisposition_and_risk": 40,
        "risk_duration": 22139538,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_584_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "584 ACUTE RENAL FAILURE",
        "rr": 2.42,
        "risk_count": 24871,
        "predisposition_and_risk": 71,
        "risk_duration": 27364121,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_285.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "285.2* ANEMIA IN CHRONIC ILLNESS",
        "rr": 2.41,
        "risk_count": 28055,
        "predisposition_and_risk": 80,
        "risk_duration": 27258246,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_485",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "485* BRONCHOPNEUMONIA, ORGANISM UNSPECIFIED",
        "rr": 2.41,
        "risk_count": 12960,
        "predisposition_and_risk": 36,
        "risk_duration": 27958737,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_724_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "724 OTHER AND UNSPECIFIED DISORDERS OF BACK",
        "rr": 2.39,
        "risk_count": 3778,
        "predisposition_and_risk": 11,
        "risk_duration": 23163961,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_723.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "723.5* TORTICOLLIS, UNSPECIFIED",
        "rr": 2.38,
        "risk_count": 4101,
        "predisposition_and_risk": 11,
        "risk_duration": 28638727,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_793.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "793.1* NONSPECIF.ABNORMAL FINDINGS LUNG FIELD,(COIN LESION)(SHADOW)",
        "rr": 2.38,
        "risk_count": 10722,
        "predisposition_and_risk": 29,
        "risk_duration": 28339728,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_451.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "451.1* PHLEBITIS AND THROMBOPHLEBITIS,DEEP VESSELS LOWER EXTREMITIES",
        "rr": 2.37,
        "risk_count": 30906,
        "predisposition_and_risk": 89,
        "risk_duration": 26478929,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_466.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "466.1* ACUTE BRONCHIOLITIS",
        "rr": 2.37,
        "risk_count": 6735,
        "predisposition_and_risk": 18,
        "risk_duration": 28515051,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_372.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "372.5* CONJUNCTIVAL DEGENERATIONS AND DEPOSITS",
        "rr": 2.36,
        "risk_count": 8187,
        "predisposition_and_risk": 24,
        "risk_duration": 22694086,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790 NONSPECIFIC FINDINGS ON EXAMINATION OF BLOOD",
        "rr": 2.36,
        "risk_count": 20751,
        "predisposition_and_risk": 58,
        "risk_duration": 27201102,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_356_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "356 HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY",
        "rr": 2.35,
        "risk_count": 53386,
        "predisposition_and_risk": 190,
        "risk_duration": 18640202,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_287.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "287.2* OTHER NONTHROMBOCYTOPENIC PURPURAS",
        "rr": 2.34,
        "risk_count": 22387,
        "predisposition_and_risk": 62,
        "risk_duration": 27230060,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_360.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "360.4* DEGENERATED CONDITIONS OF GLOBE",
        "rr": 2.34,
        "risk_count": 3871,
        "predisposition_and_risk": 11,
        "risk_duration": 23258157,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_456.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "456.4* SCROTAL VARICES",
        "rr": 2.34,
        "risk_count": 3863,
        "predisposition_and_risk": 11,
        "risk_duration": 23149519,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_041.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.3* FRIEDLANDER'S BACILLUS;CONDITION CLASSIF.ELSEWHERE,UNSP.SITE",
        "rr": 2.33,
        "risk_count": 6111,
        "predisposition_and_risk": 16,
        "risk_duration": 28667861,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.0* PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA",
        "rr": 2.33,
        "risk_count": 12020,
        "predisposition_and_risk": 32,
        "risk_duration": 28214125,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V42.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V42.2* HEART VALVE REPLACED BY TRANSPLANT",
        "rr": 2.33,
        "risk_count": 4244,
        "predisposition_and_risk": 12,
        "risk_duration": 23257958,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_112.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "112.3* CANDIDIASIS OF SKIN AND NAILS",
        "rr": 2.32,
        "risk_count": 5631,
        "predisposition_and_risk": 16,
        "risk_duration": 23038312,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_365.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "365.5* GLAUCOMA ASSOCIATED WITH DISORDERS OF THE LENS",
        "rr": 2.32,
        "risk_count": 4246,
        "predisposition_and_risk": 11,
        "risk_duration": 28888581,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V58.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V58.4* OTHER AFTERCARE FOLLOWING SURGERY",
        "rr": 2.32,
        "risk_count": 5638,
        "predisposition_and_risk": 16,
        "risk_duration": 23088726,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_041.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.1* STAPHYLOCOCCUS INFECT.IN CONDIT.CLASSIF.ELSEWHERE,UNSP.SITE",
        "rr": 2.31,
        "risk_count": 6156,
        "predisposition_and_risk": 16,
        "risk_duration": 28613554,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_D77",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "D77* MALIGN.NEOPL.OTHER/UNSPEC.",
        "rr": 2.31,
        "risk_count": 8133,
        "predisposition_and_risk": 23,
        "risk_duration": 23003083,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_388.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "388.1* NOISE EFFECTS ON INNER EAR",
        "rr": 2.3,
        "risk_count": 8000,
        "predisposition_and_risk": 23,
        "risk_duration": 22617280,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z33.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z33.2* DIAGNOSTIC PROCEDURES ON LUNG AND BRONCHUS",
        "rr": 2.3,
        "risk_count": 4642,
        "predisposition_and_risk": 13,
        "risk_duration": 23207401,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_789.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "789.5* ASCITES",
        "rr": 2.29,
        "risk_count": 27949,
        "predisposition_and_risk": 76,
        "risk_duration": 27097091,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_135_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "135 SARCOIDOSIS",
        "rr": 2.29,
        "risk_count": 27144,
        "predisposition_and_risk": 75,
        "risk_duration": 26753183,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_370_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "370 KERATITIS",
        "rr": 2.29,
        "risk_count": 7100,
        "predisposition_and_risk": 20,
        "risk_duration": 22920046,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.2* PAROXYSMAL TACHYCARDIA, UNSPECIFIED",
        "rr": 2.27,
        "risk_count": 7014,
        "predisposition_and_risk": 18,
        "risk_duration": 28476327,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_371.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "371.0* CORNEAL SCARS AND OPACITIES",
        "rr": 2.26,
        "risk_count": 11404,
        "predisposition_and_risk": 32,
        "risk_duration": 22774314,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_714.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "714.0* RHEUMATOID ARTHRITIS",
        "rr": 2.26,
        "risk_count": 57544,
        "predisposition_and_risk": 177,
        "risk_duration": 23662741,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V49.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V49.7* LOWER LIMB AMPUTATION STATUS",
        "rr": 2.26,
        "risk_count": 8970,
        "predisposition_and_risk": 23,
        "risk_duration": 28412408,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_285.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "285.2* ANEMIA IN CHRONIC ILLNESS",
        "rr": 2.23,
        "risk_count": 26818,
        "predisposition_and_risk": 78,
        "risk_duration": 21639502,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_736.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "736.7* OTHER ACQUIRED DEFORMITIES OF ANKLE AND FOOT",
        "rr": 2.23,
        "risk_count": 7114,
        "predisposition_and_risk": 18,
        "risk_duration": 28402011,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V67.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V67.5* FOLLOW-UP EXAMINATION FOLLOWING OTHER TREATMENT",
        "rr": 2.23,
        "risk_count": 10594,
        "predisposition_and_risk": 27,
        "risk_duration": 28219576,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_566",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "566* ABSCESS OF ANAL AND RECTAL REGIONS",
        "rr": 2.23,
        "risk_count": 4369,
        "predisposition_and_risk": 11,
        "risk_duration": 28595146,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_240.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "240.9* GOITER, UNSPECIFIED",
        "rr": 2.22,
        "risk_count": 10916,
        "predisposition_and_risk": 28,
        "risk_duration": 27936580,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_375.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "375.2* EPIPHORA",
        "rr": 2.22,
        "risk_count": 11631,
        "predisposition_and_risk": 32,
        "risk_duration": 22750028,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_584.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "584.9* ACUTE RENAL FAILURE, UNSPECIFIED",
        "rr": 2.22,
        "risk_count": 30876,
        "predisposition_and_risk": 82,
        "risk_duration": 26967239,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_426.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "426.1* ATRIOVENTRICULAR BLOCK, OTHER AND UNSPECIFIED",
        "rr": 2.21,
        "risk_count": 5245,
        "predisposition_and_risk": 13,
        "risk_duration": 28766894,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_198.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "198.2* SECONDARY MALIGNANT NEOPLASM OF SKIN",
        "rr": 2.2,
        "risk_count": 7414,
        "predisposition_and_risk": 20,
        "risk_duration": 23030216,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_389.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "389.9* UNSPECIFIED HEARING LOSS",
        "rr": 2.2,
        "risk_count": 4860,
        "predisposition_and_risk": 13,
        "risk_duration": 23191231,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_924.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "924.0* CONTUSION OF HIP AND THIGH",
        "rr": 2.2,
        "risk_count": 9950,
        "predisposition_and_risk": 25,
        "risk_duration": 28152534,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z86.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z86.3* LOCAL EXCISION OF LESION OF SKIN AND SUBCUTANEOUS TISSUE",
        "rr": 2.2,
        "risk_count": 6689,
        "predisposition_and_risk": 18,
        "risk_duration": 23030455,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_448.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "448.1* NEVUS, NON-NEOPLASTIC",
        "rr": 2.19,
        "risk_count": 5591,
        "predisposition_and_risk": 15,
        "risk_duration": 23037885,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_998.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "998.5* POSTOPERATIVE INFECTION, NOT ELSEWHERE CLASSIFIED",
        "rr": 2.19,
        "risk_count": 6864,
        "predisposition_and_risk": 17,
        "risk_duration": 28536717,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z56.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z56.3* DIAGNOSTIC PROCEDURES ON URETER",
        "rr": 2.19,
        "risk_count": 4484,
        "predisposition_and_risk": 12,
        "risk_duration": 23103239,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_807_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "807 FRACTURE OF RIB(S), STERNUM, LARYNX, AND TRACHEA",
        "rr": 2.19,
        "risk_count": 8051,
        "predisposition_and_risk": 20,
        "risk_duration": 28352152,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_812_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "812 FRACTURE OF HUMERUS",
        "rr": 2.19,
        "risk_count": 4503,
        "predisposition_and_risk": 12,
        "risk_duration": 23173477,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_423.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "423.9* UNSPECIFIED DISEASE OF PERICARDIUM",
        "rr": 2.18,
        "risk_count": 8478,
        "predisposition_and_risk": 21,
        "risk_duration": 28382836,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.6* PREMATURE BEATS",
        "rr": 2.18,
        "risk_count": 13949,
        "predisposition_and_risk": 35,
        "risk_duration": 27945748,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z81.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z81.5* TOTAL HIP REPLACEMENT",
        "rr": 2.18,
        "risk_count": 25312,
        "predisposition_and_risk": 65,
        "risk_duration": 27381705,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_W72",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "W72* MALIGNANT NEOPLASM **",
        "rr": 2.18,
        "risk_count": 12408,
        "predisposition_and_risk": 31,
        "risk_duration": 28073852,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_172.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "172.9* MELANOMA OF SKIN, SITE UNSPECIFIED",
        "rr": 2.17,
        "risk_count": 20175,
        "predisposition_and_risk": 56,
        "risk_duration": 22103491,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z37.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z37.8* REPLACEMENT, REVISION, AND REMOVAL OF CARDIAC PACEMAKER SYSTEM",
        "rr": 2.15,
        "risk_count": 5348,
        "predisposition_and_risk": 14,
        "risk_duration": 23206192,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_480_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "480 VIRAL PNEUMONIA",
        "rr": 2.15,
        "risk_count": 5783,
        "predisposition_and_risk": 14,
        "risk_duration": 28580007,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V85.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V85.3* BODY MASS INDEX BETWEEN 30-39, ADULT",
        "rr": 2.14,
        "risk_count": 6085,
        "predisposition_and_risk": 16,
        "risk_duration": 23018475,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_R74",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "R74* U.R.I. (HEAD COLD)",
        "rr": 2.14,
        "risk_count": 8935,
        "predisposition_and_risk": 24,
        "risk_duration": 22522524,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_S09",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "S09* INFECTED FINGER/TOE/PARONYCHIA",
        "rr": 2.14,
        "risk_count": 4967,
        "predisposition_and_risk": 13,
        "risk_duration": 23050734,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_281.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "281.9* UNSPECIFIED DEFICIENCY ANEMIA",
        "rr": 2.13,
        "risk_count": 6909,
        "predisposition_and_risk": 18,
        "risk_duration": 23058094,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_340.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "340.0* MULTIPLE SCLEROSIS",
        "rr": 2.13,
        "risk_count": 12869,
        "predisposition_and_risk": 32,
        "risk_duration": 27555970,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_611.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "611.7* SIGNS AND SYMPTOMS IN BREAST",
        "rr": 2.13,
        "risk_count": 5382,
        "predisposition_and_risk": 14,
        "risk_duration": 23099769,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.7* UNSPECIFIED BACTEREMIA",
        "rr": 2.13,
        "risk_count": 7519,
        "predisposition_and_risk": 18,
        "risk_duration": 28600451,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.8* OTHER RETINAL DISORDERS",
        "rr": 2.12,
        "risk_count": 10644,
        "predisposition_and_risk": 28,
        "risk_duration": 22703418,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V43.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V43.6* JOINT REPLACED BY OTHER MEANS",
        "rr": 2.12,
        "risk_count": 4276,
        "predisposition_and_risk": 11,
        "risk_duration": 23251103,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z87.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z87.4* OTHER X-RAY OF THORAX",
        "rr": 2.12,
        "risk_count": 49504,
        "predisposition_and_risk": 135,
        "risk_duration": 25026161,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_790_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790 NONSPECIFIC FINDINGS ON EXAMINATION OF BLOOD",
        "rr": 2.12,
        "risk_count": 26487,
        "predisposition_and_risk": 74,
        "risk_duration": 21429157,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_053.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "053.9* HERPES ZOSTER WITHOUT MENTION OF COMPLICATION",
        "rr": 2.11,
        "risk_count": 28710,
        "predisposition_and_risk": 81,
        "risk_duration": 21140600,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_584.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "584.9* ACUTE RENAL FAILURE, UNSPECIFIED",
        "rr": 2.11,
        "risk_count": 40602,
        "predisposition_and_risk": 118,
        "risk_duration": 20488774,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_600.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "600.2* BENIGN LOCALIZED HYPERPLASIA OF PROSTATE",
        "rr": 2.11,
        "risk_count": 5069,
        "predisposition_and_risk": 13,
        "risk_duration": 23253654,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_995.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "995.9* SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)",
        "rr": 2.11,
        "risk_count": 13670,
        "predisposition_and_risk": 33,
        "risk_duration": 28132656,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L10",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L10* ELBOW SYMPTOMS/COMPLAINTS",
        "rr": 2.11,
        "risk_count": 14779,
        "predisposition_and_risk": 37,
        "risk_duration": 27132312,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.6* ENLARGEMENT OF LYMPH NODES",
        "rr": 2.1,
        "risk_count": 25695,
        "predisposition_and_risk": 72,
        "risk_duration": 21166040,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_F02_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F02 DEMENTIA IN OTHER DISEASES CLASSIFIED ELSEWHERE",
        "rr": 2.1,
        "risk_count": 5503,
        "predisposition_and_risk": 14,
        "risk_duration": 23300439,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_530.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "530.8* OTHER SPECIFIED DISORDERS OF ESOPHAGUS",
        "rr": 2.09,
        "risk_count": 6621,
        "predisposition_and_risk": 17,
        "risk_duration": 22992781,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_783.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "783.0* ANOREXIA",
        "rr": 2.09,
        "risk_count": 8572,
        "predisposition_and_risk": 22,
        "risk_duration": 22939686,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_054.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "054.9* HERPES SIMPLEX WITHOUT MENTION OF COMPLICATION",
        "rr": 2.08,
        "risk_count": 8507,
        "predisposition_and_risk": 22,
        "risk_duration": 22683004,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_198.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "198.5* SECONDARY MALIGNANT NEOPLASM OF BONE AND BONE MARROW",
        "rr": 2.06,
        "risk_count": 4782,
        "predisposition_and_risk": 12,
        "risk_duration": 23215513,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_426.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "426.2* LEFT BUNDLE BRANCH HEMIBLOCK",
        "rr": 2.06,
        "risk_count": 8290,
        "predisposition_and_risk": 21,
        "risk_duration": 22998600,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V85.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V85.3* BODY MASS INDEX BETWEEN 30-39, ADULT",
        "rr": 2.06,
        "risk_count": 7289,
        "predisposition_and_risk": 17,
        "risk_duration": 28502387,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_428.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "428.3* DIASTOLIC HEART FAILURE",
        "rr": 2.05,
        "risk_count": 10653,
        "predisposition_and_risk": 27,
        "risk_duration": 22797614,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V71.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V71.9* OBSERVATION FOR UNSPECIFIED SUSPECTED CONDITION",
        "rr": 2.05,
        "risk_count": 8176,
        "predisposition_and_risk": 19,
        "risk_duration": 28380206,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z99.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.2* INJECT.OR INFUSION OF OTHER THERAPEUTIC OR PROPHYLACTIC SUBS.",
        "rr": 2.05,
        "risk_count": 48399,
        "predisposition_and_risk": 144,
        "risk_duration": 19413787,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z99.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.6* CONVERSION OF CARDIAC RHYTHM",
        "rr": 2.05,
        "risk_count": 8622,
        "predisposition_and_risk": 20,
        "risk_duration": 28539486,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_241_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "241 NONTOXIC NODULAR GOITER",
        "rr": 2.05,
        "risk_count": 7706,
        "predisposition_and_risk": 18,
        "risk_duration": 28325774,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_453.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "453.4* VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF LOWER EXTREMITY",
        "rr": 2.04,
        "risk_count": 4844,
        "predisposition_and_risk": 12,
        "risk_duration": 23188697,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.4* JAUNDICE, UNSPECIFIED, NOT OF NEWBORN",
        "rr": 2.04,
        "risk_count": 6370,
        "predisposition_and_risk": 16,
        "risk_duration": 22969911,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_276.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "276.8* HYPOPOTASSEMIA",
        "rr": 2.03,
        "risk_count": 14960,
        "predisposition_and_risk": 35,
        "risk_duration": 27890253,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_518.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "518.4* ACUTE EDEMA OF LUNG, UNSPECIFIED",
        "rr": 2.03,
        "risk_count": 8411,
        "predisposition_and_risk": 21,
        "risk_duration": 22929404,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "722.7* INTERVERTEBRAL DISC DISORDER WITH MYELOPATHY",
        "rr": 2.03,
        "risk_count": 10690,
        "predisposition_and_risk": 25,
        "risk_duration": 27981319,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_785.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.5* SHOCK WITHOUT MENTION OF TRAUMA",
        "rr": 2.02,
        "risk_count": 7462,
        "predisposition_and_risk": 17,
        "risk_duration": 28565562,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_424.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "424.2* TRICUSPID VALVE DISORDERS, SPECIFIED AS NONRHEUMATIC",
        "rr": 2.01,
        "risk_count": 12257,
        "predisposition_and_risk": 28,
        "risk_duration": 28302712,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_454.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "454.3* VARICOSE VEINS SEVERE",
        "rr": 2.01,
        "risk_count": 4879,
        "predisposition_and_risk": 12,
        "risk_duration": 23079445,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_041.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.4* ESCHERICHIA COLI(E. COLI),CONDITI.CLASSIF.ELSEWHERE,UNSP.SITE",
        "rr": 2,
        "risk_count": 12720,
        "predisposition_and_risk": 29,
        "risk_duration": 28191571,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_282.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "282.4* THALASSEMIAS",
        "rr": 2,
        "risk_count": 9637,
        "predisposition_and_risk": 22,
        "risk_duration": 28268563,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_728.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "728.2* MUSCULAR WASTING AND DISUSE ATROPHY, NOT ELSEWHERE CLASSIFIED",
        "rr": 2,
        "risk_count": 10483,
        "predisposition_and_risk": 24,
        "risk_duration": 28210919,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.0* SOFT TISSUE X-RAY OF ABDOMEN",
        "rr": 2,
        "risk_count": 14719,
        "predisposition_and_risk": 34,
        "risk_duration": 27896411,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_382.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "382.3* UNSPECIFIED CHRONIC SUPPURATIVE OTITIS MEDIA",
        "rr": 1.99,
        "risk_count": 10858,
        "predisposition_and_risk": 27,
        "risk_duration": 22527061,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_426.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "426.3* OTHER LEFT BUNDLE BRANCH BLOCK",
        "rr": 1.99,
        "risk_count": 5375,
        "predisposition_and_risk": 13,
        "risk_duration": 23201640,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_790.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.9* OTHER NONSPECIFIC FINDINGS ON EXAMINATION OF BLOOD",
        "rr": 1.99,
        "risk_count": 6576,
        "predisposition_and_risk": 16,
        "risk_duration": 23056277,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_727.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "727.4* GANGLION AND CYST OF SYNOVIUM, TENDON, AND BURSA",
        "rr": 1.98,
        "risk_count": 6154,
        "predisposition_and_risk": 15,
        "risk_duration": 22888235,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_783.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "783.1* ABNORMAL WEIGHT GAIN",
        "rr": 1.98,
        "risk_count": 9250,
        "predisposition_and_risk": 21,
        "risk_duration": 28098224,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_K90",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "K90* STROKE/CEREBROVASC.ACC.",
        "rr": 1.97,
        "risk_count": 6322,
        "predisposition_and_risk": 14,
        "risk_duration": 28618752,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L89",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L89* OSTEOARTHRITIS OF HIP",
        "rr": 1.97,
        "risk_count": 14982,
        "predisposition_and_risk": 34,
        "risk_duration": 27924654,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_009.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "009.0* INFECTIOUS COLITIS, ENTERITIS, AND GASTROENTERITIS",
        "rr": 1.96,
        "risk_count": 9764,
        "predisposition_and_risk": 22,
        "risk_duration": 27986640,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_276.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "276.5* VOLUME DEPLETION DISORDER",
        "rr": 1.96,
        "risk_count": 15445,
        "predisposition_and_risk": 38,
        "risk_duration": 22456872,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_730.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "730.0* ACUTE OSTEOMYELITIS",
        "rr": 1.96,
        "risk_count": 7674,
        "predisposition_and_risk": 17,
        "risk_duration": 28451828,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V72.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V72.0* EXAMINATION OF EYES AND VISION",
        "rr": 1.96,
        "risk_count": 4606,
        "predisposition_and_risk": 11,
        "risk_duration": 23193496,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_041.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.3* FRIEDLANDER'S BACILLUS;CONDITION CLASSIF.ELSEWHERE,UNSP.SITE",
        "rr": 1.95,
        "risk_count": 5465,
        "predisposition_and_risk": 13,
        "risk_duration": 23170645,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_381.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "381.4* NONSUPPURATIVE OTITIS MEDIA, NOT SPECIFIED AS ACUTE OR CHRONIC",
        "rr": 1.95,
        "risk_count": 8532,
        "predisposition_and_risk": 19,
        "risk_duration": 28188732,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_721.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721.3* LUMBOSACRAL SPONDYLOSIS WITHOUT MYELOPATHY",
        "rr": 1.95,
        "risk_count": 17656,
        "predisposition_and_risk": 44,
        "risk_duration": 22057574,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_753.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "753.1* CONGENITAL CYSTIC KIDNEY DISEASE",
        "rr": 1.95,
        "risk_count": 15488,
        "predisposition_and_risk": 35,
        "risk_duration": 27839720,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V13.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V13.0* PERSONAL HISTORY OF DISORDERS OF URINARY SYSTEM",
        "rr": 1.95,
        "risk_count": 5466,
        "predisposition_and_risk": 13,
        "risk_duration": 23177563,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_367.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "367.2* ASTIGMATISM",
        "rr": 1.94,
        "risk_count": 18689,
        "predisposition_and_risk": 47,
        "risk_duration": 21811284,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_698.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698.0* PRURITUS ANI",
        "rr": 1.94,
        "risk_count": 10337,
        "predisposition_and_risk": 23,
        "risk_duration": 28031646,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_280_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "280 IRON DEFICIENCY ANEMIAS",
        "rr": 1.94,
        "risk_count": 6806,
        "predisposition_and_risk": 15,
        "risk_duration": 28409934,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_441_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "441 AORTIC ANEURYSM",
        "rr": 1.94,
        "risk_count": 14107,
        "predisposition_and_risk": 34,
        "risk_duration": 22707718,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_367.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "367.2* ASTIGMATISM",
        "rr": 1.93,
        "risk_count": 23984,
        "predisposition_and_risk": 56,
        "risk_duration": 26633220,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_924.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "924.2* CONTUSION OF ANKLE AND FOOT, EXCLUDING TOE(S)",
        "rr": 1.93,
        "risk_count": 16950,
        "predisposition_and_risk": 39,
        "risk_duration": 27054058,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_112.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "112.0* CANDIDIASIS OF MOUTH",
        "rr": 1.92,
        "risk_count": 6355,
        "predisposition_and_risk": 15,
        "risk_duration": 22986630,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z68.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z68.9* OTHER AND UNSPECIFIED HYSTERECTOMY",
        "rr": 1.92,
        "risk_count": 7794,
        "predisposition_and_risk": 17,
        "risk_duration": 28380084,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A28",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A28* DISABILITY/IMPAIRMENT NOS",
        "rr": 1.92,
        "risk_count": 13340,
        "predisposition_and_risk": 32,
        "risk_duration": 22639395,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_997.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "997.9* COMPLICATIONS AFFECTING SPECIFIED BODY SYSTEMS,NOT ELSEW.CLASS.",
        "rr": 1.91,
        "risk_count": 7258,
        "predisposition_and_risk": 17,
        "risk_duration": 22988203,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_367_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "367 DISORDERS OF REFRACTION AND ACCOMMODATION",
        "rr": 1.91,
        "risk_count": 6790,
        "predisposition_and_risk": 16,
        "risk_duration": 22892841,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_F01_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F01 VASCULAR DEMENTIA",
        "rr": 1.91,
        "risk_count": 6920,
        "predisposition_and_risk": 15,
        "risk_duration": 28414227,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_444.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "444.2* EMBOLISM AND THROMBOSIS OF ARTERIES OF THE EXTREMITIES",
        "rr": 1.89,
        "risk_count": 7739,
        "predisposition_and_risk": 18,
        "risk_duration": 22940018,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_930.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "930.0* CORNEAL FOREIGN BODY",
        "rr": 1.89,
        "risk_count": 10755,
        "predisposition_and_risk": 26,
        "risk_duration": 22028120,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_F43.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F43.2* ADJUSTMENT DISORDERS",
        "rr": 1.89,
        "risk_count": 10116,
        "predisposition_and_risk": 22,
        "risk_duration": 27946133,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z01.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z01.2* CRANIOTOMY AND CRANIECTOMY",
        "rr": 1.88,
        "risk_count": 7787,
        "predisposition_and_risk": 18,
        "risk_duration": 22897219,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_285.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "285.9* ANEMIA, UNSPECIFIED",
        "rr": 1.87,
        "risk_count": 64756,
        "predisposition_and_risk": 162,
        "risk_duration": 24052354,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_368.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368.1* SUBJECTIVE VISUAL DISTURBANCES",
        "rr": 1.87,
        "risk_count": 4833,
        "predisposition_and_risk": 11,
        "risk_duration": 23161204,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_785.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.4* GANGRENE",
        "rr": 1.87,
        "risk_count": 12199,
        "predisposition_and_risk": 26,
        "risk_duration": 28199790,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_907.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "907.1* LATE EFFECT OF INJURY TO CRANIAL NERVE",
        "rr": 1.87,
        "risk_count": 24509,
        "predisposition_and_risk": 61,
        "risk_duration": 21207381,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_506.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "506.1* ACUTE PULMONARY EDEMA DUE TO FUMES AND VAPORS",
        "rr": 1.86,
        "risk_count": 25028,
        "predisposition_and_risk": 60,
        "risk_duration": 21854361,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_729.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "729.2* NEURALGIA, NEURITIS, AND RADICULITIS, UNSPECIFIED",
        "rr": 1.86,
        "risk_count": 40817,
        "predisposition_and_risk": 112,
        "risk_duration": 19144871,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_730.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "730.1* CHRONIC OSTEOMYELITIS",
        "rr": 1.86,
        "risk_count": 9005,
        "predisposition_and_risk": 19,
        "risk_duration": 28337666,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_782.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.2* LOCALIZED SUPERFICIAL SWELLING, MASS, OR LUMP",
        "rr": 1.86,
        "risk_count": 17331,
        "predisposition_and_risk": 38,
        "risk_duration": 27283567,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_041.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.8* OTHER SPEC.BACTERIAL INF;IN CONDIT.CLASS.ELSEWHERE,UNSP.SITE",
        "rr": 1.85,
        "risk_count": 5761,
        "predisposition_and_risk": 12,
        "risk_duration": 28622188,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_523.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "523.0* ACUTE GINGIVITIS",
        "rr": 1.85,
        "risk_count": 5735,
        "predisposition_and_risk": 12,
        "risk_duration": 28438472,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_704.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "704.9* UNSPECIFIED DISEASE OF HAIR AND HAIR FOLLICLES",
        "rr": 1.85,
        "risk_count": 9460,
        "predisposition_and_risk": 20,
        "risk_duration": 28187762,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_714.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "714.0* RHEUMATOID ARTHRITIS",
        "rr": 1.85,
        "risk_count": 20461,
        "predisposition_and_risk": 49,
        "risk_duration": 21848527,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_584_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "584 ACUTE RENAL FAILURE",
        "rr": 1.85,
        "risk_count": 31735,
        "predisposition_and_risk": 79,
        "risk_duration": 20940983,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_275.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "275.4* DISORDERS OF CALCIUM METABOLISM",
        "rr": 1.84,
        "risk_count": 34079,
        "predisposition_and_risk": 77,
        "risk_duration": 26287205,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_298.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "298.2* REACTIVE CONFUSION",
        "rr": 1.82,
        "risk_count": 9737,
        "predisposition_and_risk": 20,
        "risk_duration": 28493766,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_530.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "530.2* ULCER OF ESOPHAGUS",
        "rr": 1.81,
        "risk_count": 6775,
        "predisposition_and_risk": 15,
        "risk_duration": 23021676,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V15.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V15.8* OTHER SPECIFIED PERSONAL HISTORY PRESENTING HAZARDS TO HEALTH",
        "rr": 1.81,
        "risk_count": 29266,
        "predisposition_and_risk": 64,
        "risk_duration": 26689481,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V45.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V45.7* ACQUIRED ABSENCE OF ORGAN",
        "rr": 1.81,
        "risk_count": 6341,
        "predisposition_and_risk": 14,
        "risk_duration": 23118743,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z93.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z93.8* OTHER REHABILITATION THERAPY",
        "rr": 1.81,
        "risk_count": 11117,
        "predisposition_and_risk": 23,
        "risk_duration": 28250403,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_276.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "276.8* HYPOPOTASSEMIA",
        "rr": 1.8,
        "risk_count": 13695,
        "predisposition_and_risk": 31,
        "risk_duration": 22498851,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_429.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "429.3* CARDIOMEGALY",
        "rr": 1.8,
        "risk_count": 14589,
        "predisposition_and_risk": 33,
        "risk_duration": 22451025,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_593.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "593.2* CYST OF KIDNEY, ACQUIRED",
        "rr": 1.8,
        "risk_count": 13074,
        "predisposition_and_risk": 27,
        "risk_duration": 28121687,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z87.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z87.4* OTHER X-RAY OF THORAX",
        "rr": 1.8,
        "risk_count": 52050,
        "predisposition_and_risk": 140,
        "risk_duration": 18920768,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_035",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "035* ERYSIPELAS",
        "rr": 1.8,
        "risk_count": 19435,
        "predisposition_and_risk": 41,
        "risk_duration": 27500439,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_241.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "241.1* NONTOXIC MULTINODULAR GOITER",
        "rr": 1.79,
        "risk_count": 53817,
        "predisposition_and_risk": 130,
        "risk_duration": 23885814,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_257.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "257.2* OTHER TESTICULAR HYPOFUNCTION",
        "rr": 1.79,
        "risk_count": 12034,
        "predisposition_and_risk": 27,
        "risk_duration": 22569022,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_384.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "384.2* PERFORATION OF TYMPANIC MEMBRANE",
        "rr": 1.79,
        "risk_count": 10731,
        "predisposition_and_risk": 22,
        "risk_duration": 28130876,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_923.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "923.3* CONTUSION OF FINGER",
        "rr": 1.79,
        "risk_count": 6856,
        "predisposition_and_risk": 14,
        "risk_duration": 28260288,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.3* OTHER X-RAY",
        "rr": 1.79,
        "risk_count": 8146,
        "predisposition_and_risk": 18,
        "risk_duration": 22883889,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L89",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L89* OSTEOARTHRITIS OF HIP",
        "rr": 1.79,
        "risk_count": 9030,
        "predisposition_and_risk": 20,
        "risk_duration": 22804371,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_N01",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "N01* HEADACHE (EXCL.R09;N89)",
        "rr": 1.79,
        "risk_count": 5026,
        "predisposition_and_risk": 11,
        "risk_duration": 23025467,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_424.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "424.2* TRICUSPID VALVE DISORDERS, SPECIFIED AS NONRHEUMATIC",
        "rr": 1.78,
        "risk_count": 10019,
        "predisposition_and_risk": 22,
        "risk_duration": 22813050,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V12.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V12.5* PERSONAL HISTORY OF DISEASES OF CIRCULATORY SYSTEM",
        "rr": 1.78,
        "risk_count": 33034,
        "predisposition_and_risk": 71,
        "risk_duration": 26724228,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L11",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L11* WRIST SYMPTOMS/COMPLAINTS",
        "rr": 1.78,
        "risk_count": 9773,
        "predisposition_and_risk": 22,
        "risk_duration": 22373067,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_009.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "009.2* INFECTIOUS DIARRHEA",
        "rr": 1.77,
        "risk_count": 20961,
        "predisposition_and_risk": 49,
        "risk_duration": 21379742,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_227.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "227.1* BENIGN NEOPLASM OF PARATHYROID GLAND",
        "rr": 1.77,
        "risk_count": 6010,
        "predisposition_and_risk": 12,
        "risk_duration": 28607861,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_009.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "009.0* INFECTIOUS COLITIS, ENTERITIS, AND GASTROENTERITIS",
        "rr": 1.76,
        "risk_count": 6879,
        "predisposition_and_risk": 15,
        "risk_duration": 22829292,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_426.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "426.4* RIGHT BUNDLE BRANCH BLOCK",
        "rr": 1.76,
        "risk_count": 10107,
        "predisposition_and_risk": 22,
        "risk_duration": 22830080,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_458.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "458.9* HYPOTENSION, UNSPECIFIED",
        "rr": 1.76,
        "risk_count": 10093,
        "predisposition_and_risk": 22,
        "risk_duration": 22743150,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_550.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "550.9* INGUINAL HERNIA, WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "rr": 1.76,
        "risk_count": 10439,
        "predisposition_and_risk": 21,
        "risk_duration": 28157339,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V10.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V10.4* PERSONAL HISTORY OF MALIGNANT NEOPLASM OF GENITAL ORGANS",
        "rr": 1.76,
        "risk_count": 5573,
        "predisposition_and_risk": 11,
        "risk_duration": 28725756,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_386_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "386 VERTIGINOUS SYNDROMES AND OTHER DISORDERS OF VESTIBULAR SYSTEM",
        "rr": 1.76,
        "risk_count": 9182,
        "predisposition_and_risk": 20,
        "risk_duration": 22768024,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "722.1* DISPL.OF THORACIC OR LUMBAR INTERVERT.DISC WITHOUT MYELOPATHY",
        "rr": 1.75,
        "risk_count": 34502,
        "predisposition_and_risk": 77,
        "risk_duration": 25251800,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z60.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z60.6* OTHER PROSTATECTOMY",
        "rr": 1.75,
        "risk_count": 15638,
        "predisposition_and_risk": 34,
        "risk_duration": 22662722,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_682_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "682 OTHER CELLULITIS AND ABSCESS",
        "rr": 1.75,
        "risk_count": 10480,
        "predisposition_and_risk": 21,
        "risk_duration": 28106026,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A28",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A28* DISABILITY/IMPAIRMENT NOS",
        "rr": 1.75,
        "risk_count": 17422,
        "predisposition_and_risk": 35,
        "risk_duration": 28027673,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L71",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L71* NEOPLASMS",
        "rr": 1.75,
        "risk_count": 6086,
        "predisposition_and_risk": 13,
        "risk_duration": 23074855,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_241.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "241.0* NONTOXIC UNINODULAR GOITER",
        "rr": 1.74,
        "risk_count": 11563,
        "predisposition_and_risk": 25,
        "risk_duration": 22653664,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_595.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "595.0* ACUTE CYSTITIS",
        "rr": 1.74,
        "risk_count": 7097,
        "predisposition_and_risk": 14,
        "risk_duration": 28396954,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_738.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "738.4* ACQUIRED SPONDYLOLISTHESIS",
        "rr": 1.74,
        "risk_count": 7461,
        "predisposition_and_risk": 16,
        "risk_duration": 22904916,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z45.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z45.7* PARTIAL EXCISION OF LARGE INTESTINE",
        "rr": 1.74,
        "risk_count": 6120,
        "predisposition_and_risk": 12,
        "risk_duration": 28623319,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_053.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "053.9* HERPES ZOSTER WITHOUT MENTION OF COMPLICATION",
        "rr": 1.73,
        "risk_count": 41507,
        "predisposition_and_risk": 91,
        "risk_duration": 25350594,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_366.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "366.5* AFTER-CATARACT",
        "rr": 1.73,
        "risk_count": 21466,
        "predisposition_and_risk": 47,
        "risk_duration": 22234131,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_511.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "511.9* UNSPECIFIED PLEURAL EFFUSION",
        "rr": 1.73,
        "risk_count": 18465,
        "predisposition_and_risk": 37,
        "risk_duration": 27825051,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_696.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "696.0* PSORIATIC ARTHROPATHY",
        "rr": 1.73,
        "risk_count": 16180,
        "predisposition_and_risk": 33,
        "risk_duration": 27336669,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_793.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "793.8* NONSPECIFIC ABNORMAL FINDINGS ,BREAST",
        "rr": 1.73,
        "risk_count": 6628,
        "predisposition_and_risk": 13,
        "risk_duration": 28468599,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V45.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V45.0* POSTSURGICAL CARDIAC PACEMAKER IN SITU",
        "rr": 1.73,
        "risk_count": 15587,
        "predisposition_and_risk": 31,
        "risk_duration": 28090144,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_382.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "382.3* UNSPECIFIED CHRONIC SUPPURATIVE OTITIS MEDIA",
        "rr": 1.72,
        "risk_count": 12125,
        "predisposition_and_risk": 24,
        "risk_duration": 27985718,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z93.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z93.0* DIAGNOSTIC PHYSICAL THERAPY",
        "rr": 1.72,
        "risk_count": 8979,
        "predisposition_and_risk": 19,
        "risk_duration": 22889461,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z95.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z95.0* GENERAL AND SUBJECTIVE EYE EXAMINATION",
        "rr": 1.72,
        "risk_count": 30501,
        "predisposition_and_risk": 64,
        "risk_duration": 26408798,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_959.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "959.0* OTHER AND UNSPECIFIED INJURY TO FACE AND NECK",
        "rr": 1.71,
        "risk_count": 8271,
        "predisposition_and_risk": 16,
        "risk_duration": 28428069,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_245.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "245.2* CHRONIC LYMPHOCYTIC THYROIDITIS",
        "rr": 1.7,
        "risk_count": 15529,
        "predisposition_and_risk": 31,
        "risk_duration": 27370521,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_250.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "250.9* DIABETES WITH UNSPECIFIED COMPLICATION",
        "rr": 1.7,
        "risk_count": 9533,
        "predisposition_and_risk": 20,
        "risk_duration": 22824575,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_368.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368.3* OTHER DISORDERS OF BINOCULAR VISION",
        "rr": 1.7,
        "risk_count": 6742,
        "predisposition_and_risk": 13,
        "risk_duration": 28425287,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_374.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "374.8* OTHER DISORDERS OF EYELID",
        "rr": 1.7,
        "risk_count": 8584,
        "predisposition_and_risk": 18,
        "risk_duration": 22862358,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_388.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "388.0* DEGENERATIVE AND VASCULAR DISORDERS OF EAR",
        "rr": 1.7,
        "risk_count": 5328,
        "predisposition_and_risk": 11,
        "risk_duration": 23267252,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_394.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "394.1* RHEUMATIC MITRAL INSUFFICIENCY",
        "rr": 1.7,
        "risk_count": 10355,
        "predisposition_and_risk": 20,
        "risk_duration": 28290453,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_426.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "426.2* LEFT BUNDLE BRANCH HEMIBLOCK",
        "rr": 1.7,
        "risk_count": 7845,
        "predisposition_and_risk": 15,
        "risk_duration": 28601044,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_735.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "735.4* OTHER HAMMER TOE (ACQUIRED)",
        "rr": 1.7,
        "risk_count": 5745,
        "predisposition_and_risk": 11,
        "risk_duration": 28637199,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z95.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z95.4* NONOPERATIVE PROCEDURES RELATED TO HEARING",
        "rr": 1.7,
        "risk_count": 14111,
        "predisposition_and_risk": 28,
        "risk_duration": 27677645,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_556_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "556 IDIOPATHIC PROCTOCOLITIS",
        "rr": 1.7,
        "risk_count": 13738,
        "predisposition_and_risk": 27,
        "risk_duration": 27812559,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_518.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "518.8* OTHER DISEASES OF LUNG, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.69,
        "risk_count": 20295,
        "predisposition_and_risk": 40,
        "risk_duration": 27678407,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.2* FUNCTIONAL AND UNDIAGNOSED CARDIAC MURMURS",
        "rr": 1.69,
        "risk_count": 5319,
        "predisposition_and_risk": 11,
        "risk_duration": 23094004,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_240.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "240.0* GOITER, SPECIFIED AS SIMPLE",
        "rr": 1.68,
        "risk_count": 8675,
        "predisposition_and_risk": 18,
        "risk_duration": 22831576,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_351.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "351.0* BELL'S PALSY",
        "rr": 1.68,
        "risk_count": 20509,
        "predisposition_and_risk": 41,
        "risk_duration": 27046602,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_411.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "411.8* OTHER ACUTE AND SUBACUTE FORMS OF ISCHEMIC HEART DISEASE",
        "rr": 1.68,
        "risk_count": 11884,
        "predisposition_and_risk": 25,
        "risk_duration": 22598961,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_730.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "730.1* CHRONIC OSTEOMYELITIS",
        "rr": 1.68,
        "risk_count": 14117,
        "predisposition_and_risk": 30,
        "risk_duration": 22248540,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_E85.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "E85.8* ACCIDENTAL POISONING BY OTHER DRUGS",
        "rr": 1.68,
        "risk_count": 5869,
        "predisposition_and_risk": 12,
        "risk_duration": 23170992,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_357_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "357 INFLAMMATORY AND TOXIC NEUROPATHY",
        "rr": 1.68,
        "risk_count": 31365,
        "predisposition_and_risk": 71,
        "risk_duration": 20948446,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_S02",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "S02* PRURITUS; SKIN ITCHING",
        "rr": 1.68,
        "risk_count": 27623,
        "predisposition_and_risk": 56,
        "risk_duration": 26755569,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_783.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "783.2* ABNORMAL LOSS OF WEIGHT",
        "rr": 1.67,
        "risk_count": 61401,
        "predisposition_and_risk": 139,
        "risk_duration": 23764156,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_922.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "922.1* CONTUSION OF CHEST WALL",
        "rr": 1.67,
        "risk_count": 34601,
        "predisposition_and_risk": 73,
        "risk_duration": 25487166,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_922.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "922.3* CONTUSION OF BACK",
        "rr": 1.67,
        "risk_count": 28856,
        "predisposition_and_risk": 60,
        "risk_duration": 25825358,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_995.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "995.2* UNSP.ADV.EFFECT OF DRUG,MEDICINAL/BIOLOGICAL SUBSTANCE N.E.S.",
        "rr": 1.67,
        "risk_count": 18232,
        "predisposition_and_risk": 39,
        "risk_duration": 22085277,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z40.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z40.2* SIMPLE EXCISION OF LYMPHATIC STRUCTURE",
        "rr": 1.67,
        "risk_count": 6356,
        "predisposition_and_risk": 12,
        "risk_duration": 28580616,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z86.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z86.2* EXC.OR DESTRUCT.OF LESION OF SKIN AND SUBCUTANEOUS TISSUE",
        "rr": 1.67,
        "risk_count": 5859,
        "predisposition_and_risk": 11,
        "risk_duration": 28626651,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L10",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L10* ELBOW SYMPTOMS/COMPLAINTS",
        "rr": 1.67,
        "risk_count": 13031,
        "predisposition_and_risk": 28,
        "risk_duration": 21892786,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_368.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368.2* DIPLOPIA",
        "rr": 1.66,
        "risk_count": 11108,
        "predisposition_and_risk": 23,
        "risk_duration": 22627102,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_380.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "380.2* OTHER OTITIS EXTERNA",
        "rr": 1.66,
        "risk_count": 6888,
        "predisposition_and_risk": 13,
        "risk_duration": 28381156,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_428.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "428.0* CONGESTIVE HEART FAILURE",
        "rr": 1.66,
        "risk_count": 9712,
        "predisposition_and_risk": 20,
        "risk_duration": 22717523,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_783.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "783.0* ANOREXIA",
        "rr": 1.66,
        "risk_count": 9574,
        "predisposition_and_risk": 18,
        "risk_duration": 28376480,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.1* PERSONAL HISTORY OF ALLERGY TO OTHER ANTIBIOTIC AGENT",
        "rr": 1.66,
        "risk_count": 21959,
        "predisposition_and_risk": 43,
        "risk_duration": 27345930,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z39.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z39.2* OTHER SHUNT OR VASCULAR BYPASS",
        "rr": 1.66,
        "risk_count": 11650,
        "predisposition_and_risk": 22,
        "risk_duration": 28239277,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_280.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "280.0* IRON DEFICIENCY ANEMIA SECONDARY TO BLOOD LOSS (CHRONIC)",
        "rr": 1.65,
        "risk_count": 5978,
        "predisposition_and_risk": 12,
        "risk_duration": 23127349,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_368.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368.8* OTHER SPECIFIED VISUAL DISTURBANCES",
        "rr": 1.65,
        "risk_count": 29714,
        "predisposition_and_risk": 60,
        "risk_duration": 26312412,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_590.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "590.1* ACUTE PYELONEPHRITIS",
        "rr": 1.65,
        "risk_count": 8470,
        "predisposition_and_risk": 16,
        "risk_duration": 28117327,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_999.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "999.9* UNSPECIFIED COMPLICATIONS OF MEDICAL CARE,NOT ELSEW.CLASSIFIED",
        "rr": 1.65,
        "risk_count": 27922,
        "predisposition_and_risk": 61,
        "risk_duration": 21332777,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V15.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V15.3* PERSONAL HISTORY OF IRRADIATION, PRESENTING HAZARDS TO HEALTH",
        "rr": 1.65,
        "risk_count": 8050,
        "predisposition_and_risk": 15,
        "risk_duration": 28512076,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V58.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V58.7* ENCOUNTER FOR AFTERCARE FOLLOWING SURGERY TO SPECIF.BODY SYSTEMS, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.65,
        "risk_count": 9068,
        "predisposition_and_risk": 17,
        "risk_duration": 28393418,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z68.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z68.4* TOTAL ABDOMINAL HYSTERECTOMY",
        "rr": 1.65,
        "risk_count": 11602,
        "predisposition_and_risk": 22,
        "risk_duration": 27966257,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L13",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L13* HIP SYMPTOMS/COMPLAINTS",
        "rr": 1.65,
        "risk_count": 66371,
        "predisposition_and_risk": 155,
        "risk_duration": 22746506,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_799.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "799.9* UNKNOWN OR UNSPECIFIED CAUSE OF MORBIDITY (DIAGNOSIS DEFERRED)",
        "rr": 1.64,
        "risk_count": 9145,
        "predisposition_and_risk": 17,
        "risk_duration": 28345601,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A05",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A05* GENERAL DETERIORATION",
        "rr": 1.64,
        "risk_count": 25016,
        "predisposition_and_risk": 48,
        "risk_duration": 27531175,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_562.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "562.1* DIVERTICULA OF COLON",
        "rr": 1.63,
        "risk_count": 28333,
        "predisposition_and_risk": 61,
        "risk_duration": 21307570,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_618.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "618.2* UTEROVAGINAL PROLAPSE, INCOMPLETE",
        "rr": 1.63,
        "risk_count": 7589,
        "predisposition_and_risk": 14,
        "risk_duration": 28480992,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_726.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "726.6* ENTHESOPATHY OF KNEE",
        "rr": 1.63,
        "risk_count": 19067,
        "predisposition_and_risk": 37,
        "risk_duration": 27091321,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_923.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "923.1* CONTUSION OF ELBOW AND FOREARM",
        "rr": 1.63,
        "risk_count": 8549,
        "predisposition_and_risk": 16,
        "risk_duration": 28130297,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.8* PERSONAL HISTORY OF ALLERGY TO SPECIFIED MEDICINAL AGENTS",
        "rr": 1.63,
        "risk_count": 51243,
        "predisposition_and_risk": 107,
        "risk_duration": 25197442,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z89.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z89.5* OTHER NONOPERATIVE CARDIAC AND VASCULAR DIAGNOSTIC PROCEDURES",
        "rr": 1.63,
        "risk_count": 32844,
        "predisposition_and_risk": 65,
        "risk_duration": 26500510,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L71",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L71* NEOPLASMS",
        "rr": 1.63,
        "risk_count": 7064,
        "predisposition_and_risk": 13,
        "risk_duration": 28485951,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_428.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "428.0* CONGESTIVE HEART FAILURE",
        "rr": 1.62,
        "risk_count": 6575,
        "predisposition_and_risk": 12,
        "risk_duration": 28601667,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_477.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "477.9* ALLERGIC RHINITIS, CAUSE UNSPECIFIED",
        "rr": 1.62,
        "risk_count": 9476,
        "predisposition_and_risk": 19,
        "risk_duration": 22735687,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z39.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z39.9* OTHER OPERATIONS ON VESSELS",
        "rr": 1.62,
        "risk_count": 50271,
        "predisposition_and_risk": 104,
        "risk_duration": 25231362,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_714_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "714 RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY POLYARTHROPATHIES",
        "rr": 1.62,
        "risk_count": 11793,
        "predisposition_and_risk": 22,
        "risk_duration": 27982338,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "9* HYPERTENSION ROUTINE FOLLOW UP",
        "rr": 1.62,
        "risk_count": 9887,
        "predisposition_and_risk": 20,
        "risk_duration": 22624844,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_374.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "374.8* OTHER DISORDERS OF EYELID",
        "rr": 1.61,
        "risk_count": 18052,
        "predisposition_and_risk": 34,
        "risk_duration": 27613673,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_511.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "511.8* OTHER SPECIFIED FORMS OF PLEURAL EFFUSION, EXCEPT TUBERCULOUS",
        "rr": 1.61,
        "risk_count": 27904,
        "predisposition_and_risk": 59,
        "risk_duration": 21537098,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_511.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "511.9* UNSPECIFIED PLEURAL EFFUSION",
        "rr": 1.61,
        "risk_count": 23502,
        "predisposition_and_risk": 49,
        "risk_duration": 21816996,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_794.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "794.3* NONSPECIFIC ABNORMAL RESULTS OF CARDIOVASCULAR SYSTEM",
        "rr": 1.61,
        "risk_count": 9322,
        "predisposition_and_risk": 17,
        "risk_duration": 28365512,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_816.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "816.0* CLOSED FRACTURE OF ONE OR MORE PHALANGES OF HAND",
        "rr": 1.61,
        "risk_count": 11789,
        "predisposition_and_risk": 22,
        "risk_duration": 27804610,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V43.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V43.1* LENS REPLACED BY OTHER MEANS",
        "rr": 1.61,
        "risk_count": 23312,
        "predisposition_and_risk": 48,
        "risk_duration": 22025293,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z39.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z39.9* OTHER OPERATIONS ON VESSELS",
        "rr": 1.61,
        "risk_count": 56829,
        "predisposition_and_risk": 142,
        "risk_duration": 18148984,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_820_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "820 FRACTURE OF NECK OF FEMUR",
        "rr": 1.61,
        "risk_count": 8793,
        "predisposition_and_risk": 16,
        "risk_duration": 28487593,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_285.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "285.9* ANEMIA, UNSPECIFIED",
        "rr": 1.6,
        "risk_count": 62115,
        "predisposition_and_risk": 151,
        "risk_duration": 18575700,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "726.6* ENTHESOPATHY OF KNEE",
        "rr": 1.6,
        "risk_count": 10437,
        "predisposition_and_risk": 21,
        "risk_duration": 22487949,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z65.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z65.6* BILATERAL SALPINGO-OOPHORECTOMY",
        "rr": 1.6,
        "risk_count": 7184,
        "predisposition_and_risk": 13,
        "risk_duration": 28437393,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_472.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "472.0* CHRONIC RHINITIS",
        "rr": 1.59,
        "risk_count": 15811,
        "predisposition_and_risk": 32,
        "risk_duration": 22156560,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_704.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "704.8* OTHER SPECIFIED DISEASES OF HAIR AND HAIR FOLLICLES",
        "rr": 1.59,
        "risk_count": 8772,
        "predisposition_and_risk": 16,
        "risk_duration": 28041207,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_728.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "728.8* OTHER DISORDERS OF MUSCLE, LIGAMENT, AND FASCIA",
        "rr": 1.59,
        "risk_count": 34486,
        "predisposition_and_risk": 68,
        "risk_duration": 25921387,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z47.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z47.0* APPENDECTOMY",
        "rr": 1.59,
        "risk_count": 6614,
        "predisposition_and_risk": 13,
        "risk_duration": 22891726,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_581_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "581 NEPHROTIC SYNDROME",
        "rr": 1.59,
        "risk_count": 11989,
        "predisposition_and_risk": 22,
        "risk_duration": 27971385,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_280.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "280.1* IRON DEF.ANEMIA SECONDARY TO INADEQUATE DIETARY IRON INTAKE",
        "rr": 1.58,
        "risk_count": 35255,
        "predisposition_and_risk": 68,
        "risk_duration": 26357147,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_565.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "565.0* ANAL FISSURE",
        "rr": 1.58,
        "risk_count": 22803,
        "predisposition_and_risk": 44,
        "risk_duration": 26414231,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_682.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "682.6* CELLULITIS AND ABSCESS OF LEG, EXCEPT FOOT",
        "rr": 1.58,
        "risk_count": 10580,
        "predisposition_and_risk": 19,
        "risk_duration": 28264968,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_691.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "691.8* OTHER ATOPIC DERMATITIS AND RELATED CONDITIONS",
        "rr": 1.58,
        "risk_count": 12036,
        "predisposition_and_risk": 24,
        "risk_duration": 22346023,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.9* OTHER GENERAL SYMPTOMS",
        "rr": 1.58,
        "risk_count": 34188,
        "predisposition_and_risk": 74,
        "risk_duration": 20603194,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_789.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "789.3* ABDOMINAL OR PELVIC SWELLING, MASS, OR LUMP",
        "rr": 1.58,
        "risk_count": 9465,
        "predisposition_and_risk": 17,
        "risk_duration": 28315437,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_473_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "473 CHRONIC SINUSITIS",
        "rr": 1.58,
        "risk_count": 18656,
        "predisposition_and_risk": 35,
        "risk_duration": 27181003,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_381.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "381.1* CHRONIC SEROUS OTITIS MEDIA",
        "rr": 1.57,
        "risk_count": 6699,
        "predisposition_and_risk": 13,
        "risk_duration": 22880591,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_458.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "458.9* HYPOTENSION, UNSPECIFIED",
        "rr": 1.57,
        "risk_count": 9552,
        "predisposition_and_risk": 17,
        "risk_duration": 28358044,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_610.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "610.1* DIFFUSE CYSTIC MASTOPATHY",
        "rr": 1.57,
        "risk_count": 21162,
        "predisposition_and_risk": 41,
        "risk_duration": 26085735,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_722.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "722.0* DISPLACEM.OF CERVICAL INTERVERTEBR.DISC WITHOUT MYELOPATHY",
        "rr": 1.57,
        "risk_count": 15246,
        "predisposition_and_risk": 31,
        "risk_duration": 21756365,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_788.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "788.0* RENAL COLIC",
        "rr": 1.57,
        "risk_count": 30608,
        "predisposition_and_risk": 61,
        "risk_duration": 25343502,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_791.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "791.0* PROTEINURIA",
        "rr": 1.57,
        "risk_count": 52419,
        "predisposition_and_risk": 108,
        "risk_duration": 24482186,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.8* OTHER RETINAL DISORDERS",
        "rr": 1.56,
        "risk_count": 11238,
        "predisposition_and_risk": 20,
        "risk_duration": 28200736,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_593.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "593.8* OTHER SPECIFIED DISORDERS OF KIDNEY AND URETER",
        "rr": 1.56,
        "risk_count": 6291,
        "predisposition_and_risk": 11,
        "risk_duration": 28666249,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_618.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "618.1* UTERINE PROLAPSE WITHOUT MENTION OF VAGINAL WALL PROLAPSE",
        "rr": 1.56,
        "risk_count": 15013,
        "predisposition_and_risk": 27,
        "risk_duration": 27874086,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V43.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V43.3* HEART VALVE REPLACED BY OTHER MEANS",
        "rr": 1.56,
        "risk_count": 13933,
        "predisposition_and_risk": 25,
        "risk_duration": 28037808,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_357_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "357 INFLAMMATORY AND TOXIC NEUROPATHY",
        "rr": 1.56,
        "risk_count": 27184,
        "predisposition_and_risk": 51,
        "risk_duration": 26858025,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_298.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "298.9* UNSPECIFIED PSYCHOSIS",
        "rr": 1.55,
        "risk_count": 9692,
        "predisposition_and_risk": 17,
        "risk_duration": 28510539,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.9* CARDIAC DYSRHYTHMIA, UNSPECIFIED",
        "rr": 1.55,
        "risk_count": 7987,
        "predisposition_and_risk": 14,
        "risk_duration": 28484114,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_565.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "565.0* ANAL FISSURE",
        "rr": 1.55,
        "risk_count": 23697,
        "predisposition_and_risk": 50,
        "risk_duration": 20675026,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V12.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V12.7* PERSONAL HISTORY OF DISEASES OF DIGESTIVE SYSTEM",
        "rr": 1.55,
        "risk_count": 5820,
        "predisposition_and_risk": 11,
        "risk_duration": 23122120,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V45.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V45.1* (POSTSURGICAL)RENAL DIALYSIS STATUS",
        "rr": 1.55,
        "risk_count": 40142,
        "predisposition_and_risk": 87,
        "risk_duration": 20152420,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A03",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A03* FEVER",
        "rr": 1.55,
        "risk_count": 62224,
        "predisposition_and_risk": 161,
        "risk_duration": 16883272,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A97",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A97* NO DISEASE",
        "rr": 1.55,
        "risk_count": 51255,
        "predisposition_and_risk": 125,
        "risk_duration": 17883324,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_276.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "276.7* HYPERPOTASSEMIA",
        "rr": 1.54,
        "risk_count": 44938,
        "predisposition_and_risk": 86,
        "risk_duration": 25929632,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_375.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "375.2* EPIPHORA",
        "rr": 1.54,
        "risk_count": 17906,
        "predisposition_and_risk": 32,
        "risk_duration": 27714259,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_423.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "423.9* UNSPECIFIED DISEASE OF PERICARDIUM",
        "rr": 1.54,
        "risk_count": 6906,
        "predisposition_and_risk": 13,
        "risk_duration": 23021066,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_459.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "459.8* OTHER SPECIFIED DISORDERS OF CIRCULATORY SYSTEM",
        "rr": 1.54,
        "risk_count": 24414,
        "predisposition_and_risk": 49,
        "risk_duration": 21701672,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_596.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "596.5* OTHER FUNCTIONAL DISORDERS OF BLADDER",
        "rr": 1.54,
        "risk_count": 8920,
        "predisposition_and_risk": 17,
        "risk_duration": 22776798,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_724.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "724.7* DISORDERS OF COCCYX",
        "rr": 1.54,
        "risk_count": 9068,
        "predisposition_and_risk": 16,
        "risk_duration": 28067640,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_438_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "438 LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "rr": 1.54,
        "risk_count": 10836,
        "predisposition_and_risk": 19,
        "risk_duration": 28316828,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_309.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "309.0* ADJUSTMENT REACTION WITH BRIEF DEPRESSIVE REACTION",
        "rr": 1.53,
        "risk_count": 8030,
        "predisposition_and_risk": 14,
        "risk_duration": 28254061,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.3* ATRIAL FIBRILLATION AND FLUTTER",
        "rr": 1.53,
        "risk_count": 10828,
        "predisposition_and_risk": 19,
        "risk_duration": 28150591,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "722.9* OTHER AND UNSPECIFIED DISC DISORDER",
        "rr": 1.53,
        "risk_count": 43144,
        "predisposition_and_risk": 89,
        "risk_duration": 23871792,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_729.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "729.8* OTHER MUSCULOSKELETAL SYMPTOMS REFERABLE TO LIMBS",
        "rr": 1.53,
        "risk_count": 28505,
        "predisposition_and_risk": 59,
        "risk_duration": 20802046,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_753.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "753.1* CONGENITAL CYSTIC KIDNEY DISEASE",
        "rr": 1.53,
        "risk_count": 22769,
        "predisposition_and_risk": 45,
        "risk_duration": 21875371,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_370_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "370 KERATITIS",
        "rr": 1.53,
        "risk_count": 8060,
        "predisposition_and_risk": 14,
        "risk_duration": 28370444,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_486",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "486* PNEUMONIA, ORGANISM UNSPECIFIED",
        "rr": 1.53,
        "risk_count": 92906,
        "predisposition_and_risk": 234,
        "risk_duration": 19523822,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L13",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L13* HIP SYMPTOMS/COMPLAINTS",
        "rr": 1.53,
        "risk_count": 36526,
        "predisposition_and_risk": 78,
        "risk_duration": 20280360,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_041.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.8* OTHER SPEC.BACTERIAL INF;IN CONDIT.CLASS.ELSEWHERE,UNSP.SITE",
        "rr": 1.52,
        "risk_count": 7484,
        "predisposition_and_risk": 14,
        "risk_duration": 22972405,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_241.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "241.1* NONTOXIC MULTINODULAR GOITER",
        "rr": 1.52,
        "risk_count": 12599,
        "predisposition_and_risk": 24,
        "risk_duration": 22553333,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_354.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "354.2* LESION OF ULNAR NERVE",
        "rr": 1.52,
        "risk_count": 10469,
        "predisposition_and_risk": 20,
        "risk_duration": 22477905,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_997.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "997.9* COMPLICATIONS AFFECTING SPECIFIED BODY SYSTEMS,NOT ELSEW.CLASS.",
        "rr": 1.52,
        "risk_count": 6987,
        "predisposition_and_risk": 12,
        "risk_duration": 28577155,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.4* ARTERIOGRAPHY USING CONTRAST MATERIAL",
        "rr": 1.52,
        "risk_count": 8168,
        "predisposition_and_risk": 14,
        "risk_duration": 28476442,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_288.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "288.8* OTHER SPECIFIED DISEASE OF WHITE BLOOD CELLS",
        "rr": 1.51,
        "risk_count": 10955,
        "predisposition_and_risk": 19,
        "risk_duration": 28139748,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_369.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "369.0* PROFOUND VISION IMPAIRMENT, BOTH EYES",
        "rr": 1.51,
        "risk_count": 11169,
        "predisposition_and_risk": 21,
        "risk_duration": 22687012,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_735.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "735.0* HALLUX VALGUS (ACQUIRED)",
        "rr": 1.51,
        "risk_count": 13211,
        "predisposition_and_risk": 23,
        "risk_duration": 27972964,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_789.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "789.5* ASCITES",
        "rr": 1.51,
        "risk_count": 30996,
        "predisposition_and_risk": 63,
        "risk_duration": 20904073,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z57.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z57.4* TRANSURETHRAL EXCISION OR DESTRUCTION OF BLADDER TISSUE",
        "rr": 1.51,
        "risk_count": 8089,
        "predisposition_and_risk": 15,
        "risk_duration": 23052308,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z81.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z81.4* ARTHROPLASTY OF KNEE AND ANKLE",
        "rr": 1.51,
        "risk_count": 43234,
        "predisposition_and_risk": 80,
        "risk_duration": 26318092,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_361.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "361.3* RETINAL DEFECTS WITHOUT DETACHMENT",
        "rr": 1.5,
        "risk_count": 6492,
        "predisposition_and_risk": 11,
        "risk_duration": 28560983,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_368.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368.2* DIPLOPIA",
        "rr": 1.5,
        "risk_count": 7660,
        "predisposition_and_risk": 13,
        "risk_duration": 28382495,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_574.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "574.2* CALCULUS OF GALLBLADDER WITHOUT MENTION OF CHOLECYSTITIS",
        "rr": 1.5,
        "risk_count": 43375,
        "predisposition_and_risk": 94,
        "risk_duration": 19527186,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.4* GANGRENE",
        "rr": 1.5,
        "risk_count": 20587,
        "predisposition_and_risk": 40,
        "risk_duration": 21768684,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_995.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "995.2* UNSP.ADV.EFFECT OF DRUG,MEDICINAL/BIOLOGICAL SUBSTANCE N.E.S.",
        "rr": 1.5,
        "risk_count": 28077,
        "predisposition_and_risk": 51,
        "risk_duration": 26613573,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z60.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z60.2* TRANSURETHRAL PROSTATECTOMY",
        "rr": 1.5,
        "risk_count": 11338,
        "predisposition_and_risk": 21,
        "risk_duration": 22908432,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.0* SOFT TISSUE X-RAY OF ABDOMEN",
        "rr": 1.5,
        "risk_count": 14236,
        "predisposition_and_risk": 27,
        "risk_duration": 22377895,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_487_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "487 INFLUENZA",
        "rr": 1.5,
        "risk_count": 13443,
        "predisposition_and_risk": 24,
        "risk_duration": 27008225,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_276.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "276.5* VOLUME DEPLETION DISORDER",
        "rr": 1.49,
        "risk_count": 17279,
        "predisposition_and_risk": 30,
        "risk_duration": 27716880,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_287.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "287.2* OTHER NONTHROMBOCYTOPENIC PURPURAS",
        "rr": 1.49,
        "risk_count": 23354,
        "predisposition_and_risk": 45,
        "risk_duration": 21788678,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_307.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "307.8* PSYCHALGIA",
        "rr": 1.49,
        "risk_count": 28017,
        "predisposition_and_risk": 52,
        "risk_duration": 25801163,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_428.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "428.1* LEFT HEART FAILURE",
        "rr": 1.49,
        "risk_count": 31197,
        "predisposition_and_risk": 62,
        "risk_duration": 21194060,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_681.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "681.1* CELLULITIS AND ABSCESS OF TOE",
        "rr": 1.49,
        "risk_count": 13866,
        "predisposition_and_risk": 24,
        "risk_duration": 27752476,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_F43.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F43.2* ADJUSTMENT DISORDERS",
        "rr": 1.49,
        "risk_count": 8582,
        "predisposition_and_risk": 16,
        "risk_duration": 22581597,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V14.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.1* PERSONAL HISTORY OF ALLERGY TO OTHER ANTIBIOTIC AGENT",
        "rr": 1.49,
        "risk_count": 11326,
        "predisposition_and_risk": 21,
        "risk_duration": 22661286,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V14.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.8* PERSONAL HISTORY OF ALLERGY TO SPECIFIED MEDICINAL AGENTS",
        "rr": 1.49,
        "risk_count": 36698,
        "predisposition_and_risk": 75,
        "risk_duration": 20574956,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V49.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V49.8* OTHER SPECIFIED PROBLEMS INFLUENCING HEALTH STATUS",
        "rr": 1.49,
        "risk_count": 9480,
        "predisposition_and_risk": 16,
        "risk_duration": 28523790,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_682_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "682 OTHER CELLULITIS AND ABSCESS",
        "rr": 1.49,
        "risk_count": 10197,
        "predisposition_and_risk": 19,
        "risk_duration": 22554003,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_307.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "307.8* PSYCHALGIA",
        "rr": 1.48,
        "risk_count": 11749,
        "predisposition_and_risk": 22,
        "risk_duration": 22252585,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_388.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "388.7* OTALGIA",
        "rr": 1.48,
        "risk_count": 40667,
        "predisposition_and_risk": 79,
        "risk_duration": 24489088,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_527.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "527.2* SIALOADENITIS",
        "rr": 1.48,
        "risk_count": 7119,
        "predisposition_and_risk": 13,
        "risk_duration": 22858431,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_692.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "692.8* CONTACT DERMATITIS + ECZEMA DUE TO OTHER SPECIFIED AGENTS",
        "rr": 1.48,
        "risk_count": 8852,
        "predisposition_and_risk": 15,
        "risk_duration": 28128308,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_709.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "709.2* SCAR CONDITIONS AND FIBROSIS OF SKIN",
        "rr": 1.48,
        "risk_count": 7143,
        "predisposition_and_risk": 13,
        "risk_duration": 22951651,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_788.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "788.2* RETENTION OF URINE",
        "rr": 1.48,
        "risk_count": 15836,
        "predisposition_and_risk": 27,
        "risk_duration": 27924229,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z13.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z13.7* INSERTION OF PROSTHETIC LENS (PSEUDOPHAKOS)",
        "rr": 1.48,
        "risk_count": 52440,
        "predisposition_and_risk": 109,
        "risk_duration": 20055520,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_S18",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "S18* LACERATION/CUT",
        "rr": 1.48,
        "risk_count": 9391,
        "predisposition_and_risk": 16,
        "risk_duration": 28028490,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_110.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "110.3* DERMATOPHYTOSIS OF GROIN AND PERIANAL AREA",
        "rr": 1.47,
        "risk_count": 12338,
        "predisposition_and_risk": 21,
        "risk_duration": 27848090,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_373.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "373.2* CHALAZION",
        "rr": 1.47,
        "risk_count": 19360,
        "predisposition_and_risk": 34,
        "risk_duration": 26921311,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_611.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "611.1* HYPERTROPHY OF BREAST",
        "rr": 1.47,
        "risk_count": 11491,
        "predisposition_and_risk": 21,
        "risk_duration": 22716179,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.0* PERSONAL HISTORY OF ALLERGY TO PENICILLIN",
        "rr": 1.47,
        "risk_count": 38635,
        "predisposition_and_risk": 70,
        "risk_duration": 26085259,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z47.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z47.0* APPENDECTOMY",
        "rr": 1.47,
        "risk_count": 7187,
        "predisposition_and_risk": 12,
        "risk_duration": 28391962,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_278_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "278 OBESITY AND OTHER HYPERALIMENTATION",
        "rr": 1.47,
        "risk_count": 14972,
        "predisposition_and_risk": 28,
        "risk_duration": 22239086,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_F32_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F32 DEPRESSIVE EPISODE",
        "rr": 1.47,
        "risk_count": 10113,
        "predisposition_and_risk": 17,
        "risk_duration": 28176121,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_455.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "455.3* EXTERNAL HEMORRHOIDS WITHOUT MENTION OF COMPLICATION",
        "rr": 1.46,
        "risk_count": 8232,
        "predisposition_and_risk": 15,
        "risk_duration": 22562400,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_576.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "576.1* CHOLANGITIS",
        "rr": 1.46,
        "risk_count": 6186,
        "predisposition_and_risk": 11,
        "risk_duration": 23115802,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_593.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "593.2* CYST OF KIDNEY, ACQUIRED",
        "rr": 1.46,
        "risk_count": 20378,
        "predisposition_and_risk": 38,
        "risk_duration": 22117946,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_714.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "714.9* UNSPECIFIED INFLAMMATORY POLYARTHROPATHY",
        "rr": 1.46,
        "risk_count": 11315,
        "predisposition_and_risk": 19,
        "risk_duration": 27962883,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_723.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "723.9* UNSPEC.MUSCULOSKELETAL DISORDERS + SYMPTOMS REFERABLE TO NECK",
        "rr": 1.46,
        "risk_count": 6640,
        "predisposition_and_risk": 11,
        "risk_duration": 28371916,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z00.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z00.6* PROCEDURES OF BLOOD VESSELS",
        "rr": 1.46,
        "risk_count": 14265,
        "predisposition_and_risk": 24,
        "risk_duration": 28017966,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_R75",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "R75* SINUSITIS ACUTE/CHRON.",
        "rr": 1.46,
        "risk_count": 6101,
        "predisposition_and_risk": 11,
        "risk_duration": 22827764,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_377.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "377.1* OPTIC ATROPHY",
        "rr": 1.45,
        "risk_count": 10296,
        "predisposition_and_risk": 17,
        "risk_duration": 28294597,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_428.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "428.3* DIASTOLIC HEART FAILURE",
        "rr": 1.45,
        "risk_count": 13857,
        "predisposition_and_risk": 23,
        "risk_duration": 28226033,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_682.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "682.6* CELLULITIS AND ABSCESS OF LEG, EXCEPT FOOT",
        "rr": 1.45,
        "risk_count": 12101,
        "predisposition_and_risk": 22,
        "risk_duration": 22515493,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_700.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "700.9* CLAVUS",
        "rr": 1.45,
        "risk_count": 17624,
        "predisposition_and_risk": 30,
        "risk_duration": 27408963,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_782.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.1* RASH AND OTHER NONSPECIFIC SKIN ERUPTION",
        "rr": 1.45,
        "risk_count": 33613,
        "predisposition_and_risk": 61,
        "risk_duration": 25669931,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_692_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "692 CONTACT DERMATITIS AND OTHER ECZEMA",
        "rr": 1.45,
        "risk_count": 30427,
        "predisposition_and_risk": 61,
        "risk_duration": 20407309,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_272.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "272.2* MIXED HYPERLIPIDEMIA",
        "rr": 1.44,
        "risk_count": 13911,
        "predisposition_and_risk": 23,
        "risk_duration": 27974785,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_721.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721.3* LUMBOSACRAL SPONDYLOSIS WITHOUT MYELOPATHY",
        "rr": 1.44,
        "risk_count": 29675,
        "predisposition_and_risk": 52,
        "risk_duration": 26500438,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_P76.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "P76.0* ISSUE OF REPEAT PRESCRIPTION",
        "rr": 1.44,
        "risk_count": 15618,
        "predisposition_and_risk": 29,
        "risk_duration": 21839655,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z13.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z13.4* EXTRACAPS.EXTRACT.OF LENS BY FRAGMENT.AND ASPIRATION TECHN.",
        "rr": 1.44,
        "risk_count": 45757,
        "predisposition_and_risk": 91,
        "risk_duration": 20451418,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_443.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "443.0* RAYNAUD'S SYNDROME",
        "rr": 1.43,
        "risk_count": 7975,
        "predisposition_and_risk": 13,
        "risk_duration": 28311885,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_791.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "791.0* PROTEINURIA",
        "rr": 1.43,
        "risk_count": 64317,
        "predisposition_and_risk": 146,
        "risk_duration": 17807176,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_799.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "799.9* UNKNOWN OR UNSPECIFIED CAUSE OF MORBIDITY (DIAGNOSIS DEFERRED)",
        "rr": 1.43,
        "risk_count": 10648,
        "predisposition_and_risk": 19,
        "risk_duration": 22657185,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_949.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "949.0* BURN OF UNSPECIFIED SITE, UNSPECIFIED DEGREE",
        "rr": 1.43,
        "risk_count": 6774,
        "predisposition_and_risk": 11,
        "risk_duration": 28330172,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_995.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "995.3* ALLERGY, UNSPECIFIED, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.43,
        "risk_count": 23855,
        "predisposition_and_risk": 45,
        "risk_duration": 21319983,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_232_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "232 CARCINOMA IN SITU OF SKIN",
        "rr": 1.43,
        "risk_count": 9106,
        "predisposition_and_risk": 16,
        "risk_duration": 22940191,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V16_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V16 FAMILY HISTORY OF MALIGNANT NEOPLASM",
        "rr": 1.43,
        "risk_count": 10279,
        "predisposition_and_risk": 17,
        "risk_duration": 27910738,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_D90",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "D90* HIATUS (DIAPHR.) HERNIA",
        "rr": 1.43,
        "risk_count": 12219,
        "predisposition_and_risk": 20,
        "risk_duration": 28106739,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_396.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "396.3* MITRAL VALVE INSUFFICIENCY AND AORTIC VALVE INSUFFICIENCY",
        "rr": 1.42,
        "risk_count": 13026,
        "predisposition_and_risk": 23,
        "risk_duration": 22711921,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_401.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "401.1* BENIGN ESSENTIAL HYPERTENSION",
        "rr": 1.42,
        "risk_count": 16116,
        "predisposition_and_risk": 29,
        "risk_duration": 22289294,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_596.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "596.5* OTHER FUNCTIONAL DISORDERS OF BLADDER",
        "rr": 1.42,
        "risk_count": 6855,
        "predisposition_and_risk": 11,
        "risk_duration": 28418574,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_627.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "627.3* POSTMENOPAUSAL ATROPHIC VAGINITIS",
        "rr": 1.42,
        "risk_count": 22962,
        "predisposition_and_risk": 39,
        "risk_duration": 26884055,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_697.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "697.0* LICHEN PLANUS",
        "rr": 1.42,
        "risk_count": 10412,
        "predisposition_and_risk": 17,
        "risk_duration": 28076214,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_730.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "730.0* ACUTE OSTEOMYELITIS",
        "rr": 1.42,
        "risk_count": 12314,
        "predisposition_and_risk": 22,
        "risk_duration": 22350931,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_733.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "733.9* OTHER AND UNSPECIFIED DISORDERS OF BONE AND CARTILAGE",
        "rr": 1.42,
        "risk_count": 30220,
        "predisposition_and_risk": 52,
        "risk_duration": 26591929,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_783.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "783.2* ABNORMAL LOSS OF WEIGHT",
        "rr": 1.42,
        "risk_count": 54313,
        "predisposition_and_risk": 116,
        "risk_duration": 18706866,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_R80.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "R80.9* MICROALBUMINURIA",
        "rr": 1.42,
        "risk_count": 12401,
        "predisposition_and_risk": 22,
        "risk_duration": 22563182,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V45.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V45.1* (POSTSURGICAL)RENAL DIALYSIS STATUS",
        "rr": 1.42,
        "risk_count": 33806,
        "predisposition_and_risk": 58,
        "risk_duration": 26664931,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z44.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z44.1* DIAGNOSTIC PROCEDURES ON STOMACH",
        "rr": 1.42,
        "risk_count": 9307,
        "predisposition_and_risk": 15,
        "risk_duration": 28425602,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z57.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z57.9* OTHER OPERATIONS ON BLADDER",
        "rr": 1.42,
        "risk_count": 8012,
        "predisposition_and_risk": 14,
        "risk_duration": 23011491,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z99.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.6* CONVERSION OF CARDIAC RHYTHM",
        "rr": 1.42,
        "risk_count": 13501,
        "predisposition_and_risk": 24,
        "risk_duration": 22599351,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_698_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698 PRURITUS AND RELATED CONDITIONS",
        "rr": 1.42,
        "risk_count": 16123,
        "predisposition_and_risk": 29,
        "risk_duration": 22277753,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_054.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "054.9* HERPES SIMPLEX WITHOUT MENTION OF COMPLICATION",
        "rr": 1.41,
        "risk_count": 19046,
        "predisposition_and_risk": 32,
        "risk_duration": 27009089,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_357.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "357.2* POLYNEUROPATHY IN DIABETES",
        "rr": 1.41,
        "risk_count": 7477,
        "predisposition_and_risk": 12,
        "risk_duration": 28270705,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_458.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "458.0* ORTHOSTATIC HYPOTENSION",
        "rr": 1.41,
        "risk_count": 13106,
        "predisposition_and_risk": 23,
        "risk_duration": 22687420,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_728.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "728.6* CONTRACTURE OF PALMAR FASCIA",
        "rr": 1.41,
        "risk_count": 7484,
        "predisposition_and_risk": 13,
        "risk_duration": 22872230,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V10.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V10.0* PERSONAL HISTORY OF MAL.NEOPLASM OF GASTROINTESTINAL TRACT",
        "rr": 1.41,
        "risk_count": 7525,
        "predisposition_and_risk": 13,
        "risk_duration": 23041997,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V45.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V45.7* ACQUIRED ABSENCE OF ORGAN",
        "rr": 1.41,
        "risk_count": 8802,
        "predisposition_and_risk": 14,
        "risk_duration": 28474036,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z39.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z39.6* PROCEDURES AUXILIARY TO OPEN HEART SURGERY",
        "rr": 1.41,
        "risk_count": 10793,
        "predisposition_and_risk": 19,
        "risk_duration": 22622498,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_491_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "491 CHRONIC BRONCHITIS",
        "rr": 1.41,
        "risk_count": 22065,
        "predisposition_and_risk": 37,
        "risk_duration": 27163395,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_486",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "486* PNEUMONIA, ORGANISM UNSPECIFIED",
        "rr": 1.41,
        "risk_count": 90418,
        "predisposition_and_risk": 240,
        "risk_duration": 14962987,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L16",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L16* ANKLE SYMPTOMS/COMPLAINTS",
        "rr": 1.41,
        "risk_count": 45541,
        "predisposition_and_risk": 87,
        "risk_duration": 23716966,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_355.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "355.1* MERALGIA PARESTHETICA",
        "rr": 1.4,
        "risk_count": 30311,
        "predisposition_and_risk": 52,
        "risk_duration": 26337003,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_410.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "410.9* ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE",
        "rr": 1.4,
        "risk_count": 10344,
        "predisposition_and_risk": 18,
        "risk_duration": 22730624,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_440.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "440.2* ATHEROSCLEROSIS OF ARTERIES OF THE EXTREMITIES",
        "rr": 1.4,
        "risk_count": 14729,
        "predisposition_and_risk": 26,
        "risk_duration": 22384839,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_621.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "621.0* POLYP OF CORPUS UTERI",
        "rr": 1.4,
        "risk_count": 9361,
        "predisposition_and_risk": 15,
        "risk_duration": 28195221,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_682.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "682.7* CELLULITIS AND ABSCESS OF FOOT, EXCEPT TOES",
        "rr": 1.4,
        "risk_count": 41252,
        "predisposition_and_risk": 73,
        "risk_duration": 25436009,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_724.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "724.0* SPINAL STENOSIS, OTHER THAN CERVICAL",
        "rr": 1.4,
        "risk_count": 57086,
        "predisposition_and_risk": 105,
        "risk_duration": 24506611,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.9* OTHER SYMPTOMS INVOLVING CARDIOVASCULAR SYSTEM",
        "rr": 1.4,
        "risk_count": 7603,
        "predisposition_and_risk": 13,
        "risk_duration": 23033074,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_844.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "844.0* SPRAIN OF LATERAL COLLATERAL LIGAMENT OF KNEE",
        "rr": 1.4,
        "risk_count": 6905,
        "predisposition_and_risk": 11,
        "risk_duration": 28345711,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_996.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "996.7* COMPLICATION OF INTERNAL PROSTHETIC DEVICE,IMPLANT,GRAFT",
        "rr": 1.4,
        "risk_count": 10048,
        "predisposition_and_risk": 16,
        "risk_duration": 28351879,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V15.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V15.0* PERSONAL HISTORY OF ALLERGY,OTHER THAN TO MEDICINAL AGENTS",
        "rr": 1.4,
        "risk_count": 14794,
        "predisposition_and_risk": 26,
        "risk_duration": 22434726,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z37.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z37.9* OTHER OPERATIONS ON HEART AND PERICARDIUM",
        "rr": 1.4,
        "risk_count": 10378,
        "predisposition_and_risk": 18,
        "risk_duration": 22827241,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "9* HYPERTENSION ROUTINE FOLLOW UP",
        "rr": 1.4,
        "risk_count": 11792,
        "predisposition_and_risk": 19,
        "risk_duration": 27948186,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_372.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "372.7* CONJUNCTIVAL VASCULAR DISORDERS AND CYSTS",
        "rr": 1.39,
        "risk_count": 21254,
        "predisposition_and_risk": 35,
        "risk_duration": 27162638,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_464.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "464.0* ACUTE LARYNGITIS",
        "rr": 1.39,
        "risk_count": 9812,
        "predisposition_and_risk": 17,
        "risk_duration": 22557614,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_572.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "572.2* HEPATIC COMA",
        "rr": 1.39,
        "risk_count": 8143,
        "predisposition_and_risk": 14,
        "risk_duration": 22847734,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V14.2* PERSONAL HISTORY OF ALLERGY TO SULFONAMIDES",
        "rr": 1.39,
        "risk_count": 7017,
        "predisposition_and_risk": 11,
        "risk_duration": 28612129,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z99.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.1* INJECT.OR INFUSION OF THERAPEUTIC OR PROPHYLACTIC SUBSTANCE",
        "rr": 1.39,
        "risk_count": 13655,
        "predisposition_and_risk": 24,
        "risk_duration": 22305567,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_506.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "506.1* ACUTE PULMONARY EDEMA DUE TO FUMES AND VAPORS",
        "rr": 1.38,
        "risk_count": 18797,
        "predisposition_and_risk": 30,
        "risk_duration": 27909208,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_524.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "524.6* TEMPOROMANDIBULAR JOINT DISORDERS",
        "rr": 1.38,
        "risk_count": 14698,
        "predisposition_and_risk": 26,
        "risk_duration": 22030281,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_709.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "709.2* SCAR CONDITIONS AND FIBROSIS OF SKIN",
        "rr": 1.38,
        "risk_count": 10108,
        "predisposition_and_risk": 16,
        "risk_duration": 28161769,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_820.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "820.2* PERTROCHANTERIC FRACTURE OF FEMUR, CLOSED",
        "rr": 1.38,
        "risk_count": 8273,
        "predisposition_and_risk": 14,
        "risk_duration": 22938186,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z54.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z54.9* OTHER OPERATIONS OF ABDOMINAL REGION",
        "rr": 1.38,
        "risk_count": 8298,
        "predisposition_and_risk": 13,
        "risk_duration": 28460798,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_K04",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "K04* PALPITATIONS/AWARE OF HEARTBEAT",
        "rr": 1.38,
        "risk_count": 10725,
        "predisposition_and_risk": 17,
        "risk_duration": 28128902,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L05",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L05* FLANK SYMPTOMS/COMPLAINTS",
        "rr": 1.38,
        "risk_count": 30547,
        "predisposition_and_risk": 59,
        "risk_duration": 20130853,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_244.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "244.9* UNSPECIFIED ACQUIRED HYPOTHYROIDISM",
        "rr": 1.37,
        "risk_count": 8131,
        "predisposition_and_risk": 14,
        "risk_duration": 22514680,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_427.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.6* PREMATURE BEATS",
        "rr": 1.37,
        "risk_count": 15655,
        "predisposition_and_risk": 27,
        "risk_duration": 22351480,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_569.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "569.4* OTHER SPECIFIED DISORDERS OF RECTUM AND ANUS",
        "rr": 1.37,
        "risk_count": 15606,
        "predisposition_and_risk": 25,
        "risk_duration": 27540346,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_625.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "625.6* STRESS INCONTINENCE, FEMALE",
        "rr": 1.37,
        "risk_count": 20260,
        "predisposition_and_risk": 33,
        "risk_duration": 27027672,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_782.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.0* DISTURBANCE OF SKIN SENSATION",
        "rr": 1.37,
        "risk_count": 66140,
        "predisposition_and_risk": 140,
        "risk_duration": 20854357,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_786.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "786.3* HEMOPTYSIS",
        "rr": 1.37,
        "risk_count": 22969,
        "predisposition_and_risk": 41,
        "risk_duration": 21677448,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_923.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "923.0* CONTUSION OF SHOULDER AND UPPER ARM",
        "rr": 1.37,
        "risk_count": 26354,
        "predisposition_and_risk": 44,
        "risk_duration": 26393255,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V10.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V10.3* PERSONAL HISTORY OF MALIGNANT NEOPLASM OF BREAST",
        "rr": 1.37,
        "risk_count": 21262,
        "predisposition_and_risk": 34,
        "risk_duration": 27591576,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z57.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z57.3* DIAGNOSTIC PROCEDURES ON BLADDER",
        "rr": 1.37,
        "risk_count": 8354,
        "predisposition_and_risk": 14,
        "risk_duration": 22985268,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.5* ANGIOCARDIOGRAPHY USING CONTRAST MATERIAL",
        "rr": 1.37,
        "risk_count": 52867,
        "predisposition_and_risk": 94,
        "risk_duration": 24771051,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L03",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L03* LOW BACK COMPLT.W/O RADIATION",
        "rr": 1.37,
        "risk_count": 60614,
        "predisposition_and_risk": 123,
        "risk_duration": 21775975,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L18",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L18* MUSCLE PAIN/FIBROSITIS",
        "rr": 1.37,
        "risk_count": 10731,
        "predisposition_and_risk": 17,
        "risk_duration": 27946972,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_578.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "578.9* HEMORRHAGE OF GASTROINTESTINAL TRACT, UNSPECIFIED",
        "rr": 1.36,
        "risk_count": 11617,
        "predisposition_and_risk": 18,
        "risk_duration": 28297485,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_593.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "593.8* OTHER SPECIFIED DISORDERS OF KIDNEY AND URETER",
        "rr": 1.36,
        "risk_count": 10133,
        "predisposition_and_risk": 17,
        "risk_duration": 22905306,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_610.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "610.2* FIBROADENOSIS OF BREAST",
        "rr": 1.36,
        "risk_count": 13272,
        "predisposition_and_risk": 21,
        "risk_duration": 27698983,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.2* SYNCOPE AND COLLAPSE",
        "rr": 1.36,
        "risk_count": 60920,
        "predisposition_and_risk": 115,
        "risk_duration": 23139641,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_598_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "598 URETHRAL STRICTURE",
        "rr": 1.36,
        "risk_count": 7829,
        "predisposition_and_risk": 13,
        "risk_duration": 23048618,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.5* DEGENERATION OF MACULA AND POSTERIOR POLE OF RETINA",
        "rr": 1.35,
        "risk_count": 40993,
        "predisposition_and_risk": 74,
        "risk_duration": 21178497,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_374.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "374.0* ENTROPION AND TRICHIASIS OF EYELID",
        "rr": 1.35,
        "risk_count": 9000,
        "predisposition_and_risk": 15,
        "risk_duration": 22931216,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_459.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "459.8* OTHER SPECIFIED DISORDERS OF CIRCULATORY SYSTEM",
        "rr": 1.35,
        "risk_count": 39900,
        "predisposition_and_risk": 67,
        "risk_duration": 25809490,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "726.9* UNSPECIFIED ENTHESOPATHY",
        "rr": 1.35,
        "risk_count": 14999,
        "predisposition_and_risk": 26,
        "risk_duration": 21981996,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_799.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "799.3* DEBILITY, UNSPECIFIED",
        "rr": 1.35,
        "risk_count": 48357,
        "predisposition_and_risk": 98,
        "risk_duration": 18738822,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_813.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "813.0* FRACTURE OF UPPER END OF RADIUS AND ULNA, CLOSED",
        "rr": 1.35,
        "risk_count": 12159,
        "predisposition_and_risk": 21,
        "risk_duration": 22038154,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P76.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "P76.0* ISSUE OF REPEAT PRESCRIPTION",
        "rr": 1.35,
        "risk_count": 20648,
        "predisposition_and_risk": 33,
        "risk_duration": 27131519,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z80.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z80.2* ARTHROSCOPY",
        "rr": 1.35,
        "risk_count": 7719,
        "predisposition_and_risk": 13,
        "risk_duration": 22566497,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.7* DIAGNOSTIC ULTRASOUND",
        "rr": 1.35,
        "risk_count": 50191,
        "predisposition_and_risk": 100,
        "risk_duration": 19065953,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z89.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z89.5* OTHER NONOPERATIVE CARDIAC AND VASCULAR DIAGNOSTIC PROCEDURES",
        "rr": 1.35,
        "risk_count": 34044,
        "predisposition_and_risk": 63,
        "risk_duration": 20582967,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_566",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "566* ABSCESS OF ANAL AND RECTAL REGIONS",
        "rr": 1.35,
        "risk_count": 11548,
        "predisposition_and_risk": 20,
        "risk_duration": 22075681,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L16",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L16* ANKLE SYMPTOMS/COMPLAINTS",
        "rr": 1.35,
        "risk_count": 26128,
        "predisposition_and_risk": 48,
        "risk_duration": 20700260,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_355.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "355.0* LESION OF SCIATIC NERVE",
        "rr": 1.34,
        "risk_count": 13473,
        "predisposition_and_risk": 23,
        "risk_duration": 22220095,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_381.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "381.0* ACUTE NONSUPPURATIVE OTITIS MEDIA",
        "rr": 1.34,
        "risk_count": 24643,
        "predisposition_and_risk": 45,
        "risk_duration": 20712723,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_518.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "518.8* OTHER DISEASES OF LUNG, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.34,
        "risk_count": 22038,
        "predisposition_and_risk": 38,
        "risk_duration": 21929428,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_724.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "724.0* SPINAL STENOSIS, OTHER THAN CERVICAL",
        "rr": 1.34,
        "risk_count": 58485,
        "predisposition_and_risk": 117,
        "risk_duration": 18860603,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z96.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z96.7* OTHER CONTINUOUS MECHANICAL VENTILATION",
        "rr": 1.34,
        "risk_count": 17684,
        "predisposition_and_risk": 30,
        "risk_duration": 22245216,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z99.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z99.1* INJECT.OR INFUSION OF THERAPEUTIC OR PROPHYLACTIC SUBSTANCE",
        "rr": 1.34,
        "risk_count": 13576,
        "predisposition_and_risk": 21,
        "risk_duration": 27921741,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_708_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "708 URTICARIA",
        "rr": 1.34,
        "risk_count": 22700,
        "predisposition_and_risk": 37,
        "risk_duration": 26519219,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_110.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "110.5* DERMATOPHYTOSIS OF THE BODY",
        "rr": 1.33,
        "risk_count": 22238,
        "predisposition_and_risk": 39,
        "risk_duration": 21378011,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_366.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "366.5* AFTER-CATARACT",
        "rr": 1.33,
        "risk_count": 25080,
        "predisposition_and_risk": 39,
        "risk_duration": 27608525,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_374.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "374.0* ENTROPION AND TRICHIASIS OF EYELID",
        "rr": 1.33,
        "risk_count": 12522,
        "predisposition_and_risk": 19,
        "risk_duration": 28313413,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_454.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "454.0* VARICOSE VEINS OF LOWER EXTREMITIES WITH ULCER",
        "rr": 1.33,
        "risk_count": 22697,
        "predisposition_and_risk": 39,
        "risk_duration": 21831286,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_575.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "575.0* ACUTE CHOLECYSTITIS",
        "rr": 1.33,
        "risk_count": 12425,
        "predisposition_and_risk": 19,
        "risk_duration": 27975974,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_728.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "728.2* MUSCULAR WASTING AND DISUSE ATROPHY, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.33,
        "risk_count": 10273,
        "predisposition_and_risk": 17,
        "risk_duration": 22605787,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_787.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "787.6* INCONTINENCE OF FECES",
        "rr": 1.33,
        "risk_count": 15678,
        "predisposition_and_risk": 24,
        "risk_duration": 27944418,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V10.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V10.5* PERSONAL HISTORY OF MALIGNANT NEOPLASM OF URINARY ORGANS",
        "rr": 1.33,
        "risk_count": 10369,
        "predisposition_and_risk": 17,
        "risk_duration": 22931092,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V87.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V87.4* PERSONAL HISTORY OF DRUG THERAPY",
        "rr": 1.33,
        "risk_count": 10572,
        "predisposition_and_risk": 16,
        "risk_duration": 28398885,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_435_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "435 TRANSIENT CEREBRAL ISCHEMIA",
        "rr": 1.33,
        "risk_count": 29773,
        "predisposition_and_risk": 48,
        "risk_duration": 26604962,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_451_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "451 PHLEBITIS AND THROMBOPHLEBITIS",
        "rr": 1.33,
        "risk_count": 11148,
        "predisposition_and_risk": 17,
        "risk_duration": 28173820,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P03_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "P03 MEDICAL OBSERVAT EVALUAT FOR SUSPECTED DISEASES CONDITIONS",
        "rr": 1.33,
        "risk_count": 9306,
        "predisposition_and_risk": 14,
        "risk_duration": 28486388,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_198.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "198.2* SECONDARY MALIGNANT NEOPLASM OF SKIN",
        "rr": 1.32,
        "risk_count": 8001,
        "predisposition_and_risk": 12,
        "risk_duration": 28323270,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_300.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "300.4* NEUROTIC DEPRESSION",
        "rr": 1.32,
        "risk_count": 32009,
        "predisposition_and_risk": 59,
        "risk_duration": 20239979,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_378.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "378.1* EXOTROPIA",
        "rr": 1.32,
        "risk_count": 6788,
        "predisposition_and_risk": 11,
        "risk_duration": 23009694,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_411.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "411.1* INTERMEDIATE CORONARY SYNDROME",
        "rr": 1.32,
        "risk_count": 24870,
        "predisposition_and_risk": 39,
        "risk_duration": 27114199,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_427.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.4* VENTRICULAR FIBRILLATION AND FLUTTER",
        "rr": 1.32,
        "risk_count": 8589,
        "predisposition_and_risk": 14,
        "risk_duration": 22861649,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_627.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "627.1* POSTMENOPAUSAL BLEEDING",
        "rr": 1.32,
        "risk_count": 26605,
        "predisposition_and_risk": 45,
        "risk_duration": 25181449,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_706.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "706.3* SEBORRHEA",
        "rr": 1.32,
        "risk_count": 14380,
        "predisposition_and_risk": 22,
        "risk_duration": 27723250,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_722.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "722.1* DISPL.OF THORACIC OR LUMBAR INTERVERT.DISC WITHOUT MYELOPATHY",
        "rr": 1.32,
        "risk_count": 31258,
        "predisposition_and_risk": 58,
        "risk_duration": 20025878,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_728.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "728.7* OTHER FIBROMATOSES OF MUSCLE, LIGAMENT, AND FASCIA",
        "rr": 1.32,
        "risk_count": 39394,
        "predisposition_and_risk": 76,
        "risk_duration": 19276354,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_781.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "781.2* ABNORMALITY OF GAIT",
        "rr": 1.32,
        "risk_count": 7376,
        "predisposition_and_risk": 11,
        "risk_duration": 28477826,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.2* LOCALIZED SUPERFICIAL SWELLING, MASS, OR LUMP",
        "rr": 1.32,
        "risk_count": 13125,
        "predisposition_and_risk": 22,
        "risk_duration": 22266865,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V44.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V44.0* TRACHEOSTOMY STATUS",
        "rr": 1.32,
        "risk_count": 10549,
        "predisposition_and_risk": 16,
        "risk_duration": 28090219,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V71.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V71.9* OBSERVATION FOR UNSPECIFIED SUSPECTED CONDITION",
        "rr": 1.32,
        "risk_count": 7955,
        "predisposition_and_risk": 13,
        "risk_duration": 22855261,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z38.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z38.1* ENDARTERECTOMY",
        "rr": 1.32,
        "risk_count": 12815,
        "predisposition_and_risk": 21,
        "risk_duration": 22720345,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_591",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "591* HYDRONEPHROSIS",
        "rr": 1.32,
        "risk_count": 18757,
        "predisposition_and_risk": 29,
        "risk_duration": 27446653,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_410.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "410.7* SUBENDOCARDIAL INFARCTION",
        "rr": 1.31,
        "risk_count": 10776,
        "predisposition_and_risk": 16,
        "risk_duration": 28368871,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_577.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "577.0* ACUTE PANCREATITIS",
        "rr": 1.31,
        "risk_count": 11323,
        "predisposition_and_risk": 17,
        "risk_duration": 28070664,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "726.5* ENTHESOPATHY OF HIP REGION",
        "rr": 1.31,
        "risk_count": 12723,
        "predisposition_and_risk": 21,
        "risk_duration": 22465396,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_923.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "923.2* CONTUSION OF WRIST AND HAND(S), EXCEPT FINGER(S) ALONE",
        "rr": 1.31,
        "risk_count": 28829,
        "predisposition_and_risk": 47,
        "risk_duration": 25854350,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P91.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "P91.1* PERSONAL HISTORY OF NONCOMPLIANCE WITH MEDICAL TREAT REGIMEN",
        "rr": 1.31,
        "risk_count": 11332,
        "predisposition_and_risk": 17,
        "risk_duration": 28039823,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V45.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V45.0* POSTSURGICAL CARDIAC PACEMAKER IN SITU",
        "rr": 1.31,
        "risk_count": 35522,
        "predisposition_and_risk": 62,
        "risk_duration": 21171908,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_698.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698.1* PRURITUS OF GENITAL ORGANS",
        "rr": 1.3,
        "risk_count": 24641,
        "predisposition_and_risk": 39,
        "risk_duration": 26437638,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V12.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V12.5* PERSONAL HISTORY OF DISEASES OF CIRCULATORY SYSTEM",
        "rr": 1.3,
        "risk_count": 41675,
        "predisposition_and_risk": 75,
        "risk_duration": 20421477,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_431",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "431* INTRACEREBRAL HEMORRHAGE",
        "rr": 1.3,
        "risk_count": 10374,
        "predisposition_and_risk": 17,
        "risk_duration": 22437039,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_W72",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "W72* MALIGNANT NEOPLASM **",
        "rr": 1.3,
        "risk_count": 11159,
        "predisposition_and_risk": 18,
        "risk_duration": 22742888,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_228.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "228.0* HEMANGIOMA, ANY SITE",
        "rr": 1.29,
        "risk_count": 25903,
        "predisposition_and_risk": 41,
        "risk_duration": 26324997,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_366.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "366.9* UNSPECIFIED CATARACT",
        "rr": 1.29,
        "risk_count": 20727,
        "predisposition_and_risk": 31,
        "risk_duration": 27765385,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_372.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "372.7* CONJUNCTIVAL VASCULAR DISORDERS AND CYSTS",
        "rr": 1.29,
        "risk_count": 19885,
        "predisposition_and_risk": 33,
        "risk_duration": 21957307,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_386.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "386.1* OTHER AND UNSPECIFIED PERIPHERAL VERTIGO",
        "rr": 1.29,
        "risk_count": 25154,
        "predisposition_and_risk": 43,
        "risk_duration": 21318878,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_426.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "426.1* ATRIOVENTRICULAR BLOCK, OTHER AND UNSPECIFIED",
        "rr": 1.29,
        "risk_count": 7576,
        "predisposition_and_risk": 12,
        "risk_duration": 23053998,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_701.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "701.1* KERATODERMA, ACQUIRED",
        "rr": 1.29,
        "risk_count": 17654,
        "predisposition_and_risk": 29,
        "risk_duration": 22087860,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.8* HYPERHIDROSIS",
        "rr": 1.29,
        "risk_count": 7540,
        "predisposition_and_risk": 11,
        "risk_duration": 28472937,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z80.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z80.2* ARTHROSCOPY",
        "rr": 1.29,
        "risk_count": 10071,
        "predisposition_and_risk": 15,
        "risk_duration": 27889320,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z89.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z89.0* DIAGNOSTIC INTERVIEW, CONSULTATION, AND EVALUATION",
        "rr": 1.29,
        "risk_count": 39104,
        "predisposition_and_risk": 71,
        "risk_duration": 20059747,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_371_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "371 CORNEAL OPACITY AND OTHER DISORDERS OF CORNEA",
        "rr": 1.29,
        "risk_count": 7570,
        "predisposition_and_risk": 11,
        "risk_duration": 28658193,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_F03_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F03 UNSPECIFIED DEMENTIA",
        "rr": 1.29,
        "risk_count": 7658,
        "predisposition_and_risk": 12,
        "risk_duration": 23196939,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_K90",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "K90* STROKE/CEREBROVASC.ACC.",
        "rr": 1.29,
        "risk_count": 10586,
        "predisposition_and_risk": 17,
        "risk_duration": 22710884,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_272.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "272.1* PURE HYPERGLYCERIDEMIA",
        "rr": 1.28,
        "risk_count": 36062,
        "predisposition_and_risk": 59,
        "risk_duration": 25143763,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_296.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "296.2* MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE",
        "rr": 1.28,
        "risk_count": 30991,
        "predisposition_and_risk": 54,
        "risk_duration": 20711880,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_372.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "372.4* PTERYGIUM",
        "rr": 1.28,
        "risk_count": 30200,
        "predisposition_and_risk": 48,
        "risk_duration": 25967896,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_720.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "720.1* SPINAL ENTHESOPATHY",
        "rr": 1.28,
        "risk_count": 8222,
        "predisposition_and_risk": 12,
        "risk_duration": 28279796,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_793.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "793.1* NONSPECIF.ABNORMAL FINDINGS LUNG FIELD,(COIN LESION)(SHADOW)",
        "rr": 1.28,
        "risk_count": 11957,
        "predisposition_and_risk": 19,
        "risk_duration": 22698677,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_924.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "924.1* CONTUSION OF KNEE AND LOWER LEG",
        "rr": 1.28,
        "risk_count": 21713,
        "predisposition_and_risk": 37,
        "risk_duration": 21170586,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V17.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V17.3* FAMILY HISTORY OF ISCHEMIC HEART DISEASE",
        "rr": 1.28,
        "risk_count": 25416,
        "predisposition_and_risk": 40,
        "risk_duration": 26210839,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V45.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V45.8* OTHER POSTSURGICAL STATUS",
        "rr": 1.28,
        "risk_count": 60574,
        "predisposition_and_risk": 103,
        "risk_duration": 24195367,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z54.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z54.9* OTHER OPERATIONS OF ABDOMINAL REGION",
        "rr": 1.28,
        "risk_count": 11256,
        "predisposition_and_risk": 18,
        "risk_duration": 22668799,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_531_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "531 GASTRIC ULCER",
        "rr": 1.28,
        "risk_count": 14201,
        "predisposition_and_risk": 21,
        "risk_duration": 27910899,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_824_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "824 FRACTURE OF ANKLE",
        "rr": 1.28,
        "risk_count": 10168,
        "predisposition_and_risk": 15,
        "risk_duration": 28041847,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_110.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "110.3* DERMATOPHYTOSIS OF GROIN AND PERIANAL AREA",
        "rr": 1.27,
        "risk_count": 24117,
        "predisposition_and_risk": 41,
        "risk_duration": 21058902,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_280.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "280.1* IRON DEF.ANEMIA SECONDARY TO INADEQUATE DIETARY IRON INTAKE",
        "rr": 1.27,
        "risk_count": 30546,
        "predisposition_and_risk": 51,
        "risk_duration": 21432759,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_451.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "451.1* PHLEBITIS AND THROMBOPHLEBITIS,DEEP VESSELS LOWER EXTREMITIES",
        "rr": 1.27,
        "risk_count": 28689,
        "predisposition_and_risk": 49,
        "risk_duration": 20906814,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_511.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "511.8* OTHER SPECIFIED FORMS OF PLEURAL EFFUSION, EXCEPT TUBERCULOUS",
        "rr": 1.27,
        "risk_count": 20310,
        "predisposition_and_risk": 30,
        "risk_duration": 27613053,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_784.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "784.2* SWELLING, MASS, OR LUMP IN HEAD AND NECK",
        "rr": 1.27,
        "risk_count": 8954,
        "predisposition_and_risk": 13,
        "risk_duration": 28246830,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_789.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "789.2* SPLENOMEGALY",
        "rr": 1.27,
        "risk_count": 13163,
        "predisposition_and_risk": 21,
        "risk_duration": 22433472,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_816.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "816.0* CLOSED FRACTURE OF ONE OR MORE PHALANGES OF HAND",
        "rr": 1.27,
        "risk_count": 8144,
        "predisposition_and_risk": 13,
        "risk_duration": 22453533,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_R80.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "R80.9* MICROALBUMINURIA",
        "rr": 1.27,
        "risk_count": 11027,
        "predisposition_and_risk": 16,
        "risk_duration": 28248491,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_368_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368 VISUAL DISTURBANCES",
        "rr": 1.27,
        "risk_count": 25569,
        "predisposition_and_risk": 39,
        "risk_duration": 26739320,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_581_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "581 NEPHROTIC SYNDROME",
        "rr": 1.27,
        "risk_count": 15296,
        "predisposition_and_risk": 25,
        "risk_duration": 21914188,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_825_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "825 FRACTURE OF ONE OR MORE TARSAL AND METATARSAL BONES",
        "rr": 1.27,
        "risk_count": 9613,
        "predisposition_and_risk": 14,
        "risk_duration": 28104435,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A03",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A03* FEVER",
        "rr": 1.27,
        "risk_count": 70957,
        "predisposition_and_risk": 143,
        "risk_duration": 20231555,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_B82",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "B82* ANEMIA OTHER/UNSPECIFIED",
        "rr": 1.27,
        "risk_count": 81299,
        "predisposition_and_risk": 147,
        "risk_duration": 22544560,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_332.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "332.0* PARALYSIS AGITANS, PARKINSON'S DISEASE",
        "rr": 1.26,
        "risk_count": 46379,
        "predisposition_and_risk": 79,
        "risk_duration": 20805960,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_332.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "332.0* PARALYSIS AGITANS, PARKINSON'S DISEASE",
        "rr": 1.26,
        "risk_count": 35862,
        "predisposition_and_risk": 54,
        "risk_duration": 27014511,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.3* RETINAL VASCULAR OCCLUSION",
        "rr": 1.26,
        "risk_count": 20981,
        "predisposition_and_risk": 31,
        "risk_duration": 27492604,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_455.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "455.3* EXTERNAL HEMORRHOIDS WITHOUT MENTION OF COMPLICATION",
        "rr": 1.26,
        "risk_count": 11007,
        "predisposition_and_risk": 16,
        "risk_duration": 27967703,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_493.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "493.9* ASTHMA, UNSPECIFIED",
        "rr": 1.26,
        "risk_count": 55126,
        "predisposition_and_risk": 95,
        "risk_duration": 23642518,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_728.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "728.8* OTHER DISORDERS OF MUSCLE, LIGAMENT, AND FASCIA",
        "rr": 1.26,
        "risk_count": 26732,
        "predisposition_and_risk": 45,
        "risk_duration": 21106348,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.1* RASH AND OTHER NONSPECIFIC SKIN ERUPTION",
        "rr": 1.26,
        "risk_count": 21162,
        "predisposition_and_risk": 35,
        "risk_duration": 21550195,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_813.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "813.4* FRACTURE OF LOWER END OF RADIUS AND ULNA, CLOSED",
        "rr": 1.26,
        "risk_count": 13727,
        "predisposition_and_risk": 20,
        "risk_duration": 27833131,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V58.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V58.7* ENCOUNTER FOR AFTERCARE FOLLOWING SURGERY TO SPECIF.BODY SYSTEMS, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.26,
        "risk_count": 13884,
        "predisposition_and_risk": 22,
        "risk_duration": 22388698,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_311",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "311* DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.26,
        "risk_count": 21165,
        "predisposition_and_risk": 33,
        "risk_duration": 26108999,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_274.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "274.0* GOUTY ARTHROPATHY",
        "rr": 1.25,
        "risk_count": 9174,
        "predisposition_and_risk": 13,
        "risk_duration": 28481411,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_373.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "373.1* HORDEOLUM AND OTHER DEEP INFLAMMATION OF EYELID",
        "rr": 1.25,
        "risk_count": 16149,
        "predisposition_and_risk": 24,
        "risk_duration": 27179967,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_455.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "455.0* INTERNAL HEMORRHOIDS WITHOUT MENTION OF COMPLICATION",
        "rr": 1.25,
        "risk_count": 24520,
        "predisposition_and_risk": 37,
        "risk_duration": 26702496,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_575.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "575.0* ACUTE CHOLECYSTITIS",
        "rr": 1.25,
        "risk_count": 10932,
        "predisposition_and_risk": 17,
        "risk_duration": 22626755,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_705.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "705.8* OTHER SPECIFIED DISORDERS OF SWEAT GLANDS",
        "rr": 1.25,
        "risk_count": 9720,
        "predisposition_and_risk": 14,
        "risk_duration": 27849469,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_949.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "949.2* BLISTERS WITH EPIDERMAL LOSS,BURN 2ND.DEG.UNSPECIFIED SITE",
        "rr": 1.25,
        "risk_count": 11076,
        "predisposition_and_risk": 16,
        "risk_duration": 27911912,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V46.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V46.2* DEPENDENCE ON SUPPLEMENTAL OXYGEN",
        "rr": 1.25,
        "risk_count": 15906,
        "predisposition_and_risk": 25,
        "risk_duration": 22524241,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z39.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z39.2* OTHER SHUNT OR VASCULAR BYPASS",
        "rr": 1.25,
        "risk_count": 17437,
        "predisposition_and_risk": 28,
        "risk_duration": 21980728,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z79.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z79.3* OPEN REDUCTION OF FRACTURE WITH INTERNAL FIXATION",
        "rr": 1.25,
        "risk_count": 8434,
        "predisposition_and_risk": 12,
        "risk_duration": 28399310,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_242_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "242 THYROTOXICOSIS WITH OR WITHOUT GOITER",
        "rr": 1.25,
        "risk_count": 23922,
        "predisposition_and_risk": 39,
        "risk_duration": 21586113,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_244_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "244 ACQUIRED HYPOTHYROIDISM",
        "rr": 1.25,
        "risk_count": 32201,
        "predisposition_and_risk": 49,
        "risk_duration": 26467558,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_698_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698 PRURITUS AND RELATED CONDITIONS",
        "rr": 1.25,
        "risk_count": 21650,
        "predisposition_and_risk": 32,
        "risk_duration": 27292752,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_460",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "460* ACUTE NASOPHARYNGITIS (COMMON COLD)",
        "rr": 1.25,
        "risk_count": 34568,
        "predisposition_and_risk": 63,
        "risk_duration": 19419265,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_078.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "078.1* VIRAL WARTS",
        "rr": 1.24,
        "risk_count": 31583,
        "predisposition_and_risk": 56,
        "risk_duration": 19761177,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_535.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "535.6* __DUODENITIS____1992",
        "rr": 1.24,
        "risk_count": 10348,
        "predisposition_and_risk": 16,
        "risk_duration": 22572369,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_784.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "784.7* EPISTAXIS",
        "rr": 1.24,
        "risk_count": 34841,
        "predisposition_and_risk": 53,
        "risk_duration": 26169606,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_788.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "788.3* INCONTINENCE OF URINE",
        "rr": 1.24,
        "risk_count": 51069,
        "predisposition_and_risk": 90,
        "risk_duration": 19863987,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_F41.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F41.9* ANXIETY DISORDER, UNSPECIFIED",
        "rr": 1.24,
        "risk_count": 9841,
        "predisposition_and_risk": 14,
        "risk_duration": 28131934,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z13.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z13.4* EXTRACAPS.EXTRACT.OF LENS BY FRAGMENT.AND ASPIRATION TECHN.",
        "rr": 1.24,
        "risk_count": 54984,
        "predisposition_and_risk": 86,
        "risk_duration": 25580065,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z68.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z68.1* DIAGNOSTIC PROCEDURES ON UTERUS AND SUPPORTING STRUCTURES",
        "rr": 1.24,
        "risk_count": 7762,
        "predisposition_and_risk": 11,
        "risk_duration": 28133439,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.4* ARTERIOGRAPHY USING CONTRAST MATERIAL",
        "rr": 1.24,
        "risk_count": 15319,
        "predisposition_and_risk": 24,
        "risk_duration": 22315414,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_035",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "035* ERYSIPELAS",
        "rr": 1.24,
        "risk_count": 18316,
        "predisposition_and_risk": 29,
        "risk_duration": 22045663,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_462",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "462* ACUTE PHARYNGITIS",
        "rr": 1.24,
        "risk_count": 59092,
        "predisposition_and_risk": 132,
        "risk_duration": 15615514,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L17",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L17* FOOT & TOE SYMPTOMS/COMPLAINTS",
        "rr": 1.24,
        "risk_count": 14468,
        "predisposition_and_risk": 23,
        "risk_duration": 22073791,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_351.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "351.0* BELL'S PALSY",
        "rr": 1.23,
        "risk_count": 20017,
        "predisposition_and_risk": 32,
        "risk_duration": 21658227,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_381.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "381.0* ACUTE NONSUPPURATIVE OTITIS MEDIA",
        "rr": 1.23,
        "risk_count": 34912,
        "predisposition_and_risk": 56,
        "risk_duration": 24656603,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_443.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "443.8* OTHER SPECIFIED PERIPHERAL VASCULAR DISEASES",
        "rr": 1.23,
        "risk_count": 19556,
        "predisposition_and_risk": 31,
        "risk_duration": 21921181,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_698.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698.2* PRURIGO",
        "rr": 1.23,
        "risk_count": 12013,
        "predisposition_and_risk": 17,
        "risk_duration": 28023274,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_716.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "716.9* UNSPECIFIED ARTHROPATHY",
        "rr": 1.23,
        "risk_count": 21733,
        "predisposition_and_risk": 35,
        "risk_duration": 21501309,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_722.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "722.9* OTHER AND UNSPECIFIED DISC DISORDER",
        "rr": 1.23,
        "risk_count": 37685,
        "predisposition_and_risk": 69,
        "risk_duration": 18994525,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.6* OTHER ABNORMAL BLOOD CHEMISTRY",
        "rr": 1.23,
        "risk_count": 39595,
        "predisposition_and_risk": 62,
        "risk_duration": 25293752,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_836.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "836.0* TEAR OF MEDIAL CARTILAGE OR MENISCUS OF KNEE, CURRENT",
        "rr": 1.23,
        "risk_count": 11868,
        "predisposition_and_risk": 17,
        "risk_duration": 27731222,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_412_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "412 OLD MYOCARDIAL INFARCTION",
        "rr": 1.23,
        "risk_count": 28619,
        "predisposition_and_risk": 42,
        "risk_duration": 27028313,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_531_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "531 GASTRIC ULCER",
        "rr": 1.23,
        "risk_count": 12906,
        "predisposition_and_risk": 20,
        "risk_duration": 22413352,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_F92_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "F92 MIXED DISORDERS OF CONDUCT EMOTIONS",
        "rr": 1.23,
        "risk_count": 40401,
        "predisposition_and_risk": 68,
        "risk_duration": 20631821,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_S12",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "S12* INSECT BITE",
        "rr": 1.23,
        "risk_count": 23460,
        "predisposition_and_risk": 35,
        "risk_duration": 26633220,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_041.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "041.1* STAPHYLOCOCCUS INFECT.IN CONDIT.CLASSIF.ELSEWHERE,UNSP.SITE",
        "rr": 1.22,
        "risk_count": 12450,
        "predisposition_and_risk": 19,
        "risk_duration": 22556306,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.5* DEGENERATION OF MACULA AND POSTERIOR POLE OF RETINA",
        "rr": 1.22,
        "risk_count": 62156,
        "predisposition_and_risk": 96,
        "risk_duration": 25477163,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_397.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "397.0* DISEASES OF TRICUSPID VALVE",
        "rr": 1.22,
        "risk_count": 21846,
        "predisposition_and_risk": 31,
        "risk_duration": 27600333,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_427.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.8* OTHER SPECIFIED CARDIAC DYSRHYTHMIAS",
        "rr": 1.22,
        "risk_count": 38486,
        "predisposition_and_risk": 64,
        "risk_duration": 20658812,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_428.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "428.1* LEFT HEART FAILURE",
        "rr": 1.22,
        "risk_count": 17061,
        "predisposition_and_risk": 24,
        "risk_duration": 27955875,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_528.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "528.2* ORAL APHTHAE",
        "rr": 1.22,
        "risk_count": 13394,
        "predisposition_and_risk": 19,
        "risk_duration": 27684419,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_553.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "553.3* DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "rr": 1.22,
        "risk_count": 23088,
        "predisposition_and_risk": 37,
        "risk_duration": 21564598,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_681.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "681.0* CELLULITIS AND ABSCESS OF FINGER",
        "rr": 1.22,
        "risk_count": 17085,
        "predisposition_and_risk": 27,
        "risk_duration": 21861970,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_737.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "737.3* KYPHOSCOLIOSIS AND SCOLIOSIS",
        "rr": 1.22,
        "risk_count": 13454,
        "predisposition_and_risk": 19,
        "risk_duration": 27858653,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_785.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.6* ENLARGEMENT OF LYMPH NODES",
        "rr": 1.22,
        "risk_count": 37413,
        "predisposition_and_risk": 59,
        "risk_duration": 24887473,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z84.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z84.1* AMPUTATION OF LOWER LIMB",
        "rr": 1.22,
        "risk_count": 35708,
        "predisposition_and_risk": 61,
        "risk_duration": 20183225,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_680_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "680 CARBUNCLE AND FURUNCLE",
        "rr": 1.22,
        "risk_count": 12822,
        "predisposition_and_risk": 20,
        "risk_duration": 22093077,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_D89",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "D89* INGUINAL HERNIA",
        "rr": 1.22,
        "risk_count": 36234,
        "predisposition_and_risk": 62,
        "risk_duration": 20083339,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L05",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L05* FLANK SYMPTOMS/COMPLAINTS",
        "rr": 1.22,
        "risk_count": 47127,
        "predisposition_and_risk": 79,
        "risk_duration": 23392370,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_S18",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "S18* LACERATION/CUT",
        "rr": 1.22,
        "risk_count": 13385,
        "predisposition_and_risk": 21,
        "risk_duration": 22015962,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_241.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "241.0* NONTOXIC UNINODULAR GOITER",
        "rr": 1.21,
        "risk_count": 34246,
        "predisposition_and_risk": 52,
        "risk_duration": 25701061,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_368.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368.8* OTHER SPECIFIED VISUAL DISTURBANCES",
        "rr": 1.21,
        "risk_count": 23226,
        "predisposition_and_risk": 37,
        "risk_duration": 21492559,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_379.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "379.9* UNSPECIFIED DISORDER OF EYE AND ADNEXA",
        "rr": 1.21,
        "risk_count": 15493,
        "predisposition_and_risk": 22,
        "risk_duration": 27514335,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_564.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "564.1* IRRITABLE COLON",
        "rr": 1.21,
        "risk_count": 20864,
        "predisposition_and_risk": 30,
        "risk_duration": 27115660,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_718.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "718.4* CONTRACTURE OF JOINT",
        "rr": 1.21,
        "risk_count": 8047,
        "predisposition_and_risk": 11,
        "risk_duration": 28412775,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_721.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "721.1* CERVICAL SPONDYLOSIS WITH MYELOPATHY",
        "rr": 1.21,
        "risk_count": 11224,
        "predisposition_and_risk": 17,
        "risk_duration": 22505935,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_845.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "845.0* ANKLE SPRAIN",
        "rr": 1.21,
        "risk_count": 13972,
        "predisposition_and_risk": 22,
        "risk_duration": 21727537,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V67.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V67.5* FOLLOW-UP EXAMINATION FOLLOWING OTHER TREATMENT",
        "rr": 1.21,
        "risk_count": 10067,
        "predisposition_and_risk": 15,
        "risk_duration": 22827097,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z36.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z36.0* REMOVAL OF CORONARY ARTERY OBSTRUCTION",
        "rr": 1.21,
        "risk_count": 35819,
        "predisposition_and_risk": 53,
        "risk_duration": 26411299,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z53.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z53.0* UNILATERAL REPAIR OF INGUINAL HERNIA",
        "rr": 1.21,
        "risk_count": 8654,
        "predisposition_and_risk": 13,
        "risk_duration": 22803140,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_491_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "491 CHRONIC BRONCHITIS",
        "rr": 1.21,
        "risk_count": 21662,
        "predisposition_and_risk": 34,
        "risk_duration": 21799564,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_603_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "603 HYDROCELE",
        "rr": 1.21,
        "risk_count": 12541,
        "predisposition_and_risk": 19,
        "risk_duration": 22547322,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "726 PERIPHERAL ENTHESOPATHIES AND ALLIED SYNDROMES",
        "rr": 1.21,
        "risk_count": 8656,
        "predisposition_and_risk": 13,
        "risk_duration": 22722395,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_496",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "496* CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED",
        "rr": 1.21,
        "risk_count": 11952,
        "predisposition_and_risk": 17,
        "risk_duration": 27455026,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_228.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "228.0* HEMANGIOMA, ANY SITE",
        "rr": 1.2,
        "risk_count": 14995,
        "predisposition_and_risk": 23,
        "risk_duration": 22091924,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_365.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "365.1* OPEN-ANGLE GLAUCOMA",
        "rr": 1.2,
        "risk_count": 8145,
        "predisposition_and_risk": 11,
        "risk_duration": 28589198,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_414.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "414.0* CORONARY ATHEROSCLEROSIS",
        "rr": 1.2,
        "risk_count": 46396,
        "predisposition_and_risk": 70,
        "risk_duration": 25589385,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_443.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "443.8* OTHER SPECIFIED PERIPHERAL VASCULAR DISEASES",
        "rr": 1.2,
        "risk_count": 8782,
        "predisposition_and_risk": 12,
        "risk_duration": 28386945,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_698.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698.3* LICHENIFICATION AND LICHEN SIMPLEX CHRONICUS",
        "rr": 1.2,
        "risk_count": 11268,
        "predisposition_and_risk": 17,
        "risk_duration": 22385921,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_702.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "702.0* ACTINIC KERATOSIS",
        "rr": 1.2,
        "risk_count": 71328,
        "predisposition_and_risk": 129,
        "risk_duration": 18744134,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_707.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "707.0* DECUBITUS ULCER",
        "rr": 1.2,
        "risk_count": 31924,
        "predisposition_and_risk": 46,
        "risk_duration": 26846961,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_P02.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "P02.7* ISSUE OF MEDICAL CERTIFICATE",
        "rr": 1.2,
        "risk_count": 25015,
        "predisposition_and_risk": 40,
        "risk_duration": 21164626,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z01.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z01.2* CRANIOTOMY AND CRANIECTOMY",
        "rr": 1.2,
        "risk_count": 9556,
        "predisposition_and_risk": 13,
        "risk_duration": 28338613,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z13.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z13.7* INSERTION OF PROSTHETIC LENS (PSEUDOPHAKOS)",
        "rr": 1.2,
        "risk_count": 64018,
        "predisposition_and_risk": 99,
        "risk_duration": 25041243,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "8* DIABETES ROUTINE FOLLOW UP",
        "rr": 1.2,
        "risk_count": 10857,
        "predisposition_and_risk": 15,
        "risk_duration": 27960403,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A97",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A97* NO DISEASE",
        "rr": 1.2,
        "risk_count": 63853,
        "predisposition_and_risk": 118,
        "risk_duration": 20875667,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_B82",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "B82* ANEMIA OTHER/UNSPECIFIED",
        "rr": 1.2,
        "risk_count": 74852,
        "predisposition_and_risk": 145,
        "risk_duration": 17518207,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_251.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "251.2* HYPOGLYCEMIA, UNSPECIFIED",
        "rr": 1.19,
        "risk_count": 28748,
        "predisposition_and_risk": 41,
        "risk_duration": 26812458,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_272.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "272.2* MIXED HYPERLIPIDEMIA",
        "rr": 1.19,
        "risk_count": 16544,
        "predisposition_and_risk": 25,
        "risk_duration": 22134374,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_276.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "276.7* HYPERPOTASSEMIA",
        "rr": 1.19,
        "risk_count": 46583,
        "predisposition_and_risk": 78,
        "risk_duration": 19980885,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_365.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "365.0* BORDERLINE GLAUCOMA (GLAUCOMA SUSPECT)",
        "rr": 1.19,
        "risk_count": 28005,
        "predisposition_and_risk": 44,
        "risk_duration": 21357457,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_367.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "367.0* HYPERMETROPIA",
        "rr": 1.19,
        "risk_count": 26569,
        "predisposition_and_risk": 42,
        "risk_duration": 21315760,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_550.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "550.9* INGUINAL HERNIA, WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "rr": 1.19,
        "risk_count": 62785,
        "predisposition_and_risk": 123,
        "risk_duration": 17135145,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_611.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "611.7* SIGNS AND SYMPTOMS IN BREAST",
        "rr": 1.19,
        "risk_count": 62531,
        "predisposition_and_risk": 115,
        "risk_duration": 20851025,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.7* MALAISE AND FATIGUE",
        "rr": 1.19,
        "risk_count": 65207,
        "predisposition_and_risk": 128,
        "risk_duration": 17100848,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_784.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "784.5* OTHER SPEECH DISTURBANCE",
        "rr": 1.19,
        "risk_count": 16617,
        "predisposition_and_risk": 23,
        "risk_duration": 27768297,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_923.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "923.2* CONTUSION OF WRIST AND HAND(S), EXCEPT FINGER(S) ALONE",
        "rr": 1.19,
        "risk_count": 17390,
        "predisposition_and_risk": 27,
        "risk_duration": 21575096,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V42.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V42.0* KIDNEY REPLACED BY TRANSPLANT",
        "rr": 1.19,
        "risk_count": 17076,
        "predisposition_and_risk": 26,
        "risk_duration": 22084475,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V58.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V58.6* ENCOUNTER FOR LONG-TERM (CURRENT) DRUG USE",
        "rr": 1.19,
        "risk_count": 102883,
        "predisposition_and_risk": 198,
        "risk_duration": 19888112,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z87.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z87.0* SOFT TISSUE X-RAY OF FACE, HEAD, AND NECK",
        "rr": 1.19,
        "risk_count": 29702,
        "predisposition_and_risk": 47,
        "risk_duration": 21143865,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_185",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "185* MALIGNANT NEOPLASM OF PROSTATE",
        "rr": 1.19,
        "risk_count": 46219,
        "predisposition_and_risk": 74,
        "risk_duration": 20926127,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_429.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "429.3* CARDIOMEGALY",
        "rr": 1.18,
        "risk_count": 9734,
        "predisposition_and_risk": 13,
        "risk_duration": 28386610,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_781.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "781.0* ABNORMAL INVOLUNTARY MOVEMENTS",
        "rr": 1.18,
        "risk_count": 36734,
        "predisposition_and_risk": 53,
        "risk_duration": 26278810,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_787.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "787.9* OTHER SYMPTOMS INVOLVING DIGESTIVE SYSTEM",
        "rr": 1.18,
        "risk_count": 58783,
        "predisposition_and_risk": 111,
        "risk_duration": 17702640,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_824.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "824.2* FRACTURE OF LATERAL MALLEOLUS, CLOSED",
        "rr": 1.18,
        "risk_count": 12380,
        "predisposition_and_risk": 17,
        "risk_duration": 27729650,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_958.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "958.3* POSTTRAUMATIC WOUND INFECTION NOT ELSEWHERE CLASSIFIED",
        "rr": 1.18,
        "risk_count": 32457,
        "predisposition_and_risk": 48,
        "risk_duration": 25781581,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V17.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V17.3* FAMILY HISTORY OF ISCHEMIC HEART DISEASE",
        "rr": 1.18,
        "risk_count": 26157,
        "predisposition_and_risk": 43,
        "risk_duration": 20284786,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_472.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "472.0* CHRONIC RHINITIS",
        "rr": 1.17,
        "risk_count": 19542,
        "predisposition_and_risk": 27,
        "risk_duration": 27213616,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_569.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "569.4* OTHER SPECIFIED DISORDERS OF RECTUM AND ANUS",
        "rr": 1.17,
        "risk_count": 15309,
        "predisposition_and_risk": 23,
        "risk_duration": 21948628,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.2* ABNORMAL GLUCOSE TOLERANCE TEST",
        "rr": 1.17,
        "risk_count": 47156,
        "predisposition_and_risk": 73,
        "risk_duration": 24400182,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_807.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "807.0* CLOSED FRACTURE OF RIB(S)",
        "rr": 1.17,
        "risk_count": 8890,
        "predisposition_and_risk": 13,
        "risk_duration": 22663696,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V16.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V16.0* FAMILY HISTORY OF MALIGNANT NEOPLASM OF GASTROINTESTINAL TRACT",
        "rr": 1.17,
        "risk_count": 22733,
        "predisposition_and_risk": 32,
        "risk_duration": 26885222,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z00.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z00.4* ADJUNCT VASCULAR SYSTEM PROCEDURES",
        "rr": 1.17,
        "risk_count": 34096,
        "predisposition_and_risk": 55,
        "risk_duration": 20433091,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z14.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z14.7* OPERATIONS ON VITREOUS",
        "rr": 1.17,
        "risk_count": 9011,
        "predisposition_and_risk": 13,
        "risk_duration": 22808144,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_726_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "726 PERIPHERAL ENTHESOPATHIES AND ALLIED SYNDROMES",
        "rr": 1.17,
        "risk_count": 17457,
        "predisposition_and_risk": 24,
        "risk_duration": 27348239,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_D09",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "D09* NAUSEA",
        "rr": 1.17,
        "risk_count": 31758,
        "predisposition_and_risk": 46,
        "risk_duration": 26030447,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_112.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "112.1* CANDIDIASIS OF VULVA AND VAGINA",
        "rr": 1.16,
        "risk_count": 19662,
        "predisposition_and_risk": 28,
        "risk_duration": 26322808,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_364.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "364.3* UNSPECIFIED IRIDOCYCLITIS",
        "rr": 1.16,
        "risk_count": 8335,
        "predisposition_and_risk": 12,
        "risk_duration": 22776094,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_472.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "472.1* CHRONIC PHARYNGITIS",
        "rr": 1.16,
        "risk_count": 9093,
        "predisposition_and_risk": 12,
        "risk_duration": 28305009,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_577.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "577.0* ACUTE PANCREATITIS",
        "rr": 1.16,
        "risk_count": 12882,
        "predisposition_and_risk": 19,
        "risk_duration": 22266406,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_578.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "578.1* MELENA",
        "rr": 1.16,
        "risk_count": 45853,
        "predisposition_and_risk": 69,
        "risk_duration": 24885564,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_698.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "698.9* UNSPECIFIED PRURITIC DISORDER",
        "rr": 1.16,
        "risk_count": 47437,
        "predisposition_and_risk": 71,
        "risk_duration": 24975903,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z88.7* DIAGNOSTIC ULTRASOUND",
        "rr": 1.16,
        "risk_count": 63501,
        "predisposition_and_risk": 105,
        "risk_duration": 22581329,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_410_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "410 ACUTE MYOCARDIAL INFARCTION",
        "rr": 1.16,
        "risk_count": 34639,
        "predisposition_and_risk": 49,
        "risk_duration": 26373130,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A05",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "A05* GENERAL DETERIORATION",
        "rr": 1.16,
        "risk_count": 24119,
        "predisposition_and_risk": 36,
        "risk_duration": 22002475,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_379.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "379.9* UNSPECIFIED DISORDER OF EYE AND ADNEXA",
        "rr": 1.15,
        "risk_count": 9757,
        "predisposition_and_risk": 14,
        "risk_duration": 22546308,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "722.0* DISPLACEM.OF CERVICAL INTERVERTEBR.DISC WITHOUT MYELOPATHY",
        "rr": 1.15,
        "risk_count": 16096,
        "predisposition_and_risk": 22,
        "risk_duration": 27072860,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_784.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "784.3* APHASIA",
        "rr": 1.15,
        "risk_count": 8489,
        "predisposition_and_risk": 12,
        "risk_duration": 22884592,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z51.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z51.2* CHOLECYSTECTOMY",
        "rr": 1.15,
        "risk_count": 30317,
        "predisposition_and_risk": 43,
        "risk_duration": 26188931,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z85.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z85.2* EXCISION OR DESTRUCTION OF BREAST TISSUE",
        "rr": 1.15,
        "risk_count": 15699,
        "predisposition_and_risk": 21,
        "risk_duration": 27769197,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_585_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "585 CHRONIC RENAL FAILURE",
        "rr": 1.15,
        "risk_count": 15728,
        "predisposition_and_risk": 23,
        "risk_duration": 22096467,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_700_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "700 CORNS AND CALLOSITIES",
        "rr": 1.15,
        "risk_count": 32276,
        "predisposition_and_risk": 46,
        "risk_duration": 25907610,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_S12",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "S12* INSECT BITE",
        "rr": 1.15,
        "risk_count": 9041,
        "predisposition_and_risk": 13,
        "risk_duration": 22656198,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_366.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "366.9* UNSPECIFIED CATARACT",
        "rr": 1.14,
        "risk_count": 18732,
        "predisposition_and_risk": 27,
        "risk_duration": 22273858,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_562.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "562.1* DIVERTICULA OF COLON",
        "rr": 1.14,
        "risk_count": 38880,
        "predisposition_and_risk": 55,
        "risk_duration": 25997497,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_599.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "599.7* HEMATURIA",
        "rr": 1.14,
        "risk_count": 56939,
        "predisposition_and_risk": 91,
        "risk_duration": 23059755,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_681.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "681.1* CELLULITIS AND ABSCESS OF TOE",
        "rr": 1.14,
        "risk_count": 12502,
        "predisposition_and_risk": 18,
        "risk_duration": 22412205,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_729.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "729.8* OTHER MUSCULOSKELETAL SYMPTOMS REFERABLE TO LIMBS",
        "rr": 1.14,
        "risk_count": 46267,
        "predisposition_and_risk": 69,
        "risk_duration": 24580019,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_787.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "787.2* DYSPHAGIA",
        "rr": 1.14,
        "risk_count": 37127,
        "predisposition_and_risk": 53,
        "risk_duration": 25628846,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_958.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "958.3* POSTTRAUMATIC WOUND INFECTION NOT ELSEWHERE CLASSIFIED",
        "rr": 1.14,
        "risk_count": 38126,
        "predisposition_and_risk": 62,
        "risk_duration": 19740898,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_437_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "437 OTHER AND ILL-DEFINED CEREBROVASCULAR DISEASE",
        "rr": 1.14,
        "risk_count": 17432,
        "predisposition_and_risk": 25,
        "risk_duration": 22332793,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_443_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "443 OTHER PERIPHERAL VASCULAR DISEASE",
        "rr": 1.14,
        "risk_count": 30450,
        "predisposition_and_risk": 42,
        "risk_duration": 26640964,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_680_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "680 CARBUNCLE AND FURUNCLE",
        "rr": 1.14,
        "risk_count": 16326,
        "predisposition_and_risk": 22,
        "risk_duration": 27169920,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_D77",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "D77* MALIGN.NEOPL.OTHER/UNSPEC.",
        "rr": 1.14,
        "risk_count": 10761,
        "predisposition_and_risk": 14,
        "risk_duration": 28196731,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_N17",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "N17* VERTIGO/DIZZINESS (EXCL.H82)",
        "rr": 1.14,
        "risk_count": 9214,
        "predisposition_and_risk": 12,
        "risk_duration": 28151943,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_607.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "607.8* OTHER SPECIFIED DISORDERS OF PENIS",
        "rr": 1.13,
        "risk_count": 69087,
        "predisposition_and_risk": 132,
        "risk_duration": 16660619,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_708.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "708.0* ALLERGIC URTICARIA",
        "rr": 1.13,
        "risk_count": 10010,
        "predisposition_and_risk": 13,
        "risk_duration": 27921054,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_716.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "716.9* UNSPECIFIED ARTHROPATHY",
        "rr": 1.13,
        "risk_count": 37637,
        "predisposition_and_risk": 54,
        "risk_duration": 25324145,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "780.9* OTHER GENERAL SYMPTOMS",
        "rr": 1.13,
        "risk_count": 53356,
        "predisposition_and_risk": 81,
        "risk_duration": 23959623,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_847.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "847.0* NECK SPRAIN",
        "rr": 1.13,
        "risk_count": 30450,
        "predisposition_and_risk": 46,
        "risk_duration": 24020915,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_214_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "214 LIPOMA",
        "rr": 1.13,
        "risk_count": 32802,
        "predisposition_and_risk": 47,
        "risk_duration": 25295276,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_470",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "470* DEVIATED NASAL SEPTUM",
        "rr": 1.13,
        "risk_count": 21787,
        "predisposition_and_risk": 33,
        "risk_duration": 21091428,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L92",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L92* SHOULDER SYNDROME",
        "rr": 1.13,
        "risk_count": 17882,
        "predisposition_and_risk": 24,
        "risk_duration": 27141803,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_110.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "110.4* DERMATOPHYTOSIS OF FOOT",
        "rr": 1.12,
        "risk_count": 61281,
        "predisposition_and_risk": 98,
        "risk_duration": 22499456,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_233.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "233.0* CARCINOMA IN SITU OF BREAST",
        "rr": 1.12,
        "risk_count": 13933,
        "predisposition_and_risk": 18,
        "risk_duration": 27827479,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_410.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "410.3* ACUTE MYOCARDIAL INFARCTION OF INFEROPOSTERIOR WALL",
        "rr": 1.12,
        "risk_count": 9392,
        "predisposition_and_risk": 13,
        "risk_duration": 22740328,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_427.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.0* PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA",
        "rr": 1.12,
        "risk_count": 8001,
        "predisposition_and_risk": 11,
        "risk_duration": 22902060,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "427.8* OTHER SPECIFIED CARDIAC DYSRHYTHMIAS",
        "rr": 1.12,
        "risk_count": 43386,
        "predisposition_and_risk": 61,
        "risk_duration": 25756512,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_447.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "447.1* STRICTURE OF ARTERY",
        "rr": 1.12,
        "risk_count": 15510,
        "predisposition_and_risk": 22,
        "risk_duration": 22191140,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_535.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "535.0* __GASTRITIS____1992 ACUTE",
        "rr": 1.12,
        "risk_count": 47687,
        "predisposition_and_risk": 72,
        "risk_duration": 23809389,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_703.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "703.0* INGROWING NAIL",
        "rr": 1.12,
        "risk_count": 13989,
        "predisposition_and_risk": 20,
        "risk_duration": 22188314,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.3* EDEMA",
        "rr": 1.12,
        "risk_count": 15405,
        "predisposition_and_risk": 22,
        "risk_duration": 22162215,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.1* PALPITATIONS",
        "rr": 1.12,
        "risk_count": 43415,
        "predisposition_and_risk": 71,
        "risk_duration": 19283372,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_812.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "812.0* FRACTURE OF UPPER END OF HUMERUS, CLOSED",
        "rr": 1.12,
        "risk_count": 21267,
        "predisposition_and_risk": 28,
        "risk_duration": 27401243,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V16.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V16.0* FAMILY HISTORY OF MALIGNANT NEOPLASM OF GASTROINTESTINAL TRACT",
        "rr": 1.12,
        "risk_count": 13992,
        "predisposition_and_risk": 20,
        "risk_duration": 22121213,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z00.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z00.6* PROCEDURES OF BLOOD VESSELS",
        "rr": 1.12,
        "risk_count": 30771,
        "predisposition_and_risk": 47,
        "risk_duration": 20748666,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z45.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z45.2* DIAGNOSTIC PROCEDURES ON LARGE INTESTINE",
        "rr": 1.12,
        "risk_count": 35858,
        "predisposition_and_risk": 50,
        "risk_duration": 25797828,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L02",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L02* BACK SYMPTOMS/COMPLAINTS",
        "rr": 1.12,
        "risk_count": 82545,
        "predisposition_and_risk": 168,
        "risk_duration": 17800957,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_377.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "377.1* OPTIC ATROPHY",
        "rr": 1.11,
        "risk_count": 12259,
        "predisposition_and_risk": 17,
        "risk_duration": 22558887,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_464.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "464.1* ACUTE TRACHEITIS",
        "rr": 1.11,
        "risk_count": 16147,
        "predisposition_and_risk": 21,
        "risk_duration": 27420494,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_555.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "555.9* REGIONAL ENTERITIS OF UNSPECIFIED SITE",
        "rr": 1.11,
        "risk_count": 11442,
        "predisposition_and_risk": 16,
        "risk_duration": 22384599,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_705.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "705.8* OTHER SPECIFIED DISORDERS OF SWEAT GLANDS",
        "rr": 1.11,
        "risk_count": 7916,
        "predisposition_and_risk": 11,
        "risk_duration": 22630652,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_724.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "724.6* DISORDERS OF SACRUM",
        "rr": 1.11,
        "risk_count": 13213,
        "predisposition_and_risk": 17,
        "risk_duration": 27806425,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_784.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "784.7* EPISTAXIS",
        "rr": 1.11,
        "risk_count": 33593,
        "predisposition_and_risk": 50,
        "risk_duration": 21000189,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V67.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V67.0* FOLLOW-UP EXAMINATION FOLLOWING SURGERY",
        "rr": 1.11,
        "risk_count": 8032,
        "predisposition_and_risk": 11,
        "risk_duration": 22889195,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L03",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L03* LOW BACK COMPLT.W/O RADIATION",
        "rr": 1.11,
        "risk_count": 42777,
        "predisposition_and_risk": 73,
        "risk_duration": 18425057,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L14",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L14* LEG/THIGH SYMPTOMS/COMPLAINTS",
        "rr": 1.11,
        "risk_count": 40684,
        "predisposition_and_risk": 65,
        "risk_duration": 19630163,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.0* DIABETIC RETINOPATHY",
        "rr": 1.1,
        "risk_count": 8643,
        "predisposition_and_risk": 12,
        "risk_duration": 22271466,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_493.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "493.9* ASTHMA, UNSPECIFIED",
        "rr": 1.1,
        "risk_count": 27749,
        "predisposition_and_risk": 41,
        "risk_duration": 21062563,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_692.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "692.3* CONT.DERMAT.+ECZEMA DUE TO DRUGS/MEDEC.IN CONTACT WITH SKIN",
        "rr": 1.1,
        "risk_count": 8734,
        "predisposition_and_risk": 11,
        "risk_duration": 28248298,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_692.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "692.9* CONTACT DERMATITIS AND OTHER ECZEMA, UNSPECIFIED CAUSE",
        "rr": 1.1,
        "risk_count": 42080,
        "predisposition_and_risk": 60,
        "risk_duration": 24765791,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_702.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "702.0* ACTINIC KERATOSIS",
        "rr": 1.1,
        "risk_count": 69715,
        "predisposition_and_risk": 102,
        "risk_duration": 24200156,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_702.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "702.9* ACTINIC KERATOSIS",
        "rr": 1.1,
        "risk_count": 15901,
        "predisposition_and_risk": 22,
        "risk_duration": 22499460,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_879.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "879.8* OPEN WOUND(S)(MULTIPLE)OF UNSPECIFIED SITE(S),WITHOUT COMPLIC.",
        "rr": 1.1,
        "risk_count": 15715,
        "predisposition_and_risk": 20,
        "risk_duration": 27762163,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V57.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V57.8* CARE INVOLVING OTHER SPECIFIED REHABILITATION PROCEDURE",
        "rr": 1.1,
        "risk_count": 10441,
        "predisposition_and_risk": 13,
        "risk_duration": 28342509,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_368_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "368 VISUAL DISTURBANCES",
        "rr": 1.1,
        "risk_count": 17029,
        "predisposition_and_risk": 24,
        "risk_duration": 22011048,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_438_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "438 LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "rr": 1.1,
        "risk_count": 16534,
        "predisposition_and_risk": 23,
        "risk_duration": 22326842,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P74",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "P74* ANXIETY DISORDER/ANXIETY STATE",
        "rr": 1.1,
        "risk_count": 19110,
        "predisposition_and_risk": 25,
        "risk_duration": 27039151,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_244.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "244.0* POSTSURGICAL HYPOTHYROIDISM",
        "rr": 1.09,
        "risk_count": 9628,
        "predisposition_and_risk": 12,
        "risk_duration": 28280757,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_298.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "298.2* REACTIVE CONFUSION",
        "rr": 1.09,
        "risk_count": 10397,
        "predisposition_and_risk": 14,
        "risk_duration": 22885093,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_342.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "342.9* HEMIPLEGIA, UNSPECIFIED",
        "rr": 1.09,
        "risk_count": 11180,
        "predisposition_and_risk": 14,
        "risk_duration": 28156106,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_366.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "366.1* SENILE CATARACT",
        "rr": 1.09,
        "risk_count": 48899,
        "predisposition_and_risk": 75,
        "risk_duration": 20106324,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_433.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "433.1* OCCLUSION AND STENOSIS OF CAROTID ARTERY",
        "rr": 1.09,
        "risk_count": 66900,
        "predisposition_and_risk": 109,
        "risk_duration": 18897165,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_438.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "438.9* UNSP. LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "rr": 1.09,
        "risk_count": 14448,
        "predisposition_and_risk": 18,
        "risk_duration": 28164252,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_524.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "524.6* TEMPOROMANDIBULAR JOINT DISORDERS",
        "rr": 1.09,
        "risk_count": 42274,
        "predisposition_and_risk": 61,
        "risk_duration": 24424778,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_785.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "785.2* FUNCTIONAL AND UNDIAGNOSED CARDIAC MURMURS",
        "rr": 1.09,
        "risk_count": 8889,
        "predisposition_and_risk": 11,
        "risk_duration": 28353096,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_788.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "788.2* RETENTION OF URINE",
        "rr": 1.09,
        "risk_count": 49596,
        "predisposition_and_risk": 76,
        "risk_duration": 20035708,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_799.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "799.3* DEBILITY, UNSPECIFIED",
        "rr": 1.09,
        "risk_count": 65268,
        "predisposition_and_risk": 108,
        "risk_duration": 21310603,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_799.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "799.8* OTHER ILL-DEFINED CONDITIONS",
        "rr": 1.09,
        "risk_count": 50315,
        "predisposition_and_risk": 84,
        "risk_duration": 18450676,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z55.6",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z55.6* TRANSPLANT OF KIDNEY",
        "rr": 1.09,
        "risk_count": 19871,
        "predisposition_and_risk": 28,
        "risk_duration": 21761408,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z81.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z81.5* TOTAL HIP REPLACEMENT",
        "rr": 1.09,
        "risk_count": 13915,
        "predisposition_and_risk": 19,
        "risk_duration": 22503972,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z93.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z93.9* RESPIRATORY THERAPY",
        "rr": 1.09,
        "risk_count": 11106,
        "predisposition_and_risk": 15,
        "risk_duration": 22798356,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z95.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z95.4* NONOPERATIVE PROCEDURES RELATED TO HEARING",
        "rr": 1.09,
        "risk_count": 14359,
        "predisposition_and_risk": 20,
        "risk_duration": 22142850,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_355.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "355.1* MERALGIA PARESTHETICA",
        "rr": 1.08,
        "risk_count": 41258,
        "predisposition_and_risk": 64,
        "risk_duration": 19736301,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.0* DIABETIC RETINOPATHY",
        "rr": 1.08,
        "risk_count": 8824,
        "predisposition_and_risk": 11,
        "risk_duration": 27877206,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_388.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "388.3* TINNITUS",
        "rr": 1.08,
        "risk_count": 69667,
        "predisposition_and_risk": 112,
        "risk_duration": 21669933,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_413.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "413.9* OTHER AND UNSPECIFIED ANGINA PECTORIS",
        "rr": 1.08,
        "risk_count": 59192,
        "predisposition_and_risk": 85,
        "risk_duration": 24340830,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_618.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "618.0* PROLAPSE OF VAGINAL WALLS WITHOUT MENTION OF UTERINE PROLAPSE",
        "rr": 1.08,
        "risk_count": 43130,
        "predisposition_and_risk": 60,
        "risk_duration": 25085661,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_681.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "681.4* HELICOBACTER PYLORI",
        "rr": 1.08,
        "risk_count": 15789,
        "predisposition_and_risk": 20,
        "risk_duration": 27510158,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_696.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "696.1* OTHER PSORIASIS AND SIMILAR DISORDERS",
        "rr": 1.08,
        "risk_count": 23047,
        "predisposition_and_risk": 33,
        "risk_duration": 21214330,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_794.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "794.3* NONSPECIFIC ABNORMAL RESULTS OF CARDIOVASCULAR SYSTEM",
        "rr": 1.08,
        "risk_count": 11795,
        "predisposition_and_risk": 16,
        "risk_duration": 22498114,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_H02",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "H02* HEARING COMPLAINTS",
        "rr": 1.08,
        "risk_count": 40147,
        "predisposition_and_risk": 62,
        "risk_duration": 19733271,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_300.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "300.4* NEUROTIC DEPRESSION",
        "rr": 1.07,
        "risk_count": 54533,
        "predisposition_and_risk": 82,
        "risk_duration": 22827779,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.3* RETINAL VASCULAR OCCLUSION",
        "rr": 1.07,
        "risk_count": 19694,
        "predisposition_and_risk": 27,
        "risk_duration": 22046790,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_386.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "386.1* OTHER AND UNSPECIFIED PERIPHERAL VERTIGO",
        "rr": 1.07,
        "risk_count": 51025,
        "predisposition_and_risk": 73,
        "risk_duration": 24103590,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_571.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "571.8* OTHER CHRONIC NONALCOHOLIC LIVER DISEASE",
        "rr": 1.07,
        "risk_count": 57862,
        "predisposition_and_risk": 87,
        "risk_duration": 22827403,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_600.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "600.9* UNSPECIFIED HYPERPLASIA OF PROSTATE",
        "rr": 1.07,
        "risk_count": 84780,
        "predisposition_and_risk": 146,
        "risk_duration": 17453068,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_681.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "681.0* CELLULITIS AND ABSCESS OF FINGER",
        "rr": 1.07,
        "risk_count": 30714,
        "predisposition_and_risk": 41,
        "risk_duration": 25789634,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_787.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "787.3* FLATULENCE, ERUCTATION, AND GAS PAIN",
        "rr": 1.07,
        "risk_count": 14771,
        "predisposition_and_risk": 20,
        "risk_duration": 22224839,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_836.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "836.0* TEAR OF MEDIAL CARTILAGE OR MENISCUS OF KNEE, CURRENT",
        "rr": 1.07,
        "risk_count": 8920,
        "predisposition_and_risk": 12,
        "risk_duration": 22409626,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_931.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "931.0* FOREIGN BODY EAR",
        "rr": 1.07,
        "risk_count": 9057,
        "predisposition_and_risk": 12,
        "risk_duration": 22744531,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z45.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z45.2* DIAGNOSTIC PROCEDURES ON LARGE INTESTINE",
        "rr": 1.07,
        "risk_count": 34697,
        "predisposition_and_risk": 51,
        "risk_duration": 20541440,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_251.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "251.2* HYPOGLYCEMIA, UNSPECIFIED",
        "rr": 1.06,
        "risk_count": 27854,
        "predisposition_and_risk": 39,
        "risk_duration": 21455096,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_592.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "592.0* CALCULUS OF KIDNEY",
        "rr": 1.06,
        "risk_count": 62335,
        "predisposition_and_risk": 95,
        "risk_duration": 22330991,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_620.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "620.0* FOLLICULAR CYST OF OVARY",
        "rr": 1.06,
        "risk_count": 20024,
        "predisposition_and_risk": 26,
        "risk_duration": 26380965,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_706.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "706.8* OTHER SPECIFIED DISEASES OF SEBACEOUS GLANDS",
        "rr": 1.06,
        "risk_count": 29512,
        "predisposition_and_risk": 38,
        "risk_duration": 26602535,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_717.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "717.0* OLD BUCKET HANDLE TEAR OF MEDIAL MENISCUS",
        "rr": 1.06,
        "risk_count": 10640,
        "predisposition_and_risk": 13,
        "risk_duration": 27934858,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "782.0* DISTURBANCE OF SKIN SENSATION",
        "rr": 1.06,
        "risk_count": 53219,
        "predisposition_and_risk": 92,
        "risk_duration": 17267229,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_787.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "787.0* NAUSEA AND VOMITING",
        "rr": 1.06,
        "risk_count": 62172,
        "predisposition_and_risk": 93,
        "risk_duration": 22817818,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_787.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "787.9* OTHER SYMPTOMS INVOLVING DIGESTIVE SYSTEM",
        "rr": 1.06,
        "risk_count": 78682,
        "predisposition_and_risk": 129,
        "risk_duration": 20891638,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z89.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z89.1* ANATOM-PHYSIOL.MEASUREMENTS/MANUAL EXAMIN.-NERVOUS SYSTEM",
        "rr": 1.06,
        "risk_count": 10641,
        "predisposition_and_risk": 14,
        "risk_duration": 22721210,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_216_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "216 BENIGN NEOPLASM OF SKIN",
        "rr": 1.06,
        "risk_count": 25746,
        "predisposition_and_risk": 37,
        "risk_duration": 20861157,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_272_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "272 DISORDERS OF LIPOID METABOLISM",
        "rr": 1.06,
        "risk_count": 42252,
        "predisposition_and_risk": 57,
        "risk_duration": 25223583,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_696_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "696 PSORIASIS AND SIMILAR DISORDERS",
        "rr": 1.06,
        "risk_count": 36142,
        "predisposition_and_risk": 49,
        "risk_duration": 25146380,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_463",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "463* ACUTE TONSILLITIS",
        "rr": 1.06,
        "risk_count": 32905,
        "predisposition_and_risk": 53,
        "risk_duration": 18602767,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_153.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "153.9* MALIGNANT NEOPLASM OF COLON, UNSPECIFIED",
        "rr": 1.05,
        "risk_count": 14780,
        "predisposition_and_risk": 20,
        "risk_duration": 21937906,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_211.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "211.3* BENIGN NEOPLASM OF COLON",
        "rr": 1.05,
        "risk_count": 43979,
        "predisposition_and_risk": 58,
        "risk_duration": 25654149,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_373.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "373.0* BLEPHARITIS",
        "rr": 1.05,
        "risk_count": 50528,
        "predisposition_and_risk": 77,
        "risk_duration": 19373123,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_379.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "379.2* DISORDERS OF VITREOUS BODY",
        "rr": 1.05,
        "risk_count": 54792,
        "predisposition_and_risk": 85,
        "risk_duration": 19165929,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_379.3",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "379.3* APHAKIA AND OTHER DISORDERS OF LENS",
        "rr": 1.05,
        "risk_count": 42398,
        "predisposition_and_risk": 60,
        "risk_duration": 20977345,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_691.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "691.8* OTHER ATOPIC DERMATITIS AND RELATED CONDITIONS",
        "rr": 1.05,
        "risk_count": 15411,
        "predisposition_and_risk": 19,
        "risk_duration": 27398061,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_788.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "788.4* FREQUENCY OF URINATION AND POLYURIA",
        "rr": 1.05,
        "risk_count": 43404,
        "predisposition_and_risk": 58,
        "risk_duration": 25252584,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_412_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "412 OLD MYOCARDIAL INFARCTION",
        "rr": 1.05,
        "risk_count": 61838,
        "predisposition_and_risk": 101,
        "risk_duration": 18180485,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_440_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "440 ATHEROSCLEROSIS",
        "rr": 1.05,
        "risk_count": 8510,
        "predisposition_and_risk": 11,
        "risk_duration": 22815670,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_461_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "461 ACUTE SINUSITIS",
        "rr": 1.05,
        "risk_count": 44519,
        "predisposition_and_risk": 73,
        "risk_duration": 18084394,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_477_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "477 ALLERGIC RHINITIS",
        "rr": 1.05,
        "risk_count": 37748,
        "predisposition_and_risk": 57,
        "risk_duration": 19595609,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_379.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "379.2* DISORDERS OF VITREOUS BODY",
        "rr": 1.04,
        "risk_count": 89595,
        "predisposition_and_risk": 139,
        "risk_duration": 21605641,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_411.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "411.1* INTERMEDIATE CORONARY SYNDROME",
        "rr": 1.04,
        "risk_count": 41620,
        "predisposition_and_risk": 62,
        "risk_duration": 19606552,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_458.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "458.0* ORTHOSTATIC HYPOTENSION",
        "rr": 1.04,
        "risk_count": 10156,
        "predisposition_and_risk": 12,
        "risk_duration": 28392991,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_578.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "578.1* MELENA",
        "rr": 1.04,
        "risk_count": 44278,
        "predisposition_and_risk": 67,
        "risk_duration": 19409523,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_715.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "715.0* OSTEOARTHROSIS, GENERALIZED",
        "rr": 1.04,
        "risk_count": 8591,
        "predisposition_and_risk": 11,
        "risk_duration": 22856255,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_736.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "736.7* OTHER ACQUIRED DEFORMITIES OF ANKLE AND FOOT",
        "rr": 1.04,
        "risk_count": 8562,
        "predisposition_and_risk": 11,
        "risk_duration": 22782728,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_790.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "790.2* ABNORMAL GLUCOSE TOLERANCE TEST",
        "rr": 1.04,
        "risk_count": 35553,
        "predisposition_and_risk": 52,
        "risk_duration": 19981962,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_918.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "918.1* SUPERFICIAL INJURY OF CORNEA",
        "rr": 1.04,
        "risk_count": 11418,
        "predisposition_and_risk": 15,
        "risk_duration": 22308929,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V43.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V43.1* LENS REPLACED BY OTHER MEANS",
        "rr": 1.04,
        "risk_count": 24682,
        "predisposition_and_risk": 30,
        "risk_duration": 27583430,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z51.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z51.2* CHOLECYSTECTOMY",
        "rr": 1.04,
        "risk_count": 18678,
        "predisposition_and_risk": 25,
        "risk_duration": 21985927,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z87.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z87.0* SOFT TISSUE X-RAY OF FACE, HEAD, AND NECK",
        "rr": 1.04,
        "risk_count": 27230,
        "predisposition_and_risk": 34,
        "risk_duration": 26944652,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z93.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "Z93.8* OTHER REHABILITATION THERAPY",
        "rr": 1.04,
        "risk_count": 13696,
        "predisposition_and_risk": 18,
        "risk_duration": 22371347,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_242_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "242 THYROTOXICOSIS WITH OR WITHOUT GOITER",
        "rr": 1.04,
        "risk_count": 35483,
        "predisposition_and_risk": 47,
        "risk_duration": 25397196,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_278_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "278 OBESITY AND OTHER HYPERALIMENTATION",
        "rr": 1.04,
        "risk_count": 18002,
        "predisposition_and_risk": 22,
        "risk_duration": 27420651,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_595_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "595 CYSTITIS",
        "rr": 1.04,
        "risk_count": 8518,
        "predisposition_and_risk": 11,
        "risk_duration": 22829722,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_D09",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "D09* NAUSEA",
        "rr": 1.04,
        "risk_count": 13649,
        "predisposition_and_risk": 18,
        "risk_duration": 22288494,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L14",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L14* LEG/THIGH SYMPTOMS/COMPLAINTS",
        "rr": 1.04,
        "risk_count": 51611,
        "predisposition_and_risk": 73,
        "risk_duration": 23624184,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_365.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "365.0* BORDERLINE GLAUCOMA (GLAUCOMA SUSPECT)",
        "rr": 1.03,
        "risk_count": 43530,
        "predisposition_and_risk": 56,
        "risk_duration": 25686853,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_384.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "384.2* PERFORATION OF TYMPANIC MEMBRANE",
        "rr": 1.03,
        "risk_count": 8611,
        "predisposition_and_risk": 11,
        "risk_duration": 22806320,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_553.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "553.2* VENTRAL HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "rr": 1.03,
        "risk_count": 31578,
        "predisposition_and_risk": 40,
        "risk_duration": 26169160,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_692.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "692.9* CONTACT DERMATITIS AND OTHER ECZEMA, UNSPECIFIED CAUSE",
        "rr": 1.03,
        "risk_count": 36693,
        "predisposition_and_risk": 53,
        "risk_duration": 20061782,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_784.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "784.4* VOICE DISTURBANCE",
        "rr": 1.03,
        "risk_count": 35206,
        "predisposition_and_risk": 51,
        "risk_duration": 20154321,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_784.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "784.5* OTHER SPEECH DISTURBANCE",
        "rr": 1.03,
        "risk_count": 26469,
        "predisposition_and_risk": 36,
        "risk_duration": 21452086,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_788.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "788.4* FREQUENCY OF URINATION AND POLYURIA",
        "rr": 1.03,
        "risk_count": 69797,
        "predisposition_and_risk": 116,
        "risk_duration": 17508284,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_820.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "820.2* PERTROCHANTERIC FRACTURE OF FEMUR, CLOSED",
        "rr": 1.03,
        "risk_count": 10327,
        "predisposition_and_risk": 12,
        "risk_duration": 28458955,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V70.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V70.0* ROUTINE GENERAL MEDICAL EXAMINATION AT A HEALTH CARE FACILITY",
        "rr": 1.03,
        "risk_count": 21926,
        "predisposition_and_risk": 30,
        "risk_duration": 21267981,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_443_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "443 OTHER PERIPHERAL VASCULAR DISEASE",
        "rr": 1.03,
        "risk_count": 64008,
        "predisposition_and_risk": 105,
        "risk_duration": 17645837,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_532_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "532 DUODENAL ULCER",
        "rr": 1.03,
        "risk_count": 15262,
        "predisposition_and_risk": 20,
        "risk_duration": 22139745,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_S02",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "S02* PRURITUS; SKIN ITCHING",
        "rr": 1.03,
        "risk_count": 18980,
        "predisposition_and_risk": 25,
        "risk_duration": 21960375,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_009.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "009.1* COLITIS,ENTERITIS,GASTROENTERITIS PRESUMED INFECTIOUS ORIGIN",
        "rr": 1.02,
        "risk_count": 47747,
        "predisposition_and_risk": 70,
        "risk_duration": 22334804,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_110.5",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "110.5* DERMATOPHYTOSIS OF THE BODY",
        "rr": 1.02,
        "risk_count": 17535,
        "predisposition_and_risk": 21,
        "risk_duration": 27331538,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "362.1* OTHER BACKGROUND RETINOPATHY AND RETINAL VASCULAR CHANGES",
        "rr": 1.02,
        "risk_count": 56156,
        "predisposition_and_risk": 75,
        "risk_duration": 24562080,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_410.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "410.4* ACUTE MYOCARDIAL INFARCTION OF OTHER INFERIOR WALL",
        "rr": 1.02,
        "risk_count": 17535,
        "predisposition_and_risk": 23,
        "risk_duration": 21986019,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_535.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "535.0* __GASTRITIS____1992 ACUTE",
        "rr": 1.02,
        "risk_count": 31630,
        "predisposition_and_risk": 45,
        "risk_duration": 20152184,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_564.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "564.1* IRRITABLE COLON",
        "rr": 1.02,
        "risk_count": 8622,
        "predisposition_and_risk": 11,
        "risk_duration": 22662913,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_729.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "729.2* NEURALGIA, NEURITIS, AND RADICULITIS, UNSPECIFIED",
        "rr": 1.02,
        "risk_count": 56004,
        "predisposition_and_risk": 80,
        "risk_duration": 22904172,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_E88.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "E88.8* OTHER AND UNSPECIFIED ACCIDENTAL FALL",
        "rr": 1.02,
        "risk_count": 51416,
        "predisposition_and_risk": 75,
        "risk_duration": 19768214,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_346_",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "346 MIGRAINE",
        "rr": 1.02,
        "risk_count": 23304,
        "predisposition_and_risk": 32,
        "risk_duration": 23983574,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_436",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "436* ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE",
        "rr": 1.02,
        "risk_count": 26033,
        "predisposition_and_risk": 35,
        "risk_duration": 21419510,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L92",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "L92* SHOULDER SYNDROME",
        "rr": 1.02,
        "risk_count": 11558,
        "predisposition_and_risk": 15,
        "risk_duration": 22268246,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_266.2",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "266.2* OTHER B-COMPLEX DEFICIENCIES",
        "rr": 1.01,
        "risk_count": 58610,
        "predisposition_and_risk": 97,
        "risk_duration": 17281440,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_333.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "333.1* ESSENTIAL AND OTHER SPECIFIED FORMS OF TREMOR",
        "rr": 1.01,
        "risk_count": 17273,
        "predisposition_and_risk": 20,
        "risk_duration": 28053712,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_367.4",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "367.4* PRESBYOPIA",
        "rr": 1.01,
        "risk_count": 40521,
        "predisposition_and_risk": 62,
        "risk_duration": 18716414,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_592.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "592.1* CALCULUS OF URETER",
        "rr": 1.01,
        "risk_count": 14680,
        "predisposition_and_risk": 19,
        "risk_duration": 21921404,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_703.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "703.8* OTHER SPECIFIED DISEASES OF NAIL",
        "rr": 1.01,
        "risk_count": 15393,
        "predisposition_and_risk": 18,
        "risk_duration": 27703566,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_707.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "707.0* DECUBITUS ULCER",
        "rr": 1.01,
        "risk_count": 39033,
        "predisposition_and_risk": 54,
        "risk_duration": 20621054,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_723.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "723.0* SPINAL STENOSIS IN CERVICAL REGION",
        "rr": 1.01,
        "risk_count": 17476,
        "predisposition_and_risk": 21,
        "risk_duration": 26954152,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_729.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "729.1* MYALGIA AND MYOSITIS, UNSPECIFIED",
        "rr": 1.01,
        "risk_count": 33959,
        "predisposition_and_risk": 49,
        "risk_duration": 19660379,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V49.7",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "V49.7* LOWER LIMB AMPUTATION STATUS",
        "rr": 1.01,
        "risk_count": 18525,
        "predisposition_and_risk": 24,
        "risk_duration": 22006065,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_078.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "078.1* VIRAL WARTS",
        "rr": 1,
        "risk_count": 41661,
        "predisposition_and_risk": 56,
        "risk_duration": 23996728,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_173.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "173.9* OTHER MALIGNANT NEOPLASM OF SKIN, SITE UNSPECIFIED",
        "rr": 1,
        "risk_count": 81837,
        "predisposition_and_risk": 134,
        "risk_duration": 17246544,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_433.1",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "433.1* OCCLUSION AND STENOSIS OF CAROTID ARTERY",
        "rr": 1,
        "risk_count": 51076,
        "predisposition_and_risk": 64,
        "risk_duration": 25777143,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_438.9",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "438.9* UNSP. LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "rr": 1,
        "risk_count": 20283,
        "predisposition_and_risk": 26,
        "risk_duration": 22110552,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_715.0",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "715.0* OSTEOARTHROSIS, GENERALIZED",
        "rr": 1,
        "risk_count": 28161,
        "predisposition_and_risk": 34,
        "risk_duration": 26800019,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_879.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "879.8* OPEN WOUND(S)(MULTIPLE)OF UNSPECIFIED SITE(S),WITHOUT COMPLIC.",
        "rr": 1,
        "risk_count": 19907,
        "predisposition_and_risk": 26,
        "risk_duration": 21697586,
        "predisposition_and_risk_duration": 28218,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_E88.8",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "E88.8* OTHER AND UNSPECIFIED ACCIDENTAL FALL",
        "rr": 1,
        "risk_count": 80689,
        "predisposition_and_risk": 114,
        "risk_duration": 22808848,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_R75",
        "predisposition": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "risk": "R75* SINUSITIS ACUTE/CHRON.",
        "rr": 1,
        "risk_count": 14362,
        "predisposition_and_risk": 17,
        "risk_duration": 27240718,
        "predisposition_and_risk_duration": 32216,
        "type": "ICD9"
      }
    ],
    "figures": null,
    "messageType": "chronicDiseaseCohorts.report",
    "requestId": "9bd19a64-4249-4823-97d2-e126d175e594",
    "cohortId": "c_4e119a7b3d6488e8bfae3b8a184279f2"
  },
  "id": "9bd19a64-4249-4823-97d2-e126d175e594"
}